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Abstract
Membrane-active proteins are a class of proteins that interact with lipid mem-
branes in the body. I study two kinds of membrane-active proteins, antimicrobial
peptides (AMPs) and lung surfactant (LS) proteins. In the first part of my PhD
project I did computer simulation studies with two AMPs, Gaduscidin-1 and -2
(GAD-1 and GAD-2). These peptides are histidine rich and thus expected to exhibit
pH-dependent activity. In this work I have performed molecular dynamics (MD)
simulations with the peptides in both histidine-charged and histidine-neutral forms,
along with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid molecules,
employing GROMACS software and an OPLS-AA force field. My results show a high
tendency for pairs of histidines to interact with pore regions in both histidine-charged
and histidine-neutral simulations. This work is published in Biophysica et Biochimica
Acta (BBA)-Biomembranes (2014).
In the second part of my PhD research I performed computational simulations on
lung surfactant protein B (SP-B) interacting with lipid bilayer. SP-B is a hydropho-
bic protein with 79 residues, from the saposin superfamily. Because of the extreme
hydrophobicity of SP-B, the experimental structure of the protein is unknown. Thus,
I combined the Mini-B (a fragment of SP-B) experimental structure and homology
modelling based on proteins in saposin family to construct my initial model of SP-B.
I run MD (using OPLS-AA and PACE force fields) and replica-exchange MD (using
PACE force field) simulations with GROMACS software. I modelled SP-B in open
and bent (V-shaped) structures, placed within or near a POPC lipid bilayer. My
results demonstrate energetically feasible structures for SP-B, in which salt bridges
ii
play a significant role. My simulations provide hypotheses for how SP-B promotes
the rearrangement of planar lipid bilayers. Part of this work has been accepted for
publication in Biophysica et Biochimica Acta (BBA)-Biomembranes (2016).
In the third part of my project I employed solid state nuclear magnetic resonance
(NMR) using 2H, 31P and 15N experiments, to study SP-B interacting with mechan-
ically oriented lipid bilayer. Here, I used full-length 15N-labelled SP-B, which was
recombinantly expressed in our lab, to find the orientation of protein with respect to
the bilayer. In this part of my thesis, the final goal was to compare the experimental
15N spectra with the spectra, predicted from the structures we got from computa-
tional simulations to help define the protein’s structure. Since, I was not able to gain
15N NMR signals in my SP-B in lipid bilayer experiments, I did not fulfill the final
goal of this part of my project. However, I was able to predict 15N NMR spectra of
my computational SP-B structures. My NMR results indicate that more optimization
needs to be done to modify our SP-B preparation protocol to 1) increase the yields
of isotope-labelled protein and 2) increase the protein:lipid ratio when refolding into
lipids. My simulated 15N spectra indicate that uniform 15N-labelling is unlikely to
constrain SP-B’s structure and topology very much and it will likely be necessary to
use a more specifically labelled sample for these experiments.
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Chapter 1
Introduction
1.1 Overview
In this thesis, I present computational and experimental studies on two types of
membrane active proteins. In this present chapter, I give an overall introduction to the
concepts and methods I use in my thesis. In Chapter 2, I present the computational
study I carried out on two antimicrobial peptide paralogues, GAD-1 and GAD-2,
which are derived from cod fish. The work presented in Chapter 2 has been published
as an article in BBA-Biomembranes [1]. In Chapter 3, I describe my computational
study of the lung surfactant protein, SP-B, interacting with a lipid bilayer. Part of
this chapter has been accepted for publication in BBA-Biomembranes [2]. The goal
of Chapter 4 is to study experimentally with solid state NMR the same SP-B and
bilayer system as in Chapter 3. We present predictions of solid state NMR spectra,
based on structures obtained in Chapter 3, and the experimental eﬀorts to obtain the
NMR spectra.
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1.2 Proteins and Lipids
Proteins are biological macromolecular polymers composed of monomeric units called
amino acids (Figure 1.1). There are 20 diﬀerent amino acids. All of the proteins
in living cells are made of linear sequences of these amino acids. Each amino acid is
made up of a C↵ carbon, which acts as a connector between an amino group (NH2 ),
a carboxyl group ( COOH), a hydrogen atom and an R group, or side chain, which
distinguishes the diﬀerent amino acids. These amino acids polymerize through the
formation of a peptide bond that links the N of the amino group to the C of the
carboxyl group while liberating H2O. As a result, one end of the protein (the N-
terminus) maintains its amino group, while the other end (the C-terminus) maintains
its carboxyl group, unless of course further chemical alteration of the ends takes place.
Traditionally, the amino acid sequence of a protein is written out from left to right,
starting with the N-terminus and ending with the C-termus [3]. In general, if the
number of amino acid residues in the sequence is greater than 2 but less than 50, it
is called a peptide, and if the number of residues exceeds 50, it is called a protein.
Along with proteins, lipids are an important class of molecule in cells, particu-
larly in membranes. Lipids tend to be soluble in non-polar solvents and are water
insoluble [3, 4]. They contain two parts, a hydrophilic head group and hydrocarbon
tail, which is hydrophobic. Depending on the particular lipid, the head group can be
neutral (containing no charge), positively charged, negatively charged or even zwitte-
rionic (containing both positively and negatively charged parts). In most lipids, the
tail contains one or more hydrocarbon chains of potentially diﬀerent length, but some
lipids, such as cholesterol, can have more complex hydrocarbon structures. The am-
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Figure 1.1: The schematic structure of a peptide containing four diﬀerent amino acids.
Here we can see the N- and C-terminals of the peptide, the backbone and residues.
The N-terminus is circled in black, the C-terminus is circled in red, the side chains
(residues) are circled in blue and the rest of the structure is the backbone.
phipathic properties of lipids help them to aggregate and form biological membranes.
1.3 Membrane-active Proteins
The outer layer of the cell is covered by a membrane which is composed of lipid
molecules and proteins. The lipid part of the membrane is responsible for the shape
and the structure of the membrane, while the proteins control the communications
between the inner part of the cell and the regions outside the cell, i.e. signalling and
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channeling across the membrane [5]. While membrane proteins enhance the function-
ality of the membrane, there are other types of proteins, like antimicrobial peptides
(AMPs), that are termed “membane-active” and can interact with the membrane of
target cells to kill them. In addition to cell membranes, there are also other lipid
membranes of biophysical interest. Lung surfactant (LS), a mixture of lipids and
proteins, that allows us to breathe by lowering the surface tension at the air-water
interface within the lung.
As of 10th of April 2016, there are approximately 105 000 protein structures en-
tered in the Protein Data Bank (PDB) [14], including those for approximately 1901
membrane proteins. Among these 1901, only 607 of them are unique proteins [15].
The main problem with membrane proteins is that they are intimately associated with
membranes, and hence technically diﬃcult to determine atomic resolution structures
for them [5].
1.4 Lipid Bilayers
Lipid molecules are composed of two parts, a hydrophilic head group and a hydropho-
bic tail. When placed in water, these molecules, depending on their properties, gen-
erate specific structures to satisfy their hydrophobicity (Figure 1.2). Depending on
the concentration and shape of the lipid molecules (the size of lipid headgroup, the
length of lipid tail and their number), they can self-assemble into small structures,
like micelles, or larger structures, like vesicles and lipid bilayers. Depending on the
experimental methods employed, researchers study membrane-active proteins inter-
acting with diﬀerent lipid structures [7, 27, 29, 30]. For example, so-called solution
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Figure 1.2: The schematic structure of POPC lipid molecule (top) and assembled
lipid bilayer of 128 POPC lipid molecules (bottom). The green spheres represents
the headgroup part of the POPC and the gray lines represents the acyl-chains of the
lipids.
NMR is often done with proteins interacting with micelles. However, the chief goal
is to determine structure and function of the protein while it is in its physiologically
relevant environment.
In biological settings, membranes consist of mixtures of diﬀerent kinds of lipids.
A model lipid membrane chosen for a protein study, whether in simulation or ex-
periment, should ideally represent the essential features of the biological system, be
technically expedient for carrying out the study, and be as simple as possible. Here
I provide some background motivating my choice of lipid.
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Bacterial membranes mainly consist of lipids with phosphatidylglycerol (PG) and
phosphatidylethanolamine (PE) headgroups, which are negatively charged and zwit-
terionic, respectively [10]. There is a variety of acyl chains encountered in bacterial
membranes: saturated, unsaturated, single-chained, double-chained, short, long etc.
POPC’s zwitterionic headgroup is representative of headgroups in bacterial mem-
branes and its acyl chains are not uncharacteristic of the same.
In lung surfactant, 80% of lipids are zwitterionic phosphocholine (PC) lipids, and
half of these are 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC) [11] (40%
of lipid content). Another major component of lung surfactant lipid is 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) [13]. In addition to PC lipids, there
are 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) lipids in lung surfac-
tant [13]. POPC and POPG have the same two acyl-chains, a saturated chain with
16 carbons and an unsaturated chain with 18 carbons (Figure 1.2-A), but in DPPC
both of the acyl-chains are saturated and have 16 carbon atoms. The saturated acyl-
chains makes the DPPC lipid highly ordered and tightly packed as a bilayer, which
causes its gel-to-liquid transition temperature to be rather high at 42 C, rendering
it immobile (i.e. lipids do not diﬀuse) at body temperatures. Thus, POPC is a good
model lipid in the context of lung surfactant studies, since it combines a common
headgroup (PC) and common acyl chain (PO), and is mobile.
I use POPC for all the studies in this thesis: simulation of GAD-1 and GAD-2
AMPs, simulations of lung surfactant protein SP-B and solid state NMR experiments
on SP-B. POPC is a commonly used model membrane in the context of simulations
of protein-lipid interactions, since the force fields used to describe it reproduce ex-
perimental results with reasonable accuracy. In the solid state NMR experiments,
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the fact that POPC is zwitterionic makes it significantly easier to prepare oriented
samples using mica plates.
1.5 AMPs
Antimicrobial peptides have a key role in the immune systems of many diﬀerent or-
ganisms, from humans to fish to insects [16–18]. In general, these peptides are amphi-
pathic (having hydrophilic and hydrophobic faces) and cationic (positively charged)
in nature [19], and thus, well suited to interactions with phospholipid bilayers. The
cationic nature of AMPs helps them to interact with charged head groups of mem-
branes while their amphipathicity helps them to interact with fatty acyl-chains. The
positive charge of the AMPs facilitates their interaction with anionic lipids, such as
those in bacterial membranes, but in high concentrations they are also toxic to mam-
malian cell membranes, even though these membranes are less anionic, in that they
contain a smaller percentage of negatively charged residues. There are other studies,
where in addition to the role of AMPs in the innate immune system, they are scruti-
nized for their potential to be used as a treatment for drug resistant infections [24–26]
and cancer [27,28,42].
Nguyen et al. [20] recently reviewed 20 diﬀerent ways of how AMPs interact with
the membrane of their target bacteria (Figure 1.3). In their work, they give account
of the importance of secondary structure for how AMPs interact with their target,
which can be either the membrane itself or elements in the interior of the cell, such
as DNA. Extended AMPs, which do not have a regular secondary structure, usually
interact with lipid intracellular targets and do not disturb the lipid membrane [20].
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Figure 1.3: Example ways of ↵-helical AMPs interacting with lipid bilayers. A)
Toroidal pore, B) Barrel stave, C) Carpet model, D) Membrane thinning and E)
Charged lipids clustering. Figure is inspired from Ref. 20.
Figure 1.3 shows examples of how ↵-helical AMPs can interact with lipid bilayers,
including forming pores. The length of ↵-helical AMPs is usually long enough to allow
simultaneous interaction with both leaflets of a lipid membrane. Figure 1.3-A shows
a toroidal pore, for which lipid headgroups are interspersed between the peptides as
they form a curved pore lining. Depending on the amphipathicity of the ↵-helices,
they can alternatively produce a so-called barrel stave, for which the hydrophilic
parts of the AMPs face towards the water and the hydrophobic parts face towards
the lipid acyl-chains (Figure 1.3-B). In high concentrations, AMPs can completely
disrupt the membrane, making micelle-like lipid structures and leaving big pores
behind in the membrane (Figure 1.3-C). ↵-helical AMPs can also induce membrane
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thinning through localization on the bilayer surface (Figure 1.3-D), which may help
initiate pore formation. Membrane thickening is also possible. The AMPs can change
the distribution of charged lipids by attracting anionic lipids (Figure 1.3-E). The
resulting clustering of anionic lipids may in turn aﬀect the stability of the membrane.
As my simulations will show, GAD AMPs exhibit heterogenous structure with
varying degrees of helicity, and thus do not necessarily follow the classical ↵-helical
AMP picture. The diﬀerent ways in which the polymorphic or disordered character-
istics of the GAD AMPs allow them to interact with planar and pore-like portions of
lipid bilayers is the subject of Chapter 2. The work described in Chapter 2 has been
published in Biochimica et Biophysica Acta (BBA) - Biomembranes.
1.6 Lung Surfactant
Lung surfactant, a complex mixture of lipids and proteins, is found at the surface of
the water film that lines the air sacs (alveoli) of the lungs. Lung surfactant prevents
the lungs from collapsing by decreasing the surface tension at the air-water interface
within alveoli, and thus allows us to breathe. Its action greatly decreases the eﬀort
required of breathing muscles, i.e. the diaphragm and intercostal muscles of the rib
cage [12].
To help understand the physics behind breathing, we present a simple model of
the lung in Figure 1.4-A, where we represent the lung as a single spherical alveolus
and the thoracic cavity as a box around it. We need to introduce the Young-Laplace
equation to help explain the role of LS. It relates pressures inside and outside a
bubble-like object in mechanical equilibrium with the so-called Laplace pressure that
9
arises from surface tension,
 Pi,c = Pi   Pc = 2 
R
, (1.1)
where Pi is the pressure inside the alveolus, Pc is the pressure outside the aveoulus
(the so-called intrapleural pressure of the thoracic cavity),  Pi,c is the diﬀerence
between the two, R is the radius of the air sac, which is approximately 100 µm in
diameter [31], and   is the surface tension. In equilibrium,   is about 25 mN/m [11],
which through Equation 1.1 gives 2 /R = 500 N/m2 ' 4 mmHg. Thus, Pi needs to
be greater than Pc by this amount in order to balance the tendency of surface tension
to shrink the alveolus. In actual fact, Pc is generally below atmospheric pressure (a
gauge pressure of roughly -5 mmHg in equilibrium) [12], and this prevents the lung
from collapsing. One should note that lung function requires the pressure inside the
air sacs to be very near to atmospheric pressure [29].
In a typical breathing cycle, contraction of the breathing muscles during inhala-
tion increases the volume of the chest cavity, which decreases Pc from -5 mmHg to
-10 mmHg. In response, the lung expands and Pi becomes slightly lower than atmo-
spheric pressure. This lower value of Pi allows air to flow into the lung. Here, we
seem to have a contradiction: R has increased, implying that 2 /R has decreased,
and yet  Pi,c has increased. The answer to this puzzle is that  , in fact, increases as
R increases.
Of course this simple view neglects the complex dynamics of breathing. However,
it does provide a rationale for why it is beneficial that   should increase as R increases.
Physically,   increases because the surfactant area concentration decreases as an
alveolus expands.
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Figure 1.4: Schematics of lungs. A) Schematic steps in breathing, and B) Pair of
diﬀerent attached alveoli. The irregular hexagon represent the thoracic cavity and the
circle represents an alveolus. Patm represents atmospheric pressure, Pi represents the
pressure inside the alveoli and Pc represents the intrapleural cavity pressure. During
inhalation the volume of thoracic cavity increases, which decreases the intrapleural
pressure (A-left), while during exhalation the volume of thoracic cavity decreases,
which increases the intrapleural pressure (A-right).
During exhalation, the breathing muscles relax in order to decrease the volume of
the chest cavity, which increases Pc up to a maximum of nearly atmospheric pressure.
In response, the lung shrinks and the pressure inside the lung becomes slightly above
atmospheric pressure (roughly +1 mmHg) [12]. This higher value of pressure inside
the lung produces an air flow out of the lung. At the end of exhalation,  Pi,c has
decreased through nearly 0. If the alveolus is to remain in mechanical equilibrium,
and not collapse because of the Laplace pressure,   must also approach zero. This
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occurs in the shrinking alveolus as the surfactant area concentration increases.
To further appreciate the role of the surface tension’s flexibility in alveoli, we
should study the behaviour of two connected alveoli, schematically represented in
Figure 1.4-B. Using Equation 1.1, we have:
 P1,c = P1   Pc = 2 1
R1
,
 P2,c = P2   Pc = 2 2
R2
.
Assuming constant  , P2>P1 since R2 is smaller than R1, and hence the air inside the
smaller alveolus should flow into the bigger one, causing the smaller one to collapse
and the bigger one to possibly burst. However, if   decreases with the decreasing R,
then  2 could be nearly 0 while  1 has a non-zero, positive value. Then, based on
Equation 1.1,
 P2,c = P2   Pc ' 0 ! Pc = P2,
 P1,c = P1   Pc = P1   P2 = 2 1
R1
> 0.
Thus P1>P2, and air flows from alveolus 1 into alveolus 2, which equilibrates the
pressure inside the lungs.
There are four diﬀerent types of surfactant proteins, SP-A, SP-B, SP-C and SP-
D. SP-A and SP-D are hydrophilic proteins, while SP-B and SP-C are hydrophobic
proteins. SP-B is an essential protein for life, without which we can not breathe [32].
Despite its importance, its 3D structure is unknown and therefore its mechanism of
action is poorly understood.
The second part of my research is devoted to studying SP-B, both computationally
and experimentally. Chapter 3 describes molecular dynamics and replica-exchange
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molecular dynamics simulations of SP-B interacting with a POPC lipid bilayer. I
use two force fields, an all-atom force field (OPLS-AA) and a potential that em-
ploys coarse-graining (PACE) in hopes of increasing the speed of simulations without
losing essential physics. The parts related to the all-atom force field simulations of
Chapter 3 are accepted to be published in Biochimica et Biophysica Acta (BBA) -
Biomembranes. In Chapter 4, I present my solid state NMR experiments on SP-B
in a mechanically oriented lipid bilayer, as well as predictions of NMR spectra from
simulations.
1.7 Methods
1.7.1 MD Simulations
Molecular dynamics simulation is a computational technique to simulate N-body sys-
tems, e.g. biomolecular systems, and compute their equilibrium and transport prop-
erties [43]. In MD simulations we solve Newton’s equations of motion for each particle
in our system,
mi
@2ri
@t2
= Fi, i = 1, · · · , N, (1.2)
where ri is the position of particle i, N is the number of particles in the system and
the force and Fi is the net force on particle i.
Solving the coupled system of ordinary diﬀerential equations in Equation 1.2
provides us with both the position and velocity of each particle at every time step,
which generates the “trajectory” of system configurations that is useful for further
structural analysis. To solve the equations of motion, we need to use an appropriate
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numerical method, i.e. one that is reasonably accurate and computationally fast. The
Verlet algorithm [44,45] is often used as it produces reasonably accurate trajectories
for short times and conserves energy at long times.
The potential energy governing the interactions between atoms in the system is
specified by a so-called “force field”. The diﬀerences between force fields emerge from
diﬀerent approaches used for approximating the essentially quantum mechanical in-
teractions between atoms with classical pair potentials. A force field models both
non-bonded interaction, i.e. Coulombic and van der Waals forces, and bonded inter-
action, i.e. angular, translational and torsional harmonic interactions. Each kind of
interaction is described by a particular functional form and a set of parameters that
characterize a particular atomic species. In our simulations we employ a version of the
all-atom Optimized Potential for Liquid Simulations (OPLS-AA) force field [46, 47]
adapted for POPC lipid molecules [48].
Additionally, depending on the stage of our simulation protocol, we run our sys-
tems under NVT (Canonical) or NPT (isothermal-isobaric) ensembles. For the NVT
ensemble, the number of particles (N), volume of the system (V) and temperature of
the system (T) are held constant. Similarly, under the NPT ensemble, the number
of particles, pressure of the system (P) and temperature are held constant. To keep
the pressure and the temperature constant, one uses pressure couplings (barostats)
and temperature couplings (thermostats), respectively. The two main thermostats
that are frequently being used in MD simulations are the Berendsen [49] and Nose-
Hoover schemes [50,51]. The Berendsen thermostat is simpler, and works by rescaling
velocities so that their average approaches what is expected from the equipartition
theorem; it does not rigorously recover the canonical ensemble. In my simulations,
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I use Nose-Hoover thermostat, in which the Hamiltonian of the system is extended
by adding a coordinate that is coupled to the particle coordinates and the equation
of motion of which depends on the temperature. This term works as an oscillatory
damping term, which keeps the temperature of the system constant and ensures en-
ergy fluctuations follow those of the canonical ensemble [41]. The two main barostats
being used in MD simulations are Berendsen algorithm [49] and Parrinello-Rahman
approach [34, 35]. The Berendsen barostat rescales the simulation box (and particle
coordinates commensurately) so that the desired pressure is approached. Here, I em-
ploy Parrinello-Rahman barostat, which theoretically provides true NPT ensemble,
to run my simulation. This approach is similar to Nose-Hoover thermostat scheme,
in which it uses oscillatory damping method to keep the pressure constant.
The advantage of using classical MD simulations is being able to determine the po-
sitions and velocities of all particles in the system for relatively long times. However,
since we are using classical equations of motion, we can not simulate any strongly
quantum mechanical behaviour, such as hydrogen atom motion or H-bond vibrations
in our system. Thus, the modelling of certain intramolecular interactions is simplified
by replacing vibrational degrees of freedom with constraints, e.g. water molecules are
treated as rigid V-shaped objects decorated with interaction sites. Moreover, using
classical force fields one obviously can not calculate electronic properties. There are
other limitations in MD simulation arising from limitations in computing power. The
simulation box size is usually limited to contain at most few million atoms because of
the sheer number of calculations required for this number of atoms. The duration of
simulations for large systems, i.e. more than hundreds of thousands particles, is usu-
ally limited to less than a few microseconds, which is short compared to the duration
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of experiments.
One of the fastest packages for running MD simulations [55] is GROningen MA-
chine for Chemical Simulations (GROMACS), which is designed to work with diﬀer-
ent force fields. GROMACS is a free engine for classical MD simulations and energy
minimizations of biological systems like lipids, proteins and nucleic acids in various
environments, e.g. aqueous media. I use this package to run my simulations.
1.7.2 Force Fields
Each force field has two main parts: 1) equations of a particular mathematical form
that describe potential energies needed to generate forces and equations of motion and
2) parameters within these equations that are tuned so that the physical properties of
the simulated system are comparable with experimental results [41]. In GROMACS,
the equations for potential energies are divided into those for non-bonded forces, and
those for bonded forces.
Non-bonded forces, e.g. Lennard-Jones (LJ) and Coulomb forces, act between
atoms that are either on diﬀerent molecules or suﬃciently far apart on the same
molecule. For computational eﬃciency, interaction between non-bonded atoms are
explicitly calculated only up to a finite cutoﬀ distance. In GROMACS, these forces
and potentials are pair-additive and centro-symmetric:
V (r1, · · · , rN) =
X
i<j
Vij(rij) (1.3)
Fi =  
X
j
dVij(rij)
drij
rij
rij
(1.4)
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V represents the potential energy of the system, Vij represents the potential energy
between two particles i and j, rij is the distance between particle i and particle j
and rij represents the vector from particle j to particle i. Within OPLS-AA, the LJ
potential is formulated as,
Vij(rij) = 4✏ij
"⇣ ij
rij
⌘12   ⇣ ij
rij
⌘6#
, (1.5)
where ✏ij and  ij are parameters. Each particle i has an associated  i and ✏i depending
on its type. These parameter values are explicitly given in OPLS-AA. OPLS-AA then
uses geometrical combination rules to find the values for LJ constants,  ij = ( i j)1/2
and ✏ij = (✏i✏j)1/2.
For charged particles in the system, the Coulomb potential describes their inter-
action,
Vc(rij) =
f
"r
qiqje2
rij
=
1
4⇡"0"r
qiqje2
rij
, (1.6)
where e is electron charge, qi is the elementary charge of atom i, "0 is the permitivity
of free space and the relative dielectric constant "r is set to unity in our case [56].
Because of the long-range nature of Coulomb interaction, it is insuﬃcient to simply
employ a radial cutoﬀ and therefore necessary to express the Coulomb energy of
the system using Ewald summations [57] in order to calculate periodic electrostatic
interactions. In the Ewald algorithm, the slow convergence of the energy with distance
due to the 1/r form of the Coulomb interaction is dealt with by a clever mathematical
reformulation of the system energy that involves reciprocal space sums. The Coulomb
energy of a system of N particles embedded in an infinite array of periodic images is
given by,
V =
f
2
X
nx
X
ny
X
nz
NX
i
NX
j
0 qiqj
rij,n
= Vdir + Vrec + V0. (1.7)
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For a cubic simulation simulation box, ~rij,n = ~rij + L(nx, ny, nz) points from particle
j to particle i in the periodic image of the simulation cell located at L(nx, ny, nz),
and rij,n is its magnitude. nx, ny and nz are integers. The prime on the summation
indicates that the terms with i = j are omitted when n = (0, 0, 0). The direct space,
reciprocal space and self-energy correction terms are given, respectively, by,
Vdir =
f
2
NX
ij
X
nx
X
ny
X
nz
0
qiqj
erfc( rij,n)
rij,n
(1.8)
Vrec =
f
2⇡Vc
NX
ij
qiqj
X
mx
X
my
X
mz⇤
exp ( (⇡m/ )2 + 2⇡im.(ri   rj))
m2
(1.9)
V0 =   f p
⇡
NX
i
q2i , (1.10)
where   is a parameter that controls how much weight is given to the direct potential
and reciprocal potentials, erfc(x) is the complementary error function, Vc is the volume
of the simulation cell, m = (mx,my,mz) is the reciprocal space index (integer) vector
and the star indicates that the m = (0, 0, 0) term is omitted. While the energy is
invariant with respect to   in the infinite limit,   is chosen so that a relatively short
radial cutoﬀ can be safely employed in the direct space sum while using as few terms
as possible in the reciprocal space sum. In practice, especially for large systems,
refined versions of this algorithm that make use of fast Fourier transforms, such as
the particle mesh Ewald algorithm [58] are employed.
In the family of bonded interactions, there are the bond stretching (2-body), the
bond angle (3-body) and the dihedral bond angle (4-body) interactions (Figure 1.5).
A harmonic potential is introduced for the bond stretching interaction between two
particles:
Vb(rij) =
1
2
kij(rij   bij)2, (1.11)
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where k is the spring constant and b is the bond length in equilibrium. In simulations,
other terms are needed to calculate the energetics of the system more realistically and
accurately. The bond angle interactions between triplets of particles can be modelled
i" j" θ"
i"
j"
k"
i"
j"
k"
l"
A! B! C!
Figure 1.5: sketch of 3 types of bonded interactions. A) bond stretching, B) angle
vibration and C) proper dihedral angle.
with simple harmonic potential,
Va(✓ijk) =
1
2
kijk(✓ijk   ✓0ijk)2, (1.12)
where i, j, k are the particle indices, k is the angle constant and ✓0 is the angle in
equilibrium.
The proper dihedral angle torsional interaction is often described with a periodic
function:
Vd( ijkl) = k(1 + cos(n    s)), (1.13)
or Ryckaert-Bellemans function:
Vrb( ijkl) =
5X
n=0
Cn(cos( ))
n, (1.14)
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where  = –180 .
In OPLS-AA the torsional energy is expressed by a third-order Fourier expansion:
Etorsion =
X
i
V1,i
2
[1+cos( i+f1,i)]+
V2,i
2
[1  cos(2 i+f2,i)]+ V3,i
2
[1+ cos(3 i+f3,i)],
where i represents each dihedral angle,  i is the dihedral angle, V1, V2, and V3 are the
coeﬃcients in the Fourier series, and f1, f2, and f3 are phase angles [56].
Depending on the simulation, one can use all-atom, united-atom or coarse grained
force fields. An all-atom force field treats every atom explicitly and applies detailed
equations of motions to all of the particles in the system. Simulations based on these
detailed force fields are time consuming. OPLS-AA is the all-atom force field I use in
my simulations. United-atom force fields treat all the particles in detail, except for
the terminal methyl and methylene bridges, where C and H atoms are combined as a
single bead. In coarse-grained force fields, the system is represented by beads, with
each bead representing a group of particles, e.g. in the MARTINI [59] force field every
four water molecules are represented with one bead, while for most other molecules
constitute every four heavy atoms (e.g. C and/or N) is one bead, and H atoms are
mainly ignored. Using coarse-grained force fields lowers the simulation time at the
expense of losing details of the simulation.
1.7.3 REMD Simulations
Replica exchange molecular dynamics (REMD) is a method to help us sample the
configurational space of the system more eﬃciently. In this method we simulate the
same system at diﬀerent temperatures (diﬀerent replicas of our sample) at the same
time. The idea behind this method is to randomly exchange the atomic configurations
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between replicas. The probability of accepting an exchange of configurations between
two replicas is given by [41],
P (i$ j) = min
 
1, exp
✓
1
kBTi
  1
kBTj
◆
(Vi   Vj)
 !
, (1.15)
where Ti and Tj are the temperatures and Vi and Vj are the potential energies of
the two replicas i and j at the time of exchange. In this method, after exchanging
the replicas, the velocities of particles are scaled by the factor of (Ti/Tj)±0.5. In each
step, the REMD method employed by GROMACS performs exchanges only between
one of the two neighbouring replicas. As an example if we have system 0, 1, 2 and
3 in the first step of exchange we have 0-1 and 2-3 exchange attempts, while in the
second step we have 1-2 exchange attempt and this continues during the simulation.
In between exchange attempts, the system evolves according to regular MD. The
number of MD steps between exchange attempts is typically 100 steps. The number
of exchange attempts should be calibrated in a way that the acceptance ratio to be
roughly 20–30% to get higher eﬃciency [60].
To optimize the sampling of configurations between replicas over the range of
temperature used, the replicas should be assigned temperatures according to an ex-
ponential distribution [61]:
Ti = T0 ⇥ exp(k ⇥ i), (1.16)
where i is the number of replica, Ti is the temperature of each replica, T0 is the
temperature of the first replica and k is a constant value proportional to the total
number of replicas, calculated using k = 1Nrep ln
⇣
Tf
T0
⌘
, where Tf is the temperature of
the final replica and Nrep is the total number of replicas.
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1.7.4 Solid State NMR
Solid-state nuclear magnetic resonance (SSNMR) is a spectroscopic technique for
structural and dynamical studies of biological systems e.g. lipid bilayers and mem-
brane proteins. Using diﬀerent labelling isotopes like 15N and 2H on the target systems
like proteins and lipid acyl chains and using the 31P spectra [62] of phosphorus head-
groups of lipid membranes can give us precious information about the structure and
dynamics of the system. The Hamiltonian of the system can be written as [63]:
H = H0 +Hdip +Hquad +HCS + · · · , (1.17)
where H0 is the Zeeman eﬀect Hamiltonian, Hdip is the Hamiltonian of dipolar inter-
actions, Hquad is the Hamiltonian of quadrupolar interactions and HCS is the chemical
shift due to local chemical shielding interactions in the system.
The 2H-labelling of carbons in lipid acyl-chains gives us information about the
order parameter of the bilayers based on quadrupolar interactions of deuterium (2H)
in a magnetic field. Here, the smaller the splitting, the lower the order parameter,
which indicates greater fluctuation of the lipid chains. Usually, in the acyl-chain the
methylene groups (CH2) nearer to the lipid head group are more ordered and the
order parameter decreases, when reaching to the methyl group (CH3).
In addition to 2H SSNMR experiments, the 31P spectra of phosphorus atoms in
lipid headgroups also provide us information on the orientation of lipid bilayers. This
method uses the chemical shift anisotropy of 31P.
Besides 2H and 31P SSNMR experiments, using 15N chemical shifts can give us
information about the structure and orientation of a protein in a lipid bilayer [30,31].
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Similar to 31P experiments, here, we use the chemical shift anisotropy of 15N. Since
there are low amounts of the 15N nuclei in experiments, using cross-polarization (CP)
method we can enhance the signal to noise ratio in our experiments. In CP the
polarization from frequent nuclei, e.g. 1H, is transferred to dilute nuclei such as 15N.
As a part of my research, I studied orientation and conformation of SP-B in
an oriented bilayer (mechanically oriented bilayer supported on mica sheets) using
solid state NMR. In chapter 4 I will give a general overview of how I employ NMR
experiments in our project.
1.7.5 Homology Modelling
Homology modelling is a technique to predict the structure of a protein using ho-
mologous proteins, i.e., proteins with a common ancestor and hence similar amino
acid sequences. Some early uses of this method can be found in papers by Perutz
et al. [33, 34], where they discuss how to use the 3D structure of similar amino acid
regions in horse oxyhaemoglobin and sperm whale myoglobin proteins to predict the
yet unknown structure of haemoglobin. A more systematic study of the relationship
between sequence identity and protein structure by Chothia et al. [35] indicated that
to have a reasonably well predicted structure, the sequence identity of the protein
and homologue should be > 50%. Sequence identity refers to the fraction of positions
in the amino acid sequences of two proteins that have the same amino acid residue.
Through the years, homology modeling has improved. Recently, Sadowski et al. [36]
introduced their method, in which the two protein could have only 35-40% sequence
identity to produce a homology model. The SWISS-MODEL [37–40], which is a fre-
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quent model to run homology modelling (http://swissmodel.expasy.org), employs the
Sadowski et al. [36] method in their model.
1.8 Helicity Calculation
A hydrogen bond is an electrostatic interaction between a hydrogen attached to a
highly electronegative atom, i.e. fluorine, oxygen or nitrogen, and a nearby highly
electronegative atom. In the protein backbone, CO of amino acid i can make a
hydrogen bond with NH of amino acid j. Depending on the patterns appearing
in the repetition of hydrogen bonds (H-bonds) in the sequence, there are methods
to identify the secondary structure of the protein based on the hydrogen bonding
patterns.
Generally, proteins can take on ↵-helical,  -strands and sheets, 310-helix, ⇡-helix,
turn and random coil structures. Since our proteins mainly contain ↵-helical struc-
tures, we focus on this structure. For an ↵-helix (which is usually a right handed
helix), the CO of amino acid i makes a hydrogen bond with the NH of amino acid
i+4, and thus in each turn of the helix, there are 3.6 amino acids.
The main two methods of calculating the secondary structure of a protein are
STRuctural IDEntification (STRIDE) [66] and the Definition of Secondary Structure
of Protein (DSSP) [67,68]. The DSSP method is the most common method in calcu-
lating secondary structure of a protein. This method uses the electrostatic hydrogen
bond’s energy between the CO and NH groups in the protein to define the structure.
Here, the CO and NH groups have partial charges: + q1 and – q1 for CO and – q2
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and + q2 for NH. The hydrogen bond energy in kcal/mol is represented as:
E = q1q2
✓
1
r(ON)
+
1
r(CH)
  1
r(OH)
  1
r(CN)
◆
⇥ f, (1.18)
where q1=0.42e and q2=0.20e, with e being proton charge, r(ij) in Å is the distance
of atom i from atom j and f=332 kcal Å/mol is a dimensional factor. The energy
for a perfect H-bond is about -3 kcal/mol and a perfect N–O distance is d=2.9 Å.
However, this method uses the cutoﬀ energy of E  -0.5 kcal/mol, which corresponds
to d up to 5.2 Å when we have perfect alignment of CO and NH, i.e. ✓ (the angle
between CO and NH)' 0, or d=2.9 Å when ✓ changes up to 63 .
For example, in this method, to have an ↵-helical structure in a fragment of
protein, between i, i+3 AAs, we should have an H-bond between i-1, i+3 and i,
i+4 (no additional information about i+1 and i+2 is needed). GROMACS uses this
method to calculate the secondary structure of the protein.
The STRIDE model uses a more complex method to calculate the secondary
structure of the protein. This method uses terms related to the properties of each
specific amino acid. The H-bond energy is represented as:
Ehb = Er ⇥ Et ⇥ Ep, (1.19)
where Er is a function of distance, and Et and Ep are functions of angles in the
backbone (dihedral properties). In this method, if i, i+4 and i+1, i+5 satisfy the
conditions for having hydrogen bonds, this method labels i+1, i+2, i+3 and i+4
as ↵-helical region (no additional information about i+2 and i+3 is needed). VMD
program uses STRIDE as the default helicity calculator method.
25
Bibliography
[1] Khatami, M. H., Bromberek, M., Saika-Voivod, I., Booth, V. “Molecular dy-
namics simulations of histidine-containing cod antimicrobial peptide paralogs
in self-assembled bilayers” (2014) BBA - Biomembranes 1838, 2778-2787.
[2] Khatami, M. H., Saika-Voivod, I., Booth, V. “All-atom Molecular Dynamics
Simulations of Lung Surfactant Protein B: Structural Features of SP-B Promote
Lipid Reorganization” (in press 2016) BBA - Biomembranes.
[3] Wallace, R. A., Sanders, G. P. and Ferl, R. J. “Biology: The science of life”
(1990) (third edition), Harper Collins.
[4] Voet, D., Voet, J. G., and Pratt, C. W. “Fundamentals of Biochemistry ” (2005)
(second edition), John Wiley & Sons, Inc.
[5] Pebay-Peyroula, E. “Biophysical Analysis of Membrane Proteins: Investigating
Structure and Function” (2008) WILEY-VCH.
[6] Bechinger, B., Resende, J. M., Aisenbrey, C. “The structural and topologi-
cal analysis of membrane-associated polypeptides by oriented solid-state NMR
spectroscopy: established concepts and novel developments” (2011), Biophys
Chem, 153, 115-25.
26
[7] Sanders, C. R. and Sonnichsen, F. “Solution NMR of membrane proteins: prac-
tice and challenges” (2006) Magn Reson Chem, 44 Spec No, S24-40.
[8] Kandasamy, S. K., Lee, D. K., Nanga, R. P., Xu, J. Santos, J. S., Larson, R.
G., Ramamoorthy, A. “Solid-state NMR and molecular dynamics simulations
reveal the oligomeric ion-channels of TM2-GABA(A) stabilized by intermolec-
ular hydrogen bonding” (2009), Biochim Biophys Acta, 1788, 686-95.
[9] Baoukina, S. and Tieleman, P. D. “Lung Surfactant Protein SP-B Promotes
Formation of Bilayer Reservoirs from Monolayer and Lipid Transfer between
the Interface and Subphase” (2011) Biophysical Journal, 100, 1678-1687.
[10] Epand, R. F., Savage, P. B., Epand, R. M. “Bacterial lipid composition and
the antimicrobial eﬃcacy of cationic steroid compounds (Ceragenins)” (2007)
Biochimica et Biophysica Acta 1768 2500-2509.
[11] Veldhuizen, R., Nag, K., Orgeig, S., Possmayer, F. “The role of lipids in pul-
monary surfactant” (1998) Biochimica et Biophysica Acta 1408 90-108.
[12] Khanorkar, S. V. “Insights in Physiology” (2012) JP Medical Ltd.
[13] Yu, S. H., Possmayer, F. “Lipid compositional analysis of pulmonary surfac-
tant monolayers and monolayer-associated reservoirs” (2003) Journal of Lipid
Research 44, 621-629.
[14] Protein data bank current holdings structures:
http://www.rcsb.org/pdb/statistics/holdings.do (accessed: 10/04/2016).
[15] Membrane proteins of known structure:
27
http://blanco.biomol.uci.edu/mpstruc/ (accessed: 10/04/2016).
[16] Yi, H. Y., Chowdhury, M., Huang, Y. D., Yu, X. Q. “Insect antimicrobial
peptides and their applications” (2014) Appl Microbiol Biotechnol. 98(13), 5807-
22.
[17] Rajanbabu, V., Chen, J. Y. “Applications of antimicrobial peptides from fish
and perspectives for the future” (2011) Peptides 32(2), 415-420.
[18] De Smet, K., Contreras, R. “Human antimicrobial peptides: defensins, catheli-
cidins and histatins” (2005) Biotechnol Lett. 27(18), 1337-47.
[19] Wang, G., Li, X. and Wang, Z. “APD2: the updated antimicrobial peptide
database and its application in peptide design” (2009) Nucleic Acids Res 37,
D933-D937.
[20] Nguyen, L. T., Haney, E. F. and Vogel, H. J. “The expanding scope of antimi-
crobial peptide structures and their modes of action” (2011) Trends Biotechnol
29, 464-472.
[21] Zasloﬀ, M. “Antimicrobial peptides of multicellular organisms” (2002) Nature
415, 389-395.
[22] Brogden, K. A. “Antimicrobial peptides: pore formers or metabolic inhibitors
in bacteria?” (2005) Nature Reviews Microbiology 3, 238-250.
[23] Bechinger, B. and Salnikov, E. S. “The membrane interactions of antimicrobial
peptides revealed by solid-state NMR spectroscopy” (2012) Chem Phys Lipids
165, 282-301.
28
[24] Seo, M. D., Won, H. S., Kim, J. H., Mishig-Ochir, T. and Lee, B. J. “Antimi-
crobial peptides for therapeutic applications: a review.” (2012) Molecules 17,
12276-12286.
[25] Yeung, A. T., Gellatly, S. L. and Hancock, R. E. “Multifunctional cationic host
defence peptides and their clinical applications” (2011) Cell Mol Life Sci 68,
2161- 2176.
[26] Rossi, L. M., Rangasamy, P., Zhang, J., Qiu, X. Q. and Wu, G. Y. “Research
advances in the development of peptide antibiotics” (2008) J Pharm Sci 97,
1060-1070.
[27] Hoskin, D. W. and Ramamoorthy, A. “Studies on anticancer activities of an-
timicrobial peptides” (2008) Biochim Biophys Acta 1778, 357-375.
[28] Al-Benna, S., Shai, Y., Jacobsen, F. and Steinstraesser, L. “Oncolytic activities
of host defense peptides” (2011) Int J Mol Sci 12, 8027-8051.
[29] Possmayer, F. “Physicochemical Aspects of Pulmonary Surfactant ” (1998)
(Chapter 115). Fetal and Neonatal Physiology. 2nd ed. R.A. Polin, and W.W.
Fox. Philadelphia, PA: W.B. Saunders Company. 1259-1275.
[30] Blom, J. A. “Monitoring of Respiration and Circulation” (2004) CRC Press.
ISBN 978-0-8493-2083-5.
[31] Ochs, M., Nyengaard, J. R., Jung, A., Knudsen, L., Voigt, M., Wahlers, T.,
Richter, J., Gundersen, H. J. G. “The number of alveoli in the human lung”
29
(2004) American journal of respiratory and critical care medicine 169 (1), 120-
4.
[32] Wert, S. E., Whitsett, J. A., Nogee, L. M. “Genetic disorders of surfactant
dysfunction” (2009) Pediatric and Developmental Pathology 12 (4), 253-74.
[33] Pertutz, M. F. “Structure and function of haemoglobin: I. A tentative atomic
model of horse oxyhaemoglobin” (1965) J. Mol. Biol. 13, 646-668.
[34] Pertutz, M. F. “Structure and function of haemoglobin: II. Some relations be-
tween polypeptide chain configuration and amino acid sequence” (1965) J. Mol.
Biol. 13, 669-678.
[35] Chothia, C., Lesk, A. M. “The relation between the divergence of sequence and
structure in proteins” (1986) EMBO J. 5(4), 823-826.
[36] Sadowski, M. I., Jones, D. T. “Benchmarking template selection and model
quality assessment for high-resolution comparative modeling” (2007) Proteins:
Structure, Function, and Bioinformatics 69 (3), 476-485.
[37] Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T.,
Kiefer, F., Cassarino, T. G., Bertoni, M., Bordoli, L., Schwede, T. “SWISS-
MODEL: modelling protein tertiary and quaternary structure using evolution-
ary information” (2014) Nucleic Acids Research 42 (W1) W252-W258.
[38] Arnold, K., Bordoli, L., Kopp, J., Schwede, T. “The SWISS-MODEL
Workspace: A web-based environment for protein structure homology mod-
elling” (2006) Bioinformatics 22,195-201.
30
[39] Kiefer, F., Arnold, K., Kunzli, M., Bordoli, L., Schwede, T. “The SWISS-
MODEL Repository and associated resources” (2009) Nucleic Acids Research
37, D387-D392.
[40] Guex, N., Peitsch, M. C., Schwede, T. “Automated comparative protein struc-
ture modeling with SWISS-MODEL and Swiss-PdbViewer: A historical per-
spective” (2009) Electrophoresis, 30(S1), S162-S173.
[41] van der Spoel, D., Lindahl, E., Hess, B., van Buuren, A. R., Apol, E., Meulen-
hoﬀ, P. J., Tieleman, D. P., Sijbers, A. L. T. M., Feenstra, K. A., van Drunen, R.
and Berendsen, H. J. C. “Gromacs User Manual version 4.5.6” www.gromacs.org
(2010).
[42] Yates, C., Sharp, S., Jones, J., Topps, D., Coleman, M., Aneja, R., Jaynes, J.
and Turner, T. “LHRH-conjugated lytic peptides directly target prostate cancer
cells” (2011) Biochem Pharmacol 81, 104-110.
[43] Frenkel, D., Smit, B. “Understanding molecular simulation from algorithms to
applications” (1996) Academic Press.
[44] Verlet, L. “Computer “Experiments” on Classical Fluids. I. Thermodynamical
Properties of Lennard-Jones Molecules” (1967) Phys. Rev. 159, 98.
[45] Verlet, L. “Computer “Experiments” on Classical Fluids. II. Equilibrium Corre-
lation Functions” (1968) Phys. Rev. 165, 201.
[46] Jorgensen, W. L., Maxwell, D. S. and Tirado-Rives, J. “Development and testing
of the OPLS all-atom force field on conformational energetics and properties of
31
organic liquids” (1996) Journal of the American Chemical Society 118, 11225-
11236.
[47] Kaminski, G. A., Friesner, R. A., Tirado-Rives, J. and Jorgensen, W. L. “Evalu-
ation and Reparametrization of the OPLS-AA Force Field for Proteins via Com-
parison with Accurate Quantum Chemical Calculations on Peptides” (2001) J.
Phys. Chem. B 105, 6474-6487.
[48] Tieleman, D. P., MacCallum, J. L., Ash, W. L., Kandt, C., Xu, Z. and Monti-
celli, L. “Membrane protein simulations with a united-atom lipid and all-atom
protein model: Lipid-protein interactions, side chain transfer free energies and
model proteins” (2006) J Phys Condens Matter 18, S1221-S1234.
[49] Berendsen, H. J. C., Postma, J. P. M., DiNola, A., Haak, J. R. “Molecular
dynamics with coupling to an external bath” (1984) J. Chem. Phys. 81, 3684-
3690.
[50] Nose, S. A “molecular dynamics method for simulations in the canonical ensem-
ble” (1984) Mol. Phys. 52, 255-268.
[51] Hoover, W. G. “Canonical dynamics: equilibrium phase-space distributions”
(1985) Phys. Rev. A 31, 1695-1697.
[52] Berendsen, H. J. C., Postma, J. P. M., DiNola, A., Haak, J. R. “Molecular
dynamics with coupling to an external bath” (1984) J. Chem. Phys. 81, 3684-
3690.
32
[53] Parrinello, M., Rahman, A. “Polymorphic transitions in single crystals: A new
molecular dynamics method” (1981) J. Appl. Phys. 52, 7182-7190.
[54] Nose, S., Klein, M. L. “Constant pressure molecular dynamics for molecular
systems” (1983) Mol. Phys. 50, 1055-1076.
[55] Kutzner, C., Van Der Spoel, D., Fechner, M., Lindahl, E., Schmitt, U. W., De
Groot, B. L. and Grubmuller, H. “Speeding up parallel GROMACS on high-
latency networks” (2007), J. Comput. Chem., 28: 2075-2084.
[56] Jorgensen, W. L., Maxwell, D. S., Tirado-Rives, J. “Development and Testing of
the OPLS All-Atom Force Field on Conformational Energetics and Properties
of Organic Liquids” (1996) J. Am. Chem. Soc. 118, 11225-11236.
[57] Ewald, P. P. “Die berechnung optischer und elektrostatischer gitterpotentiale”
(1921) Ann. Physik, 64, 253. Translation: “The computation of optical and
electrostatic lattice potentials”.
[58] Darden, T., York, D., Pedersen, L. “Particle mesh Ewald: An N log(N) method
for Ewald sums in large systems” (1993) J. Chem. Phys. 98, 10089.
[59] Marrink, S. J., Risselada, H. J., Yefimov, S., Tieleman, D. P., de Vries, A. H.
“The MARTINI forcefield: coarse grained model for biomolecular simulations”
(2007) J. Phys. Chem. B 111, 7812-7824.
[60] Sindhikara, D., Meng, Y., Roitberg A. E. “Exchange frequency in replica ex-
change molecular dynamics” (2008) The Journal of Chemical Physics 128,
024103.
33
[61] Introduction to REMD using GROMACS:
http://www.gromacs.org/Documentation/How-tos/REMD
(accessed: 18/09/2015).
[62] Bechinger, B., Sizun, C. “Alignment and structural analysis of membrane
polypeptides by 15N and 31P solid-state NMR spectroscopy” (2003) Concepts
in Magnetic Resonance Part A, 18A(2), 130-145.
[63] Duer, M. J. “Introduction to solid state NMR spectroscopy” (2004) Blackwell
publishing.
[64] Aisenbrey, C., Sudheendra, U. S., Ridley, H., Bertani, P., Marquette, A.,
Nedelkina, S., Lakey, J. H. and Bechinger, B. “Helix orientations in membrane-
associated Bcl-X(L) determined by 15N solid-state NMR spectroscopy” (2007)
Eur Biophys J. 37, 71-80.
[65] Vosegaard, T., Kamihira-Ishijima, M., Watts, A. and Nielsen, N. C. “Helix
Conformations in 7TM Membrane Proteins Determined Using Oriented-Sample
Solid-State NMR with Multiple Residue-Specific 15N Labeling” (2008) Biophys-
ical Journal 94, 241-250.
[66] Frishman, D., Argos, P. “Knowledge-Based Protein Secondary Structure As-
signment” (1995) Proteins: Structure, Function, and Genetics 23, 566-579.
[67] Touw, W. G., Baakman, C., Black, J., te Beek, T. A., Krieger, E., Joosten, R.
P., Vriend, G. “A series of PDB related databases for everyday needs” (2015)
Nucleic Acids Research 43 (Database issue), D364-D368.
34
[68] Kabsch, W., Sander, C. “Dictionary of protein secondary structure: pattern
recognition of hydrogen-bonded and geometrical features” (1983) Biopolymers
22, 2577-2637.
35
Chapter 2
Molecular dynamics simulations of
histidine-containing cod antimicrobial
peptide paralogs in self-assembled
bilayers1
2.1 Introduction
Antimicrobial peptides (AMPs) play an important role in the immune systems of
a wide variety of organisms, from humans to fish to insects. AMPs are generally
amphipathic and cationic in nature [1], and consequently have a propensity to interact
with lipid bilayers. Much of the research into the mechanism of AMPs has focused
1This chapter is published as an article in Biophysica et Biochimica Acta (BBA)-Biomembranes
(2014).
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on their interaction with membranes, either as their direct mechanism of killing, or
as a means of getting inside the cell to disrupt intracellular targets [2–5]. Besides
their natural roles in innate immunity, AMPs are also being investigated as potential
therapeutics for conditions such as drug resistant infection [6–8] and cancer [9–11].
Many AMPs exhibit a degree of specificity and can kill pathogens at concentrations
that do not harm host cells. At least some of this specificity is believed to derive
from their cationic nature which provides for stronger interactions with, for example,
bacterial or cancer cell membranes, which are generally more anionic in character
than mammalian host cells [12, 13]. Nonetheless, one major barrier to using AMPs
as drugs is that at high concentrations, they can kill not just the target cells but the
healthy host cells as well [14,15].
One way of controlling the specificity and activity of AMPs is via controlling their
charge. This is particularly applicable to peptides that contain the amino acid his-
tidine, which is generally uncharged at neutral pH but tends to become positively
charged at mildly acidic pH. This pH sensitivity of histidine-containing AMPs can
provide a “pH switch” to activate them in lower pH environments [16–19]. Acidic
pH activation of AMPs may play a role in the endogenous functioning of AMPs; for
example, acidic pH is important in skin immune defence [16–20]. Moreover, there
are intriguing possibilities to employ pH-activated AMPs in exogenous applications,
such as the treatment of cancer [9, 10] as the environment around tumors is usually
acidic [17,21]. Thus, histidine-containing AMPs are excellent candidates as therapeu-
tics because they are likely to be much more active in the vicinity of the tumor than
elsewhere in the body. Indeed, replacement of arginines and lysines with histidine in
the AMP K6L6 was shown to make the peptide more specific; systemic injection of
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the modified peptide inhibited tumor growth in mice with reduced systemic toxicity
compared to the parent peptide [17].
At least three diﬀerent mechanisms have been suggested for the altered activity of
histidine-containing AMPs that is observed when histidines become more positively
charged at lower pH. 1) Membrane binding: Kacprzyk et al. [16] replaced the lysine
and arginine in synthetic AMP sequences with histidines to produce peptides that
were only active under acidic conditions. The diﬀerences in activity corresponded
well to observed diﬀerences in membrane binding. 2) Membrane penetration: Khara-
dia et al. [22] also replaced the lysine and arginine residues in lytic peptides with
histidines. They found that the novel peptides were much more selective for bacteria
over host tissue cells and attributed the increase in activity at lower pH not to changes
in membrane binding, but to increased membrane penetration. 3) Changing peptide
structure: This mechanism for pH-dependent activity in histidine-containing AMPs
was suggested by detailed studies of the synthetic peptide LAH4, for which pH alter-
ations induce changes in the peptide structure. At neutral pH a long helix is formed,
which associates with the membrane in a planar manner. At slightly acidic pH, a
hinge disrupts the contiguous helix structure, possibly due to electrostatic repulsion
between adjacent histidines [23].
We were interested in exploring, at an atomic level, the role of histidines in AMP-
membrane interactions. Of particular interest were histidines in natural sequences as
opposed to the synthetic sequences that have been the subjects of most mechanistic
studies of histidine containing AMPs so far. Additionally, we wanted to probe the
potential significance of histidines that appear in sequential pairs in the sequence, as
opposed to histidines flanked solely by non-histidine residues. The peptides employed
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in the study, GAD-1 and GAD-2, are derived from codfish sequence libraries [3–6].
They are paralogs, i.e., related genes found in the same organism, and their com-
parison has potential to illuminate the role of histidine pairs in evolutionarily tuned
structure-function relationships. GAD-1 and GAD-2 are members of the piscidin fam-
ily of helical AMPs. Piscidins have been subjects of several structure-function studies,
although not studies that address pH-dependent behavior and mechanisms [28–37].
GAD-1 (FIHHIIGWISHGVRAIHRAIH-NH2) has 5 histidines, two of which appear in
a pair and three of which appear singly. GAD-2 (FLHHIVGLIHHGLSLFGDR-NH2)
has 4 histidines, which appear in two sets of histidine pairs. We studied these peptides
in histidine charged forms, denoted as GAD-1p and GAD-2p, as well as in the histi-
dine neutral form (GAD-1, GAD-2). All-atom molecular dynamics simulations with
these 4 peptides along with POPC lipids were performed in order to reveal atomistic
details of their lipid interactions. As detailed in the Methods and Discussion sections,
with our system setup, pores form even in the absence of peptide, and thus our study
does not provide a kinetic picture of how the peptides bind to membranes and induce
pore formation, but rather provides details of the peptide/lipid interactions. One of
our key findings was that histidine pairs are more likely to be found closely associated
with the pore than in the more ordered, planer region of the lipid bilayers.
2.2 Methods
Our approach followed the method of Salgado et al. [7] who start unassembled lipid
molecules in random positions with a single peptide among the lipid molecules. This
method allows the system to freely assemble into a peptide-bilayer complex, thus
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avoiding any artifacts that might result from, for example, introducing the peptide
into a pre-assembled bilayer after removing lipids “by hand”. The main diﬀerence
in our implementation of this approach is that, rather than employing a script to
randomize the position of the lipids, we randomized the system by simulating at
high temperature, 1400 K. This modification provided ease of implementation, in
particular by allowing for an initial volume not too much larger than the final one,
while avoiding truly unphysical interactions, e.g. overlapping molecules.
Salgado et al. [7] found that the method produced expected outcomes in terms
of the location and orientation of the peptide with respect to the membrane, i.e.,
a hydrophobic peptide ended up in a transmembrane configuration, while a more
amphipathic peptide ended up on and parallel to the membrane surface. This lends
confidence that the assembled structures reflect low free energy states of the equi-
librium system. By contrast to these two simpler cases, imperfectly amphipathic
peptides, such as the ones we are studying,may possess many diﬀerent configurations
of similar free energy. To address this, for each system composition,we performed four
independent simulations of the self-assembly process. While computational resources
limited us to this small number, it did provide suﬃcient sampling for at least a semi-
quantitative characterization of the diﬀerences between the paralogs in their charged
and uncharged forms. Additionally, simulations were carried out in the absence of
the peptide to control for the eﬀect of the peptide on bilayer formation.
The systems consisted of 128 POPC lipid molecules (6656 atoms), a single peptide
(⇠ 350 atoms) and approximately and no less than 7360 water molecules (roughly
37,000 atoms in total) (Table 2.1). This number of lipid molecules provided a
large enough bilayer to accommodate the peptide in the presence of a pore. The
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System Number of atoms Time (ns) Class type Bilayer width (nm) Pore diameter (P) (nm) Pore diameter (W) (nm)
POPC-A 36,368 400.00 – 4.24±0.09 0.69±0.16 1.08±0.13
POPC-B 36,368 400.00 – 4.22±0.09 0.66±0.16 1.05±0.13
POPC-C 36,368 400.00 – 4.27±0.09 0.52±0.18 0.98±0.14
POPC-D 36,368 400.00 – 4.26±0.08 0.71±0.18 1.09±0.13
GAD-1-A 36,728 376.00 1 4.25±0.09 0.47±0.17 0.98±0.18
GAD-1-B 36,728 370.40 1 4.15±0.10 0.53±0.18 1.03±0.14
GAD-1-C 36,728 348.00 5 4.31±0.09 0.59±0.16 1.00±0.12
GAD-1-D 36,728 344.00 2 4.21±0.08 0.37±0.15 0.92±0.23
GAD-1p-A 36,498 344.00 1 4.17±0.08 0.62±0.21 1.18±0.21
GAD-1p-B 36,498 320.40 1 4.22±0.08 0.82±0.14 1.14±0.11
GAD-1p-C 36,498 328.00 4 4.28±0.09 0.81±0.16 1.13±0.11
GAD-1p-D 36,498 304.00 1 4.24±0.09 0.57±0.17 1.01±0.26
GAD-2-A 36,576 336.00 3 4.01±0.08 – –
GAD-2-B 36,576 332.40 2 4.25±0.09 0.77±0.21 1.18±0.10
GAD-2-C 36,576 335.00 2 4.25±0.09 0.52±0.20 1.15±0.13
GAD-2-D 36,576 324.00 2 4.19±0.08 0.40±0.20 1.04±0.17
GAD-2p-A 36,624 323.60 3 4.22±0.09 0.74±0.18 1.10±0.13
GAD-2p-B 36,624 332.00 2 4.26±0.09 0.79±0.12 1.21±0.13
GAD-2p-C 36,624 348.00 4 4.24±0.10 0.64±0.16 1.01±0.13
GAD-2p-D 36,624 328.00 1 4.21±0.09 0.58±0.16 1.06±0.15
Table 2.1: Parameters and measurement summary for each simulation. The calcula-
tions for bilayer width, pore diameter (P) and pore diameter (W) were done for last
100 ns of simulations. A, B, C and D represent individual runs of the same system
composition.
amount of water was chosen to allow for suﬃcient space to prevent periodic boundary
conditions from permitting the peptide to interact unphysically with both leaflets
through water. The number of water molecules employed is somewhat larger than
the number employed in other studies [7, 39,40].
The initial alpha-helical peptide structures were generated using Swiss PDB Viewer
(SPV) [41–44]. The C-terminus was amidated with an NH2 group to be in line with
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Figure 2.1: System set up. The peptide was initially configured as a canonical helix
and placed in the simulation box with an assembled POPC lipid bilayer (A). Keeping
the peptide position restrained, the molecule positions were randomized by heating
the system to 1400 K for 2 ns (B). The peptide backbone is shown as an orange ribbon,
the histidine side chains in purple, hydrophobic side chains in yellow, polar uncharged
side chains in green, positively charged side chains in blue, and negatively charged
side chains in red. The gray spheres represent the lipid headgroup phosphorus atoms
and the silver lines, the lipid acyl-chains.
ongoing experimental work. The peptide was placed in a cubic simulation box of side
length 8 nm along with the 128 POPC molecules, which were initially arranged in
a bilayer configuration taken from [45] (Figure 2.1-A). Suﬃcient Cl  counterions
were added to ensure overall charge neutrality: 3 ions for GAD-1, 8 for GAD-1p, 1 for
GAD-2 and 5 for GAD-2p. For histidines in GAD-1p and GAD-2p, the protonated
form of histidine was used.
GROMACS version 4.5 was used for the simulations [46]. We employed a version
of the all atom Optimized Potential for Liquid Simulations (OPLS-AA) force field [15,
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16], adapted for POPC lipid molecule properties [49].
As the first step in generating randomized starting configurations for the self-
assembly process, we carried out a simulation of the system comprising the peptide,
lipid bilayer and counter ions in the canonical ensemble at T=1400 K for 2 ns, still
within a cubic box of side length 8 nm, while restraining the position of all the peptide
atoms to preserve its helical structure. We employed the modified Berendsen thermo-
stat (v-rescale in GROMACS). Under these conditions, the lipid bilayer immediately
disassembles, equilibrating rapidly to a highly mobile fluid of lipid molecules (Fig-
ure 2.1-B). In this regime, the root mean square displacement of a lipid molecule
over 1 ns is approximately 10 nm.
Next, we added approximately 7500 TIP4P water molecules [50] to the simulation
box and, after an energy minimization, continued running at 1400 K with the peptide
still restrained. The root mean square displacement of lipid molecules over 2 ns was
approximately 8.5 nm. During this run, we harvested four configurations, one every
2 ns, that served as independent starting configurations for separate realizations of the
self-assembly process,which we label as A, B, C and D. This procedure for obtaining
four independent configurations was carried out for each variant of the peptide (GAD-
1, GAD-1p, GAD-2 and GAD-2p) as well as for a system without a peptide, which
acts as a control. In total, there were starting points for 20 simulations of the self-
assembly process.
Each self-assembly simulation began with a brief simulation of 100 ps under con-
ditions of constant temperature and constant pressure, with the peptide unrestrained.
The temperature was held constant at 310 K with the Nose-Hoover algorithm and
a time constant of 0.1 ps. An isotropic pressure of 1 bar was maintained with the
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Parrinello-Rahman algorithm employing a time constant of 5 ps and compressibility
of 4.5 ⇥ 10 5 bar 1. This short simulation was suﬃciently long to bring the density
into a steady state (it does not continue to evolve in subsequent steps), as well as
to allow the large fluctuations expected after a large drop in temperature to subside.
This run was short enough so that no significant change in the helicity of the pep-
tide occurred and the lipid molecules did not show any appreciable progress towards
bilayer assembly. The final box size was roughly 7.25 nm on each side.
At this point we began the “production” run (Figure 2.2), using a time step of 2 fs
and a radial cutoﬀ of 1.2 nm for the real space force calculations. We used the particle
mesh Ewald method for Columbic interactions with a Fourier spacing of 0.15 nm and
interpolation order of four (cubic). The temperature and pressure controls were as
for the previous step, with the exception that we use anisotropic pressure scaling in
order to avoid enforcing a bilayer normal direction (as opposed to semi-isotropic).
The average run time for these production simulations was approximately 350 ns
(Table 2.1). The beginning of these runs marks our time origin (t= 0).
We note that in some of our runs, anisotropic scaling allowed for one of the
dimensions of the box to shrink below the potential cutoﬀ, eﬀectively ending the
simulation. In retrospect, we could have used anisotropic rescaling until the bilayer
had formed, and then switched to semi-isotropic scaling to avoid this problem. In
reality, we generated additional starting configurations so as to have four realizations
of each variant and to maintain a uniform protocol across runs.
In the “Results” and “Discussion” sections, the formation and presence of pore in
lipid bilayer generated with self-assembly method will be explained and discussed.
To investigate the formation of pore in our lipid bilayers, in addition to POPC-A,
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Figure 2.2: Representative snapshots of the molecular dynamics simulation of GAD-2
peptide realization set C in POPC. (A) At the start of the production run (0 ns) with
randomized lipid positions. (B) After 50 ns, a more ordered, bilayer-like configuration
is observed. (C) The peptide is positioned inside a bilayer (100 ns). Although the
bilayer appears ordered with sharply defined lipid head group positions, a pore is
present. (D) After 300 ns, the bilayer still has a pore and the peptide is found inside
the bilayer, proximal to the pore. The peptide backbone is shown as an orange ribbon,
the histidine sidechains in purple, hydrophobic sidechains in yellow, polar uncharged
sidechains in green, positively charged sidechains in blue, and negatively charged
sidechains in red. The gray spheres represent the lipid headgroup phosphorus atoms,
the silver lines represent the lipid acyl-chains, and water is shown as cyan dots.
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POPC-B, POPC-C and POPC-D systems, we set up four other sets of simulations,
named Test-1, Test-2, Test-3 and Test-4 at T=323 K to help us study the eﬀect of
pressure coupling, temperature change and water model choice, on generation and
stability of pore in lipid bilayer during the course of simulation. The temperature is
set to 323 K for our simulations to be comparable with previously studied systems [7,
62, 63]. In Test-1 and Test-2 simulations, we used the final structure of one of our
4 peptide-free control simulations as our initial structure and run our simulations.
In the Test-1 system, we continue our simulation with the same parameters as our
control simulations, except T=323 K. This simulation ran for 73 ns until one of the
dimensions of simulation box shrank below the potential cutoﬀ. In the Test-2 system,
in addition to setting T=323 K, we change the pressure coupling to semiisotropic.
For Test-3 and Test-4 systems, we run our simulations from the beginning, with the
same simulation parameters, that we change the water model from TIP4P to SPC
water molecule [51]. In Test-3, we added ⇠ 11000 SPC water molecules, while in the
Test-4, we used 6000 SPC water molecules. Test-3 ran for 96 ns and Test-4 ran for
49 ns.
To characterize the evolution and structure of all our systems, we tracked the
potential energy of the system, lipid acyl-chain order parameter (as defined in Salgado
et al. [7]), the width of lipid bilayer, pore size, secondary structure of the peptide,
mean square displacement of particles and the number of water molecules around
diﬀerent peptide residues. To find the mean value of order parameter of acyl-chains
as a function of time, for each frame we calculated the order parameter of each of the
carbons in the unsaturated acyl-chain and averaged over all of these carbons. The
utilities included with GROMACS, such as g_energy, g_density, g_order, g_msd
46
and g_rdf, as well as the Define Secondary Structure of Proteins (DSSP) [52, 53]
plugin of the Visual Molecular Dynamics (VMD) software package [54,55] were used
to obtain these quantities.
To determine the pore size, we first needed to determine the location of the pore
axis. To do this, we found all interior P atoms, i.e., those residing within 1.5 nm of the
midway plane between bilayer leaflets. (We defined the location of a leaflet along the
bilayer normal as a peak in the P density profile). On average, for a given simulation
frame, there are six such interior P atoms. The pore axis, which by definition is
parallel to the bilayer normal, passes through the center of mass of the interior P
atoms and was defined on a frame-by-frame basis. The radius of the pore, by one
definition, was the average perpendicular distance of the interior P atoms to the
axis. Alternatively, we defined the pore size by considering all distances between the
interior water molecules (defined in the same way as interior P atoms), and finding
the largest perpendicular distance. Since there was the occasional water molecule
that diﬀused deep into the bilayer, in calculating the average pore size, we discarded
the largest 5% of sizes. We determined this cutoﬀ by looking at the distribution of
pore sizes.
To calculate the percentage of time each peptide residue takes on a helical structure
we used VMD software (version 1.9.1). We found the secondary structure of each
residue frame-by-frame in VMD, and then used this to calculate the percent helicity
per residue during the last 100 ns of the simulation (except for GAD-1p-A, where
the last 70 ns was used). Both alpha-helical and 3-10 helical structures were used to
generate the percent helical structure.
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2.3 Results
2.3.1 Peptide-free Systems
In peptide-free systems, we ran two types of simulations in which the system does not
contain peptide. For the first type, we used the main protocol to run our simulations
(POPC-A, POPC-B, POPC-C and POPC-D) and for the second type, we studied the
eﬀect of temperature, pressure scaling and water model on the formation and healing
of the pore in POPC lipid bilayer.
2.3.1.1 Main Protocol Simulations
We first investigated the behavior of the POPC/water systems in the absence of
peptide (POPC-A, POPC-B, POPC-C, POPC-D in Table 2.1). After starting with
the lipids in randomized positions, all four simulations reach apparent equilibrium
after ⇠ 100 ns, as judged by multiple parameters, including potential energy and the
mean value of order parameter of the lipid chains (Figure 2.3). From 100 ns to
the end of the simulations at ⇠ 400 ns, all 4 systems display a bilayer with a single
pore. The pore consists of a contiguous water-containing hole through both leaflets
of the bilayer that is lined by phospholipid headgroups. The area per headgroup of
the lipids lining the pores is larger than the area per headgroup for lipids found in
the planar region of the bilayer.
The bilayer width was found to be between 4.2 and 4.3 nm (Table 2.1) as defined
by the distance between the phosphorous atoms in the lipid head groups. The sizes
of the pores varied from simulation to simulation, but were in the range of 1.0 to 1.1
nm when measured using water, and in the range of 0.5 nm to 0.8 nm when measured
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Figure 2.3: Time evolution of potential energy (left) of the system and mean value
of the order parameter of the acyl-chain (right) during representative simulations. In
the top panel, shown are running averages over 50 data points, with 400 ps between
data points.
using phosphorous (Table 2.1). The diﬀerence in pore size for the two measurements
illustrates that water penetrates well into the lipids of the pore. As we shall discuss,
this more aqueous environment plays an important role in understanding the structure
and positioning of the peptide near the pore.
2.3.1.2 Pore-formation-test Simulations
To analyze the behaviour of pore with diﬀerent temperatures, pressure scaling and
water model, we studied 4 pore-formation-test simulations (Test-1, Test-2, Test-3 and
Test-4 in Table 2.2) at T=323 K, in addition to the control simulations we run in
Table 2.1 (POPC-A, POPC-B, POPC-C and POPC-D) at T=310 K. In Test-1 and
Test-2, the system keeps the initial pore inside the bilayer during simulation. The
bilayer width is smaller compared to the control simulations run at 310 K. In Test-2,
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System Number of atoms Water Pressure Bilayer width (nm) Bilayer(ns) Healing (ns) Duration (ns)
Test-1 36,368 TIP4P anisotropic 4.14±0.10 – – 73
Test-2 36,368 TIP4P semiisotropic 4.08±0.09 – – 25.2
Test-3 40,685 SPC anisotropic 4.21±0.10 20 82 104
Test-4 24,656 SCP anisotropic 4.13±0.16 32 48 49
Table 2.2: Parameters and measurement summary for pore-formation-test simula-
tions.
changing the pressure scaling to semiisotropic did not help the pore to heal. In Test-3
and Test-4, we replaced the TIP4P water molecules with SPC model water. We can
see that in these simulations the bilayer forms with a pore inside it earlier compared
to the systems with TIP4P water models and, strikingly, the pore heals during the
simulation. The smaller number of water molecules in the Test-4 system, could be
the reason that the pore heals faster compared with the Test-3 simulation. Thus, the
choice of water model has a strong influence on the longevity of the pore.
2.3.2 Systems with Peptides
Next, we added peptide to our systems. We studied four peptides, GAD-1, GAD-
1p, GAD-2, and GAD-2p, where “p” denotes the form of the peptide with histidines
positively charged. Each peptide was subjected to four independent simulations A,
B, C and D (Table 2.1). Initially, during randomization, the peptides started in
a canonical helical structure but were subsequently simulated at ambient conditions
without restraints (Figure 2.2).
Similar to the lipid-only simulations, 15 out of 16 of the peptide-lipid simulations
reach apparent equilibrium after ⇠ 100 ns. There was one outlier; the GAD-1p-A
system took ⇠ 230 ns to generate the bilayer (Figure 2.3). The GAD-1p-A system
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Figure 2.4: (A-F): Selected snapshots from near the end (⇠350-400 ns) of the simu-
lations. The peptides exhibit a variety of final structures and topologies within the
bilayer, but the systems can be grouped into five types of configurations as described
in the text and labeled on the panels. The peptide backbone is shown as an orange
ribbon, the histidine sidechains in purple, hydrophobic sidechains in yellow, polar
uncharged sidechains in green, positively charged sidechains in blue, and negatively
charged sidechains in red. The gray spheres represent the lipid headgroup phosphorus
atoms, and the silver lines, the lipid acyl-chains. Water molecules are in cyan.
initially formed with two separate micelles, which eventually coalesced into one micelle
and then formed the bilayer. All but one of the peptide-containing systems formed
pores (Figure 2.4). The one exception was GAD-2-A, the only simulation with a
perfect bilayer without a pore (Figure 2.4-C).
As for the systems without peptide, the sizes of the pores varied from simulation
to simulation, but were in the range of 1.0 to 1.2 nm when measured using water
and in the range of 0.5 nm to 0.8 nm when measured using phosphorous (Table
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2.1). These are similar to pore sizes in the systems without peptide. The bilayer
width, defined by the distance between the phosphorous atoms in the head groups, is
between 4.0 and 4.3 nm, i.e. also in the same range as for systems without peptide.
Thus, the peptide does not appear to have any large eﬀect on the pore size or bilayer
width.
As detailed below, in most cases (13 out of 15), the peptide preferentially interacts
with the pore, rather than with the planar region of the bilayer. One reason for this
preference may be the decreased density of lipid head groups in the pore (⇠0.8 nm 2)
as compared to the planar region (⇠1.5 nm 2). The reduced head group density
in the pore may allow the peptide enough space to position in such a way so as to
interact optimally with both the hydrophobic region of the lipids and the hydrophilic
headgroup/water region.
2.3.3 Peptide Structure and Residue Hydrophobic/Hydrophilic
Partitioning
During the self-assembly process, there were no restraints on the peptide, allowing its
structure to evolve freely as the bilayer formed. Following apparent equilibrium at
⇠ 100 ns, the structure of each peptide continued to evolve, but did not change sig-
nificantly in the last 100 ns. When compared to each other, the final structures of the
peptides exhibit substantial heterogeneity i.e., even for diﬀerent independent simula-
tions of the same peptide, there are diﬀerent degrees of overall helicity and variations
in the regions that are helical (Figure 2.5). Despite the structural heterogeneity, the
partitioning of each residue into either a hydrophobic or hydrophilic environment is
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Figure 2.5: Percentage of helical structuring of GAD peptides during last 100 ns of
simulation (except GAD-1p-A which is for the last 70 ns). A, B, C and D represent
individual runs of the same system composition.
very similar. Specifically, the number of water molecules within a set distance of the
center of mass of each residue (Figure 2.6) is quite consistent across the 4 diﬀerent
independent simulations of each system. The observed structural heterogeneity is
expected and is consistent with both experiments on membrane-active peptides [56]
and simulations of AMPs [39, 57]. There is no apparent diﬀerence between how the
peptides with protonated histidines versus those with neutral histidines behave in
terms of helicity and proximity to water.
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Figure 2.6: Number of water molecules within r=0.65 nm of the center of mass of
each GAD residue in the last 100 ns of simulation (except GAD-1p-A which is for the
last 70 ns). A, B, C and D represent individual runs of the same system composition.
2.3.4 Peptide-pore Interactions
Of the 15 out of 16 peptide simulations that form a pore, 14 of these show the peptide
interacting closely with the pore. This is evident from Figure 2.7, where all but one
of the peptides (GAD-2p-A) has at least one residue with its center of mass within
0.7 nm of the pore (represented by the dotted lines).
The systems can be classified into five diﬀerent types, depending on the mode of
interaction between the peptide and the pore in the last 100 ns of each simulation.
In the first and most common type (6/16 systems), there are extensive interactions
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between the pore and one of the terminal halves of the peptide, while the other half
of the peptide remains relatively distal from the pore and in the planar region of the
bilayer (Figure 2.4-A). The region of the peptide that interacts closely with the pore
takes on an oblique angle with respect to the plane of the membrane, while the non-
interacting peptide half positions more nearly parallel to the membrane surface. The
second most common type of system (5/16 systems) is exemplified in Figure 2.4-B,
where the entire peptide is proximal to the pore and makes extensive interactions
with lipids from both leaflets of the bilayer. In the third type of system (2/16),
the peptide interacts with the planar region of one of the bilayer leaflets without
interacting with a pore, e.g. Figure 2.4-C and Figure 2.4-D. The fourth class
(2/16) consists of systems (GAD-1p-C and GAD-2p-C) in which just one residue in
the peptide (H3) interacts with the rim of the pore and the rest of the peptide is not
in contact with the pore, but positions within the nearest leaflet, Figure 2.4-E. The
remaining simulation, GAD-1-C, does not fit within any of these 4 schemes and thus
is the sole occupant of the Class 5 type of system. Here, the peptide embeds deeply
in the bilayer, but with a position nearly parallel to the bilayer surface.
It appears that, at least on the timescale of these simulations, there is no inter-
conversion between class types during the simulation for class 1 and class 2 systems.
On the other hand, there were two observed cases where systems started out as class
3 type - i.e. peptide not interacting with the pore - converting to a class 4 type -
peptide interacting with the rim of the pore - during the course of the simulation.
The four diﬀerent peptides, GAD-1, GAD-1p, GAD-2, and GAD-2p show diﬀerent
propensities to form these five types of systems. GAD-1 and GAD-1p both showed
a strong tendency to display class 1 configurations, where one end of the peptide
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Figure 2.7: The distance of the center of mass of each residue from the central axis of
the pore (lines and symbols) and the radius of pore (dotted lines), as defined by lipid
phosphorous position during last 100 ns (except GAD-1p-A which is for last 70 ns) of
simulation. A, B, C and D represent individual runs of the same system composition.
interacts with the pore, and the other end interacts with the planar region of one
bilayer leaflet (Figure 2.4-A). One of the exceptions to this trend was also inter-
esting; GAD-1-C is a unique configuration among the 16 peptide-containing systems
(Figure 2.4-F) with the peptide located in proximity to the pore, deeply embedded
in the bilayer with a position parallel to the bilayer normal. Intriguingly, this system
has the highest helical structure among all simulations.
In contrast to GAD-1 and GAD-1p, the GAD-2 systems are in class two config-
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urations,with the exception of GAD-2-A. In the GAD-2-A system there is no pore.
Notably, GAD-2-A also has the most helical structure among GAD-2 simulations.
As explored in the “Discussion” section, it may well be significant that the two most
helical peptides, GAD-1-C and GAD-2-A, also display the most parallel orientation
with respect to the bilayer surface. The GAD-2p sets of simulations are the most
heterogeneous in terms of the observed topology and we observe four diﬀerent types
of systems (Table 2.1).
2.3.5 Role of Histidine Pairs in AMP-Pore Interactions
One notable observation is that the N-terminal half of all 4 peptides has a greater
tendency to interact with the pore than the C-terminal half (Figure 2.7). Again
the exceptional case is GAD-1p-A, in which the C-terminal half interacts with the
pore. A potential explanation for the strong preference for the N-terminal half to
interact with the pore is the pair of histidines, (H3 and H4) that are located near the
N-terminal half of both peptides. Consistent with this explanation, the 2nd pair of
histidines (H10 and H11) present only in GAD-2, are also found consistently in close
proximity to the pore (Figure 2.7). It appears that there is no need for the histidine
pair to be charged in order to interact closely with the POPC pore; even uncharged
histidine pairs exhibit this behavior.
To assess the importance of the pairing of the histidines to pore interactions, we
can compare the behavior of the H3-H4 pair to the only other charged pair of amino
acids in the peptides, the H17 and R18 present in GAD-1p. The H17-R18 pair has
a markedly lower tendency to interact with the pore compared to either the H3-H4
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motif present in both peptides or the H10-H11 motif present in the GAD-2 peptides
(Figure 2.7). Specifically, 7 out of 8 of the GAD-1/1p systems show much closer
interactions between the pore and the H3-H4-containing N-terminal region of the
peptide compared to the H17-R18-containing C-terminal region of the protein.
A potential alternate explanation for the behavior of the histidine pairs is that
the pore-interaction behavior might originate not from the histidines, but from their
neighboring residues. However, this does not appear to be the case as the residues
adjacent to the H3-H4, H10-H11 and H17-R18 pairs are all hydrophobic.
2.4 Discussion
In this work,we employ an approach to molecular dynamics simulation that allows
the bilayer to self-assemble [7]. This has the advantage of preventing bias, but also
prevents us from observing the early kinetic step in which the peptide binds the bi-
layer and begins to translocate. To be clear, in our system set-up, pores are formed
even in the absence of peptide, and therefore our studies indicate details of pep-
tide/bilayer interactions, rather than the kinetic process of peptide-induced pore for-
mation. Nonetheless, in combination with multiple independent simulations of each
system composition, this approach has the advantage of illustrating the variety of pep-
tide/lipid structures with favorably low energy. The final peptide structures observed
exhibit a wide variety of helicity (Figure 2.5), but a high degree of conservation
of peptide-lipid interactions at the individual amino acid level (Figure 2.6). The
simulations thus provide atomic-level insight into the structural plasticity that has
long been observed experimentally for many helical AMPs and has been argued to
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be a key part of their potency and selectivity [56, 58]. The observed structural het-
erogeneity relates to the concept of “imperfect amphipathicity” which suggests that
AMP structures that present a few polar/charged residues on a non-polar face pro-
mote the formation/stabilization of pores [59,60]. In keeping with these ideas around
AMP structural heterogeneity and imperfect amphipathicity, we observed that the
most helical and perfectly amphipathic peptide structures (GAD-1-C and GAD-2-A)
position parallel to the bilayer surface and tend to interact with the planar part of the
bilayers formed. On the other hand, the majority of the simulations showed peptides
with smaller helical contents interacting with the curved region of the bilayer in the
pore. A variety of models have been employed in trying to understand AMP-induced
pore formation, including the toroidal pore, carpet and barrel-stave models [3], and
the two-state model [61], but the results with the Gad peptides are probably bet-
ter understood in the context of models that capture the polymorphic/disordered
characteristics of many AMPs, such as Bechinger et al. [56] and Sengupta et al. [57].
Another advantage of the self-assembly method is the appearance of a pore when
the bilayer first forms. This allows us to determine whether and how the peptide
interacts with a pore. The long lifetime of the pore, present even in the lipid-only
simulations, is thus beneficial. While this persistence of the pore in our system is
not unexpected, as explained by Fuertes et al. [62], it is significantly longer than the
mere tens of nanoseconds reported in previous self-assembly studies [7, 63]. Repeat-
ing our self-assembly protocol for the lipid-only system with the SPC model of water,
which was used in previous studies, instead of TIP4P, which we used in this work,we
observed significantly faster bilayer formation and a pore lifetime of 50 ns. This
consistency with previous work indicates that the choice of water model can have a
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significant eﬀect on membrane dynamics. This is not surprising given that seemingly
small diﬀerences between water models can yield significantly diﬀerent thermody-
namic properties of simulated water [64]. We did examine other possible sources for
this discrepancy including temperature, pressure control and other protocol details,
and found no significant changes. Extending one of our lipid-only simulations (with
TIP4P) reveals that the pore persists to at least 1 µs, and that the membrane is rather
fluid, given a root-mean-square displacement of P atoms of approximately 2 nm in 100
ns. This confirms the view that the membrane-with-pore is a well-defined metastable
state quite stable to thermal fluctuations, rather than a kinetically hindered state
slowly and continuously moving towards equilibrium.
More specifically to histidine-containing AMPs, we observed a marked preference
for the N-terminal half of GAD-1 and GAD-2 to interact more closely with the pore
than the C-terminal half of the peptides (Figure 2.7). This preference corresponds
well to the location of the sequential pairs of histidines, which are themselves much
more closely positioned to the pores compared to other types of charged pairs such as
histidine-arginine. There are substantial diﬀerences in structure between histidine and
arginine (or lysine) side chains that might underlie the apparent diﬀerences in lipid
interactions (Figure 2.8). Histidine represents a relatively compact, constrained side
chain that, due to the two nitrogens present in the ring, has a hydrophilic nature in
both its charged and uncharged states (Figure 2.8-A). In contrast, arginine consists
of a long, conformationally flexible hydrophobic chain with a positively charged moi-
ety at the terminus – and is thus most precisely viewed as amphipathic in character
(Figure 2.8-B). Arginine has a well-known propensity to “snorkel” [65,66] i.e. embed
its hydrophobic region in acyl chains of the bilayer and extend the charged terminal
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Figure 2.8: 2D chemical structure of A) Histidine and B) Arginine amino acids side
chains. Histidine has a shorter and more rigid structure compared to arginine, for
which the polar groups are located at the end of a hydrophobic CH2 chain.
group out to the polar head group region. In comparison, a histidine-histidine pair
presents a relatively conformationally constrained hydrophilic moiety that may not
be able to interact easily with the densely packed lipid headgroups in the planar part
of the bilayer. By contrast, the lipid headgroups in the pore are less tightly packed
together and there is also more water available for favorable hydrophilic interactions
and may thus provide a more energetically favorable site for the histidine pair to
interact.
This potential explanation is consistent with the observation that even the un-
charged histidine pairs associate with the pores and is interesting to consider in the
light of studies which suggest that some histidine-containing AMPs have increased
selectivity, even at neutral pH [22]. For example, Ruangsri et al. [5] have probed
the antimicrobial activity of peptides with almost identical sequences to GAD-1 and
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GAD-2 and suggested that while the GAD-1-like peptide has broad spectrum an-
timicrobial activity, the GAD-2-like peptide seems to be much more specific and was
only found to be active against the fish parasite, Tetrahymena pyriformis. It is pos-
sible that the inclusion of histidine-pairs, perhaps in combination with the reduction
in overall positive charge at neutral pH as in GAD-2 compared to GAD-1, presents
one mechanism by which evolution may “tune” the structure-activity relationships of
AMPs for specificity against particular types of pathogens. Note that, our observed
absence of alteration in histidine-lipid interactions when histidine’s charge is modified
does not preclude a role for histidine charge in selectivity. It may well be the case that
the more charged versions of the peptides bind more strongly to certain membranes,
in particular to anionic ones, thus eﬀecting membrane selectivity without necessarily
aﬀecting the mode of lipid interaction once it is bound.
In a final thought on the diﬀerences between GAD-1 and GAD-2, Figure 2.9
schematically represents the two paralogs and the way they tend to interact with
a pore in the bilayer. The H-H pairs prefer the more highly curved, central region
of the pore where the increased spacing between head groups allows the compact,
conformationally constrained pair of sidechains to interact favorably at the interface.
On the other hand, the H-R pair is more able to interact with the more ordered, planar
region. The basic premise of our simulations is that the structures we observe are
representative of low free energy configurations and thus the diﬀerences in preferred
positions suggest potentially interesting diﬀerences in the kinetics of how the pores
are formed i.e., the GAD-1 preferred mode of interaction is suggestive of a more easily
accessible initial defect-promoting step, whereas the GAD-2 preferred configuration
is achieved more easily in the presence of a complete pore. The heterogeneity in the
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Figure 2.9: Schematic figure showing the two most favorable positions of GAD-1 and
GAD-2 peptides.
final structures observed in our simulations suggests a kind of “stroboscopic” view of
the potential kinetics of peptide promoted pore formation, with an initial interaction
of the peptide with a planar bilayer looking like Figure 2.4-C, followed by the
promotion of a defect in one leaflet as in Figure 2.4-E and then Figure 2.4-A,
and perhaps translocation across the pore as in Figure 2.4-B. The model suggested
by these simulations will be useful in the interpretation of experimental solution and
solid-state NMR studies of GAD-1 and GAD-2 currently being performed in our lab.
Another interesting issue to be addressed is the role of peptide oligomerization in pore
interactions, as many AMPs are thought to form dimers, or higher order oligomers
in order to exhibit their maximum toxicity [67–69]. Further studies employing more
than one GAD peptide in the simulation box would help address this question.
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Chapter 3
Computational studies of pulmonary
surfactant protein SP-B interacting
with lipid bilayers1
3.1 Introduction
By weight, human lung surfactant (LS) is a mixture of 80-85% phospholipids, 5-10%
neutral lipids and 10% proteins [1–3]. About 80% of the phospholipids are phos-
phocholine (PC) lipids, half of which are dipalmitoylphosphatidylcholine (DPPC).
Along with PC lipids, a significant amount of phosphatidylglycerol (PG) lipid is in
LS. The protein part of lung surfactant is composed of pulmonary surfactant pro-
teins SP-A, SP-B, SP-C and SP-D [4]. Hydrophilic surfactant proteins (SP-A and
1A manuscript based on the all-atom simulations in this chapter has been accepted for publication
in Biophysica et Biochimica Acta (BBA)-Biomembranes (2016).
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SP-D) have antimicrobial activity and are responsible for immune functions within
alveoli [5,6], while the hydrophobic surfactant proteins (SP-B and SP-C) increase the
surface activity of LS lipids, easing the breathing process [7,8]. Additionally, the work
Robertson and coworkers demonstrated antimicrobial activity of SP-B and SP-C on
Group B streptococci pneumonia in rabbit lung [9], and on Group B streptococci,
Staphylococcus aureus and Escherichia coli bacteria in vitro [10].
Previous studies provide a list of in vitro functions for SP-B: membrane bind-
ing, membrane lysis, membrane fusion, promotion of lipid adsorption to air-liquid
intersurfaces, stabilization of monomolecular surface films, and re-spreading of films
from a collapsed phase [8]. Moreover, it has been shown that the hydrophobic surfac-
tant proteins (SP-B and SP-C) can form pores in artificial lipid bilayers to transport
cations [11]. Despite its importance for life, the structure of SP-B at atomic resolution
is unknown and consequently a detailed understanding of its mechanism for how it
performs these activities is lacking. In this part of my thesis the goal is to find feasible
low energy structures and topologies for SP-B that will help reveal how SP-B binds
to a membrane and interacts with lipid bilayers. Structures obtained from simulation
will be useful to interpreting experimental studies of SP-B structure.
SP-B is a 79 residue protein from the saposin super family. Its sequence is FPIP
LPYCWL CRALIKRIQA MIPKGALAVA VAQVCRVVPL VAGGICQCLA ERYSV
ILLDT LLGRMLPQLV CRLVLRCSMD [8, 12] and is shown in Figure 3.1, along
with that of Mini-B [17], a shorter construct of SP-B with known experimental struc-
ture. Functionally, the first 7 N-terminal residues are believed to be important to pro-
mote insertion of SP-B from water into the air/water interface [15,16,22]. SP-B also
contains 3 disulphide bonds between cysteines C8-C77, C11-C71 and C35-C46 [17].
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Figure 3.1: Amino acid sequence of SP-B and Mini-B. Red residues indicate helical
regions, known for Mini-B and predicted for SP-B (all in ↵-helical structure, except
for C46-G47-C48, which are in 310 helix structure). We can predict that SP-B has the
same N and C-teminal ↵-helical regions as the corresponding regions in Mini-B. Blue-
bolded residues indicate regions assumed to allow for SP-B bending. M-21 is helical
in the initial open structure and non-helical in the initial bent structure. Heavy lines
indicate disulphide bonds. Details of how the secondary structure was predicted can
be found in the Methods section.
Owing to SP-B’s exceptional degree of hydrophobicity, experimental studies of SP-
B’s structure are extremely diﬃcult and have yet to yield a high resolution structure.
SP-B has a GRAVY index of 1.027 (Table 3.1) [26]. The GRAVY index indicates
the hydrophobicity of a protein: the more hydrophobic the protein, the higher the
GRAVY index (Table 3.1).
Experimental structures of proteins from the saposin super family, including Saposin
A [5], Saposin B [6], Saposin C [21–23], NK-lysin [19], granulysin [7] and amoeba-
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Protein Gravy Index
GNLY_HUM -0.648
NKL_PIG -0.117
SAP_A_HUM 0.007
SAP_B_HUM 0.001
SAP_C_HUM 0.074
SAP_D_HUM 0.082
SP-B_HUM 1.027
AMP_A_ENT 0.406
Table 3.1: Gravy index of SP-B and the other proteins in the saposin fam-
ily. We can see that the GRAVY index of SP-B is very high compared
with the rest of the proteins, indicating the extreme hydrophobicity of SP-
B. The GRAVY values calculate using an online GRAVY index calculator
(http://www.bioinformatics.org/sms2/protein_gravy.html) [67].
pore A [8, 26], are similar to each other in displaying 4 or 5 helical regions in their
secondary structure, as well as three internal disulphide bonds. Although their sec-
ondary structure is similar, in their tertiary structure they have a variety of structures
(Figure 3.2). They can be in an open structure (Figure 3.2-A), bent (V-shape)
structure (Figure 3.2-B) or closed structure (Figure 3.2-C).
To carry out simulations on systems containing a protein and a large number of
lipid and water molecules, we should keep in mind that performing all-atom (AA)
force field simulations will give us more realistic and detailed structures at the cost of
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A! B! C!
Figure 3.2: Diﬀerent tertiary structures of the saposin family, A) Saposin A (PDB
ID: 4DDJ) in an open structure, B) Saposin C (PDB ID: 1N69) in a bent structure,
C) NK-lysin (PDB ID: 1NKL) in a closed structure. The structure of Saposin A
(in LDAO detergent) and Saposin C (in a buﬀer) are determined using X-ray crys-
tallography, while the structure of NK-lysin (in water) is determined using solution
NMR.
consuming significant computer time. By using coarse-grained (CG) force fields, the
simulations will run faster, but we will lose the atomistic resolution of the system.
Recent advances in computation hardware and software have made it possible to sim-
ulate large systems. A recently developed coarse-grained force field is the MARTINI
model [24–26], which is now becoming widely used for large biomolecules [23,27,36,37].
To increase the accuracy of the simulations, researchers use hybrid model force fields
in which they use diﬀerent force fields for diﬀerent components of the simulation,
depending on the relative importance of the system components. Such a scheme may
employ the combination of an AA force field or united-atom (UA) force field for pro-
teins in the system and a CG force field for the rest of the molecules in the system,
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e.g., water and lipids [17, 38–40]. Using such an approach helps the simulation run
faster while retaining more detail on system components of interest.
Several researchers have employed modelling approaches to carry out simulations
to predict the structure and behaviour of full-length SP-B in lipid bilayers. Zaltash
et al. [42] have studied SP-B’s monomeric and dimeric structures using NK-lysin as
a template for the secondary structure of the SP-B using Monte Carlo simulations.
They have also used polymyxin-B as a template to study the functionality of protein
in lipid bilayer (polymyxin-B mimics SP-B’s functions but it is structurally diﬀerent).
Based on their model, they have predicted that the distribution of polar and non-
polar residues in the SP-B dimer is compatible both with SP-B positioning at the
water-lipid interface of a bilayer and with the ability of SP-B to cross-link membrane
multilayers. Baoukina and coworkers have performed coarse grained simulations on
monomers of SP-B and SP-C interacting with vesicles. They have studied the fusion
of two lipid vesicles in the presence of SP-B monomers [23] and the fusion of lipid
vesicles and bicelles into lipid monolayers in the presence of SP-B monomers and
dimers [27]. They have modelled SP-B employing homology modelling based on NK-
lysin, Saposin C and Mini-B structures. In their studies they have seen SP-B present
as both open and closed structures, which will be discussed later in this chapter.
SP-B purified from animal lungs exhibits a variety of oligomeric states and deletion
of C48 does not impair SP-B’s function [43]. It has been suggested that, in addition
to the C48-C48 disulfide, SP-B dimers may be stabilized through salt bridges between
E51 and R52 [42, 44]. Olmeda et al. [27] have recently proposed that SP-B acts as a
multimer of dimers, forming hydrophobic ring/tube shapes. Thus, SP-B’s functional
oligomerization state is still something of an open question.
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In this chapter we are trying to find low energy 3D structures of SP-B using
computer simulations, employing both MD and REMD techniques. To reach this
goal one should run simulations for a suﬃciently long time for the protein to find
the low energy structures. I run most of our all-atom simulations for   2 µs, which
appears to be long enough to approach equilibrium, in that we see some convergence of
structure from diﬀerent starting configurations and large-scale conformational changes
(Table 3.4). These simulations give us detailed information about the structure of
SP-B and ideas about the functional mechanism of the protein. To further explore the
structures, we employ a hybrid force field, PACE, to run two sets of MD simulations,
as well as a series of REMD simulations. PACE uses a UA force field for the protein
part and the MARTINI force field for the rest of the particles in the simulation box [17,
18]. To reduce the computer time required to equilibrate the protein, we try to use
reasonable starting model structures based on homology modelling, experimentally
determined structures for smaller proteins derived from SP-B and ideas from the
literature on the secondary structure of SP-B.
3.2 Methods
3.2.1 Modelling the Initial Structure of SP-B
A useful method to predict the structure of protein is homology modelling, which
predicts the 3D structure of a protein with an unknown structure based on sequence
similarity to a protein of known structure. Because SP-B is from the saposin family
of proteins, we can use the known structures of proteins from this protein family
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to carry out homology modelling of SP-B. This method is challenging because the
saposins with known structure are not very similar in sequence to SP-B.
Running the basic local alignment search tool (BLAST) [31] on the UniPort
webpage (http://www.uniprot.org/blast/) indicates roughly near 25% identity (for
Saposin C) in sequence of SP-B as the maximum compared to other proteins in the
saposin super family. The homology model based on one of the Saposin C structures
(PDB IDs: 2QYP [21]) produces 82% helicity, which is much higher than the ex-
perimental values for SP-B (35-50% [26]). Homology modelling based on the other
Saposin C structures (1SN6 [22] and 1M12 [23]), along with the problem of high per-
cent helicity, the model produced does not form the third disulfide bond (C35-C46).
Our approach is to pair information from homology modelling based on both
NK-lysin and Saposin C with the experimentally-determined structure of Mini-B, a
construct derived from SP-B; The structure of portions of SP-B that are in common
with Mini-B are given on the structure of Mini-B, while the structure of the rest of
SP-B is inferred from homology to NK-lysin and Saposin C with the idea of the SP-B
having amphipathic helical regions. Residues 26-62 of SP-B (residues not included
in Mini-B) do not have residue-specific experimental data, but, based on secondary
structure prediction techniques applied to SP-B [2,22] and homology to other saposins,
are believed to contain two or three amphipathic ↵-helices. In Table 3.2 we see
a comparison of helical regions in our model (Figure 3.1) to some other models
introduced for SP-B [23, 27, 48, 49]. Given the large proportion of proline in the first
seven residues (F-P-I-P-L-P-Y), this initial sequence is likely to take on an extended,
poly-proline helix-like structure. We produce our SP-B sequence by keeping the helical
regions of Mini-B (which we call H-II and H-V), and introducing helical structure to
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Ile-3–Tyr-7 (H-I), Val-31–Val-37 (H-III) and Cys-46–Leu-61 (H-IV) (Figure 3.1)
and (Table 3.2). Helices II-V are predicted to be ↵-helical based on homology (C46-
G47-C48 are in the 310 helical structure). We employed both STRIDE [42] as a VMD
plugin and DSSP [51, 52] as a GROMACS tool, to calculate the secondary structure
of the protein. These methods use two diﬀerent ways of calculating the secondary
structure. Although employing both methods to calculate the helical structure of the
initial structures of SP-B gives similar results, there are diﬀerences between them,
e. g. in the initial structure of SP-B C46-G47-C48 were defined to be in 310 helical
structure in STRIDE plug-in of VMD while the DSSP plug-in of GROMACS called
this region ↵-helical. Thus, we call all the three secondary structures of ↵-helical,
310-helical and ⇡-helical (which rarely occurs in simulations) with the general name
of “helical” structure. Residues 1-7 are likely to be in an extended, possibly poly-
proline helix like structure. As an artifact of energy minimization of the structure
in SPV software, which we used to build the structures, residues 3-7 were given an
alpha-helical starting structure.
We make our SP-B protein in two diﬀerent structures, open and bent (V-shape)
(Figure 3.3). The regions at the bend are chosen to be Met-21–Lys-23 and Gly-63–
Leu-66 in order to preserve the helical regions (Figure 3.1). The whole procedure of
constructing our SP-B model is done using Swiss PDB viewer (SPV) software [53].
For our simulations, we do not construct a model of the protein in a closed struc-
ture. Adding new structures increases the number of simulations, and hence the
demand for computational resources, required to validate them. Rather, we wish to
determine whether SP-B tends to have an open or closed structure, and do so by
simulating the bent structure, which could either open up or close in, depending on
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Figure 3.3: The two starting structure models of SP-B based on Mini-B structure
(PDB ID: 2DWF) and homology to saposin super family structures. Here we can
see the open structure of SP-B: A) side view and B) top view; and the bent (V-
shape) structure of SP-B: C) side view and D) top view. The protein backbone is
shown as an orange ribbon, the cysteine sidechains in yellow, hydrophobic sidechains
in white, polar uncharged sidechains in green, positively charged sidechains in blue,
and negatively charged sidechains in red.
the energetics of the protein.
3.2.1.1 Molecular Dynamics
In carrying out MD simulations we use both OPLS-AA and PACE force fields. We
try to keep the initial system configurations of the simulations the same for both
force fields (Table 3.3). In setting up MD simulations that use OPLS-AA, we use a
pre-assembled POPC bilayer composed of 512 lipid molecules. The bilayer employed
has a pore in order to allow lipid molecules to move from one leaflet to the other
in order to keep the lipid/area ratio in the whole bilayer constant. To generate the
84
Helical region open (bent) open (bent) model-A model-B model-C
AA model UA model
helix-I 3-7 (3-7) 3-7 (3-7) - - -
helix-II 10-21 (10-20) 10-21 (10-21) 7-21 10-20 8-22
helix-III 31-37 (31-37) 30-37 (30-37) 32-36 26-35 27-38
helix-IV 46-61 (46-62) 46-61 (46-62) 42-64 44-58 42-50
helix-V 67-76 (67-76) 67-76 (67-76) 68-76 67-78 67-74
Table 3.2: Proposed helical regions, given by residue number, of SP-B protein in
diﬀerent models. The open(bent) structure for the all-atom force field and open(bent)
structure for the united-atom force field are the four models we use in our simulations.
The previously used models are Model-A, introduced by Tieleman and coworkers [23,
27], Model-B, which was a model previously used in our group [48], and model-C,
introduced by the Johansson group [49]. The helical regions for bent structures are
enclosed in parentheses.
bilayer, we start with 3 pre-assembled perfect lipid bilayers, each composed of 128
lipid molecules and one lipid bilayer containing a pore, also composed of 128 POPC
lipids (from one of our control simulations in the previous chapter). We put these four
bilayer sections beside each other in a square to produce our lipid bilayer containing
512 POPC lipid molecules. To equilibrate the new lipid bilayer, we add water to the
system and run it under NVT conditions for 2 ns at 310 K, and subsequently under
NPT conditions for 50 ns at 310 K. The pore placed in the membrane remains in the
bilayer during the simulation as we discussed in Chapter 2.
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Packages
Box Contents GROMACS 4.5.5 GROMACS 4.6.3
Force Field OPLS-AA PACE
Method MD MD & REMD
Number of POPC 496 ⇠ 400
Number of Water 38000 ⇠ 11000
Number of Cl ions 7 7
Number of SP-B 1 1
Table 3.3: Contents of simulation box for our simulations.
Then we add protein to the system. For each of the structures (open and bent) we
put the protein in three diﬀerent positions with respect to the bilayer: inside (in), half
inside (half) and outside (out) the bilayer (Figure 3.4, Figure 3.5 and Figure 3.6).
To put the protein in a more favourable position, we put the hydrophobic face of the
protein pointing towards the bilayer centre and hydrophilic face towards the water.
SP-B is placed far from the (preformed) pore to prevent the pore and protein from
interacting. To put the protein inside the bilayer, we use the g_membed tool in
GROMACS, which embeds protein in the lipid bilayer by removing the least number
of lipid molecules. Each of our six simulation boxes generated in this way has 496
POPC lipid molecules, 38000 TIP4P water molecules, 7 Cl  counter ions and an SP-
B protein (Table 3.3). The system size in x, y and z directions before starting the
simulation are ⇠ 12.4 nm, ⇠ 12.3 nm and ⇠ 11.7 nm, respectively.
For each of the simulation boxes we use the same method to set up and run the
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Open%half*
Open%in*
Open%out*
Figure 3.4: Initial and final positions of the open structure shown in relation to the
lipid bilayer in all-atom simulations. Left: diﬀerent initial positions. Right: The
corresponding final structure at the end of the simulation.
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Bent%half*
Bent%in*
Bent%out*
Figure 3.5: Initial and final positions of the bent structure viewed in relation to the
lipid bilayer in all-atom simulations. Left: diﬀerent initial positions. Right: The
corresponding final structure at the end of the simulation.
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Bent%half%PACE.
Open%half%PACE.
Figure 3.6: Initial and final positions of Mini-B-based open with respect to the lipid
bilayer in PACE simulations. Left: Diﬀerent initial positions of open with respect
to the lipid bilayer. Right: The corresponding final structure of open at the end of
simulation.
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simulations. In the first step, under NVT conditions we run the system at 310 K
for 2 ns with protein position restrained and with a time step of 2 fs. We keep the
protein position restrained to prevent any structural changes before the production
run. In the second step, we run the system under NPT condition at 310 K and 1 atm
for 100 ps with protein position restrained and using Parrinello-Rahman isotropic
pressure coupling with ⌧p = 5 ps and compressibility = 4.5⇥10 5 bar 1. In the final
step, the production run, we simulate the system under NPT conditions at 310 K and
1 atm, using Parrinello-Rahman semi-isotropic pressure coupling, with the same time
constant and compressibility as before and removing the protein position restraints.
We run these simulations with a time step of 2 fs for 2 to 2.5 µs in duration, except
for the bent-out simulation, which runs for 700 ns as the protein fairly quickly forms
the closed structure and remains closed. Details of the simulation parameters are in
Appendix A.
In addition to the OPLS-AA all-atom force field, we use the PACE force field.
We try to keep the initial setup of the PACE simulations as close as possible to the
OPLS-AA initial setup. To set up the simulation box and to embed the protein in
lipid bilayer, we use a web based protocol explained in Ref. (58), developed for this
force field. We upload the PDB file of our SP-B to the webpage [59]. Then we select
the type and size of the bilayer and the distance and orientation of the protein with
respect to the prepared bilayer. In our case, we produce a POPC bilayer containing
⇠ 400 POPC molecules. After that, we place the bent and open forms of the protein
partially inside the bilayer with the hydrophobic side facing toward the bilayer centre.
Then we add PACE water molecules (MARTINI water, where 4 water molecules are
represented as a single coarse-grained bead) and neutralize the system by adding 7
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Cl  ions (MARTINI model). The system dimensions in the x, y and z directions
before starting the simulation are ⇠ 13 nm, ⇠ 13 nm and ⇠ 9 nm, respectively.
As a cautionary note, we mention that for MARTINI water molecules, the GRO-
MACS utility that normally solvates the system with more realistic models of water,
adds what is in eﬀect too many water molecules, leading to unwanted crystallization
owing to a high density. To prevent this, we simply add ⇠20% fewer water molecules,
so that they remain in the liquid state. We add ⇠ 11000 water “beads” to fill the
simulation box.
We run the system under NVT conditions at T = 310 K for 2 ns with a time step
of 5 fs, restraining the position of the protein. In the second and final step, we start
the production run. Under NPT condition using Parrinello-Rahman, semi-isotropic
pressure coupling with ⌧p = 5 ps and compressibility = 4.5⇥10 5 bar 1, at 310 K,
we run the system for 3 µs with a time step of 5 fs, without position restraints on
the protein. Details of the simulation parameters are in Appendix A. Based on the
initial protein position and conformation, we call the two PACE simulations “bent-
half-PACE” and “open-half-PACE”.
3.2.1.2 REMD
We carry out replica exchange molecular dynamics only with the PACE force field as
all-atom simulations would be prohibitively costly to run. The temperatures we use
range from 300 K up to 370 K divided into 32 exponentially-spaced temperatures:
300, 302, 304, 306.1, 308.2, 310.3, 312.4, 314.5, 316.7, 318.8, 321, 323.2, 325.4, 327.6,
329.8, 332, 334.3, 336.7, 338.8, 341.1, 343.5, 345.8, 348.1, 350.5, 352.9, 355.3, 357.7,
360.1, 362.6, 365, 367.5 and 370. The first temperature of 300 K is lower than the
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temperature of our MD simulations (310 K), while the last temperature of 370 K is
well above physiological temperatures but below the disruption phase transition of
our bilayer, allowing it to keep its shape. We use one of our previously made initial
structures for PACE MD simulations, the bent-half structure, as the initial structure
for all 32 of the temperature replicas. In these sets of simulations, each simulation box
contains 400 POPC lipids, 1 SP-B protein, 7 Cl  counter ions to neutralize the system
and ⇠ 8000 water molecules. Prior to commencing REMD, we first equilibrate each of
the 32 systems at its own temperature for 2 ns in a simple MD run. In the production
REMD step under NPT conditions, using Parrinello-Rahman semi-isotropic pressure
coupling with ⌧p = 5 ps and compressibility = 4.5⇥10 5 bar 1, we run the all 32
systems in parallel for 3 µs. We use a time step of 4 fs. Exchange attempts between
systems with neighbouring temperatures happens every 800 steps.
3.2.2 Other Computational Details
We use GROMACS tools and the STRIDE and salt bridge plugins of VMD 1.9.1 [54,
55] to analyze the simulation results. We use VMD 1.9.1 also to visualize our system.
We run all-atom simulations mainly using SCINET GPC clusters [56].
For the all-atom simulations, we typically run the system in parallel on 400 CPU
cores. On average, each simulation runs at a rate of 16–20 ns/day. In practice, it takes
approximately 400 days to run all six of the all-atom simulations, based on the queue
availability of our computational resources. In the case of the PACE simulations, we
use 120 cores, yielding ⇠260 ns/day. It takes almost three weeks to simulate for 3 µs.
In the case of REMD simulations, we use 16 cores per replica, for a total of 512 cores,
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yielding a simulation rate of 100 ns/day. These simulations take almost 5 weeks to
run.
3.3 Results
In our OPLS-AA simulations, there are two simulations in which the protein maintains
an open structure just inside the bilayer and parallel to it, two in which a bent
protein stabilizes defects within the membrane, and two for which the protein forms
a globular structure in the water environment outside the bilayer. In the PACE
simulations, all of our systems end up with open structure, parallel to lipid bilayer.
In all our simulations, the proteins do not reach and have no interaction with the
preformed pore that was included in the initial lipid bilayer to ease the movement of
lipid molecules between the bilayer leaflets.
3.3.1 MD Simulations
In our sets of MD simulations, we use both open and bent (V-shape) conformations
as starting structures (Figure 3.4, Figure 3.5 and Figure 3.6), and employ both
OPLS-AA and PACE force fields. A brief overview of each simulation is provided
in Table 3.4. In the following, we present quantities that give a sense of how the
systems are approaching equilibrium, a narrative of how the protein evolves in time
and structural analysis pertinent to how the protein interacts with the bilayer.
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System Number of atoms Time (ns) Description of protein behaviour
open-in-OPLS-AA 179,069 2,000 Stable structure
open-half-OPLS-AA 179,069 2,000 Stable, but sinks to similar depth as open-in-OPLS-AA
open-out-OPLS-AA 179,069 2,500 Forms closed structure after large structural changes
bent-in-OPLS-AA 179,069 2,500 Relaxes, but keeps overall positioning in membrane
bent-half-OPLS-AA 179,069 2,500 Forms pore; V-shape opens up
bent-out-OPLS-AA 179,069 700 Protein closes rapidly
open-half-PACE 13,072 3,000 Protein remains in the water lipid interface
bent-half-PACE 17,029 3,000
Protein opens up, pushes lipid head groups to place
itself in the water lipid interface
Table 3.4: Brief summery and descriptions for each simulation.
3.3.1.1 System in Equilibrium
In the case of the all-atom simulations, despite the long run times, we see from
the plots of the potential energy (Figure 3.7) that the systems are still relaxing.
However, from the nearly steady-state behaviour of the radius of gyration (Rg) of the
protein’s backbone (Figure 3.8) and the small root mean square deviation (RMSD)
values attained at the longer times (Figure 3.9), we have some indication that each
of the simulations is converging to an equilibrium state. In contrast, the PACE
simulations appear to equilibrate after approximately 1 µs according to the potential
energy time and RMSD time series, even though Rg still exhibits some evolution;
thus, system energy may not be an optimal quantity for gauging equilibration for the
PACE simulations.
We note that for the all-atom simulations, the energy plots are very close to each
other because of the identical contents of the simulation boxes. For the systems using
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Figure 3.7: Time evolution of the potential energy of open (left) and bent (right) sys-
tems in OPLS all-atom simulations (top) and PACE (bottom) during representative
simulations. In these panels, shown are running averages over 50 data points, with
1 ns between data points.
PACE force field simulations, as the number of lipid and water molecules are diﬀerent
in each simulation, the values of the potential energies are significantly oﬀset from
each other.
We use radius of gyration plots to study the shape of our proteins qualitatively
during the simulation and to find geometrical similarities in our proteins, e.g. open
structures have similar Rg values (Figure 3.8). We calculate the Rg of the protein’s
main chain, during the simulation for both all-atom and hybrid-model simulations.
The initial radius of gyration in OPLS-AA simulations for bent and open are ⇠1.6
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nm and ⇠2.1 nm respectively. Small diﬀerences in initial values are due to small
changes in protein structure that arise during preparation of the simulation box. In
general, the final Rg values for each simulation correlate nicely to the final snapshots
of the protein in Figures 3.4, Figures 3.5 and Figures 3.6, although the similarity
in Rg between the bent-half and the open simulations illustrates the limits of relying
on Rg to diﬀerentiate between structures i. e. the bent-half structure has similar Rg
with open-in and open half, but its tertiary structure is quite diﬀerent from these two
proteins.
For the case of the bent structures, the proteins in each diﬀerent system reach
diﬀerent Rg values, which represent diﬀerent final protein structures in these sets of
simulations (Figure 3.8). In the bent-out structure, the protein closes into a compact
structure in the first steps of simulation, which leads to the big drop in Rg during
the simulation. For both the bent-half and the bent-in structures, the protein starts
with similar structures but the structures diverge as the simulations continue.
In the open-out simulation, the protein structure closes after dramatic changes
in the Rg value. These changes arise as the protein’s structure optimizes in the
presence of water environment. In the open-half and open-in systems, despite the
small fluctuations, the Rg time series have similar trends and reach similar values.
Similar to the all-atom simulations, we calculate the Rg of the protein’s main
chain for hybrid-model force field simulations. We can see that in the open-half-
PACE system, apart from some notable dips, Rg remains at roughly its initial value
(Figure 3.8). In bent-half-PACE, the protein opens up slightly to produce a more
extended structure compared to its initial structure (Figure 3.8).
To further investigate conformational changes of the protein’s structure, we cal-
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Figure 3.8: Time evolution of the radius of gyration of open (left) and bent (right)
systems in OPLS all-atom simulations (top) and PACE (bottom), during representa-
tive simulations. We have used the heavy atoms of the main chain of the protein to
calculate the Rg, with 1 ns between data points.
culate RMSD values for the main chain of the protein for each system with respect
to the final configuration of each trajectory of the system for both all-atom and
hybrid-model force field simulations (Figure 3.9). For the all-atom simulations, the
RMSD plots show that each system has reached an RMSD value of less than 2 Å, a
value often taken to indicate that the system has reached an equilibrium state (Fig-
ure 3.9) [60, 61]. In all of the simulations we can see the RMSD value is decreasing
roughly monotonically, except in the open-out system, where the RMSD value de-
creases initially, but then increases as the protein significantly reconfigures itself. The
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Figure 3.9: Time evolution of RMSD (both rotational and translational) of open
(left) and bent (right) of the system in OPLS all-atom simulations (top) and PACE
(bottom) during representative simulations compared to the final structure of the
protein. We have used main chain of the protein to calculate the RMSD, with 1 ns
between data points.
RMSD dramatically decreases after that, indicating that the protein is settling into
an equilibrium conformation (Figure 3.9 and Figure 3.12).
In hybrid-model force field simulations, similar to all-atom simulations, the RMSD
values approach 2 Å by the end of the simulation (Figure 3.9). Our results indicate
that the PACE simulations have larger fluctuations in RMSD, as compared to OPLS
simulations.
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3.3.1.2 System Evolution During the Simulation
In Figures 3.10 to 3.17, we can see snapshots and plots of how each system evolves
during the simulation. In all of these simulations, the protein evolves in such a way
that the charged residues face the lipid head groups and water molecules.
In the open-in-OPLS-AA simulation, the position of the protein remains fairly
stable during the simulation (Figure 3.10). The protein is initially placed in a lipid
chain environment with hydrophilic residues facing toward lipid headgroups and water
molecules. The secondary structure of the protein changes during the simulation but
the protein retains its overall position in the lipid bilayer. The loop between the
central two alpha helices of the protein, is mobile amongst the lipid chains, and
interacts with the lipid chains of the opposite leaflet (t= 640 ns) but not to the
extent of perturbing it.
In the open-half-OPLS-AA simulation, the protein sinks deeper into the lipid
bilayer, reaching a position similar to the open-in-OPLS-AA system (Figure 3.11).
In this simulation, the protein is also initially placed among the lipid head groups
with hydrophilic residues facing toward water molecules. Here we can see the loop
between the central two alpha helices of the protein maintains more stable among
lipid headgroup in comparison to the open-in-OPLS-AA simulation just described
above.
In the open-out-OPLS-AA simulation, the protein undergoes rather dramatic
changes in its structure during the simulation. In this simulation we can see the
flexibility and changes in the orientation and structure of the the two middle helices
of the protein. The loop between the central two alpha helices also shows its flexibility,
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Figure 3.10: Snapshots of open-in-OPLS-AA system during the simulation. We can
see protein initially has an open structure, and is positioned just at the polar/apolar
interface of the. Hydrophobic sidechains (white coloured) are facing towards the
centre of bilayer, while the hydrophilic sidechains (coloured) face toward the water
molecules (blue dots). As the simulation progresses the N- and C-terminal ↵-helices,
i.e. the Mini-B region, (the helix pair on the left) largely retain their helical structure,
while the “middle” helix pair (the helix pair on the right) show larger changes in
secondary structure. The loop between the middle helix pair (as shown in the far
right of each snapshot) dips, but does not reach the other lipid leaflet.
which seems to help the protein reach to its final structure. It starts from an initially
unfavourable orientation, where the hydrophobic residues face towards the charged
headgroups of the lipid molecules. During the simulation, the secondary structure of
the protein changes in a way that the protein forms a closed structure with hydropho-
bic residues prevented from contacting water molecules. The charged groups in the
Mini-B part of the protein make the initial contacts with lipid headgroups and these
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Figure 3.11: Snapshots of open-half-OPLS-AA system during the simulation. We
can see protein initially has an open structure, placed among the lipid headgroups
half-inside the lipid bilayer. Hydrophobic sidechains (white coloured) face towards
the centre of bilayer, while the hydrophilic sidechains (coloured) face toward the
water molecules (blue dots). We can see that during the simulation the protein sinks
deeper into the lipid bilayer and the secondary structure of some regions of the protein
changes dramatically.
contacts remain during the simulation (Figure 3.12).
In the bent-in-OPLS-AA simulation, the protein remains inside the lipid bilayer,
preserving the water-containing defects initially produced in the bilayer during the
embedding of the protein (Figure 3.13). The initial sharply V-shaped structure of
the protein changes during the simulation, to form a more contiguous curve.
The most interesting system of these eight simulations is bent-half-OPLS-AA.
In this simulation, The loop between the central two alpha helices of the protein,
via Pro-39 residue, reaches across to the other leaflet and penetrates the membrane,
producing a pore in the lipid bilayer (Figure 3.14). Proline, based on Wimley-
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Figure 3.12: Snapshots of open-out-OPLS-AA system during the simulation. We
can see protein initially has an open structure, placed outside the lipid bilayer. Hy-
drophobic sidechains (white coloured) initially face toward the lipid bilayer, while the
hydrophilic sidechains (coloured) face toward the water molecules (blue dots). We
can see during the simulation the protein’s structure changes dramatically to take on
a closed structure.
White whole-residue hydrophobicity scales [62], is a hydrophilic amino acid that in
this simulation reaches to the headgroups of the other bilayer leaflet, penetrates the
bilayer. Figure 3.15 shows changes in the position of the Pro-39, with respect to the
lipid bilayer during the simulation. Here, in addition to the average position of the
phosphorus atoms within the lipid headgroups of each leaflet, we show the positions
of the phosphorus atoms located within a cylinder of radius 2 nm (parallel to the
bilayer normal) around the C  carbon atom of the Pro-39 residue, as well as the
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Figure 3.13: Snapshots of bent-in-OPLS-AA system during the simulation. We can
see protein initially has a bent structure, placed inside the lipid bilayer. Hydrophobic
sidechains (white coloured) face towards the centre of bilayer, while the hydrophilic
sidechains (coloured) face towards the water molecules (blue dots) and lipid head
groups. There are water-containing defects initially produced in the bilayer during
the preparation steps of this system, which we can see them persevered during the
course of the simulation. We can see the initial sharp bend structure converts into ca
continues curve, located inside the bilayer.
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Figure 3.14: Snapshots of bent-half-OPLS-AA system during the simulation. We
can see protein initially has a bent structure, placed half inside the lipid bilayer.
Hydrophobic sidechains (white coloured) face towards the centre of bilayer, while
the hydrophilic sidechains (coloured) face towards the water molecules. We can see
during the simulation that the Mini-B part of the protein moves toward the lipid-
water interface, parallel to the lipid bilayer, while the middle part of protein (middle
helices and the loop between them) reaches the other leaflet and produces a pore-like
defect in the bilayer. During the simulation, we can see changes to the secondary
( -strands at t=900 ns) and tertiary structure of the protein.
position of that carbon atom itself. This carbon atom tracks the action of the proline
residue within the loop region as it takes part in forming the pore, and the time
series shows instances of dipping down towards the bottom leaflet before progressing
continuously closer to the bottom leaflet, stabilizing the pore formed, aided by Pro-39
(Figure 3.14 and Figure 3.15).
In Figure 3.16 we can see the changes in the order parameter of the lipid acyl-
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Figure 3.15: Position of Pro-39 (orange) with respect to the lipid bilayer. The black
and red colours represent the position of bottom and top leaflets of the membrane,
respectively. The blue and green colours represent the position of phosphorus atoms
of the lipid bilayer near to the Pro-39 residue. We can see the protein first touches
the lipid headgroups of the bottom leaflet at about 250 ns and remains near to the
leaflet for the rest of the simulation.
chains with respect to the bilayer normal for the lipids that have the phosphorus
atom of their headgroup located within a cylinder of radius 2 nm (parallel to the
bilayer normal) around the C  carbon atom of the Pro-39 residue. Although there is
no direct point-to-point relation between the changes in the depth of the loop part of
the protein (Figure 3.15) and the order parameter of the acyl-chains (Figure 3.16),
we can see that during the penetration of the lipid bilayer (0 – ⇠ 1 µs), the order
parameter of the acyl-chains displays greater fluctuations. On the other hand, when
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Figure 3.16: Average order parameter of lipid acyl-chain in bent-half-OPLS-AA sys-
tem during the simulation with respect to the Z direction. The calculations are done
for lipid molecules with their head group within a 2 nm radius of a cylinder parallel
to bilayer normal with Pro-39 in the centre.
the protein is in a stable position in the lipid bilayer, the fluctuations in the order
parameter decreases.
In the bent-out-OPLS-AA system, the protein makes a closed structure in the first
few nano seconds of the simulation, remaining closed for the remainder (Figure 3.17).
Here, unlike the open-out-OPLS-AA system, the Mini-B part faces toward the water
molecules, while the charged residues in the loop between two middle helices interact
with the lipid headgroups.
Visual comparison of the final structures of the protein in open-in-OPLS-AA and
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Figure 3.17: Snapshots of the bent-out-OPLS-AA system during the simulation. We
can see that the protein initially has bent structure, placed outside the lipid bilayer.
Hydrophobic sidechains (white coloured) face towards the centre of bilayer, while the
hydrophilic sidechains (coloured) face towards the water molecules. We can see that
SP-B forms a closed structure very soon after the start of the simulation.
open-half-OPLS-AA simulations (Figure 3.18) and similarities in residue-residue
distances plots (Figure 3.19) indicate at least partial convergence in these two struc-
tures. The RMSD value for the last 50 ns of the open-in simulation compared to the
last structure of the open-half system is 4.75±0.13. Similarly, the RMSD value for the
last 50 ns of the open-half simulation compared to the last structure of the open-in
system is 4.95±0.14. However, for the last 50 ns of bent-half system, using the last
structure of open-in and open-half simulations as the reference structures provides
higher RMSD values of 5.43±0.29 and 7.353±0.29, respectively. In addition to visual
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Figure 3.18: Comparison of the final structures in the open-in-OPLS-AA and open-
half-OPLS-AA simulations. We can see similar helical regions in both systems.
comparison and RMSD calculations, in Figure 3.19, we can see similar patterns in
the close distances for the open-in, open-half and bent-half simulations. Although
the bent-half system has completely diﬀerent orientation in lipid bilayer compared
to open-in and open-half systems, the extended structure of bent-half (toward the
other leaflet) and the spacing between the residues makes their plots similar. On the
other hand, in open-out-OPLS-AA and bent-out-OPLS-AA simulations we can see
that although they both take on a closed globular structure, the secondary and the
tertiary structures are completely diﬀerent.
Turning to the PACE force field simulations, in the open-half-PACE system, simi-
lar to the open-half-OPLS-AA system, the protein slightly sinks into the lipid bilayer
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Figure 3.19: Average residues to residues distance over the last 200 ns of simulation.
Here, we can see that open-in-OPLS-AA, open-half-OPLS-AA and bent-half-OPLS-
AA systems have similar distance plots, indicating similar overall protein structures
in these simulations. On the other hand, in both open-out-OPLS-AA and bent-out-
OPLS-AA cases the protein forms compact, closed structures.
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Figure 3.20: Snapshots of the open-half-PACE system during the simulation. We can
see that the protein initially has an open structure, placed among the lipid headgroups
half-inside the lipid bilayer. Hydrophobic sidechains (white coloured) face towards the
centre of bilayer, while the hydrophilic sidechains (coloured) face towards the water
molecules (blue dots). We can see during the simulation the protein sinks deeper
into the lipid bilayer and the secondary structure of some parts of the protein change
dramatically. During the simulation, we can see the loop part dips in but does not
reach to the other leaflet.
with the loop part of the protein fluctuating among the acyl-chains of the bilayer (Fig-
ure 3.20). We can see the loop part of the protein is mobile during the simulation,
reaching to the other leaflet of the bilayer, but does not disrupt the bilayer.
In the bent-half-PACE simulation, the protein pushes the lipid headgroups aside
to make space for itself to take on an open position at the lipid-water interface (Fig-
ure 3.21).
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Figure 3.21: Snapshots of the bent-half-PACE system during the simulation. We can
see that the protein initially has an bent structure, placed among the lipid headgroups
half-inside the lipid bilayer. Hydrophobic sidechains (white coloured) face towards
the centre of bilayer, while the hydrophilic sidechains (coloured) face towards the
water molecules (blue dots). We can see during the simulation the protein pumps
out the lipid bilayer and pushes the head groups to place locate in an open structure,
parallel to the water-lipid interface.
3.3.1.3 Protein’s Secondary Structure
In addition to the energy, Rg and RMSD plots, we calculate, for a given protein
conformation, whether or not each residue is helical. In this way, we determine
the percentage helicity (both ↵-helical and 3-10 helical regions) of the protein as
a whole as a function of time and of each residue averaged over a period of time.
The initial helicity percentage in Figure 3.22 and Figure 3.23, is calculated based
on the structure of protein after applying the forcefield in the first step of setting
up simulation in GROMACS. The slight diﬀerences between OPLS-AA and PACE
111
simulations are due to the diﬀerent nature of each force field and their influence in
the secondary structure of the protein.
In Figure 3.22, we can see the percentage helicity of the protein during the
last 200 ns of simulation. For all of our simulations, we can see that the overall
helicity of the protein remains almost constant during this period, indicating that
the protein is in near to an equilibrium state in terms of the secondary structure.
For all-atom simulations, the mean value of helicity is nearly 35 percent, which is
comparable to experimental results [26]. We can see the percentage helicity during
this last portion of the simulation time is less than the initial helicity percentage of
protein, indicating that our initial model is more helical compared to the equilibrated
structure (Figure 3.22).
Comparing the percentage helicity of the protein in PACE and OPLS-AA simula-
tions shows that PACE simulations, overall, have slightly higher helicity, especially in
bent-half-PACE, with respect to OPLS-AA simulations (Figure 3.22). This could in-
dicate the PACE force filed induces more helicity in the protein’s secondary structure
compared to OPLS-AA force field. The small diﬀerence in initial helicity percentages
values in open and bent systems (black dots), is due to all the pre-production run
setup steps. In the bent-half-PACE system, the protein has ⇠ 45% helicity, while
in open-half-PACE system the protein has, ⇠ 40% helicity over the lat 200 ns of
simulation.
In Figure 3.23, we can see the overall percentage helicity of SP-B for each residue
over the last 200 ns of simulation for both OPLS-AA and PACE force field systems.
The initial structure of the protein has 5 helical structures, helix-I, residues 4 7,
helix-II, residues 10 ⇠20, helix-III, residues ⇠31 37, helix-IV, residues 46 ⇠60 and
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Figure 3.22: Time evolution of percentage helicity of protein in open (left) and bent
(right) for initial configuration in OPLS all-atom (top) and PACE (bottom) force
fields during the last 200 ns of simulations. We have used the STRIDE plugin of the
VMD to calculate the helicity, with 1 ns between data points. The black dot in each
plot represents the helicity percentage in initial structure, i.e. before the structure
was subjected to all the pre-production run setup steps .
helix-V, residues 67 76 (Table 3.2 and Figure 3.23).
For all-atom simulations, we can see that the helix-I and helix-II regions partially
merge into each other, except in open-out system, where the protein has a new clear
boundary between helix-I and helix-II. This indicates that the helical structure in the
N-terminus should be amalgamated into one helical region. Helix-V, in general, is
well preserved in our simulations, which in addition to the helix-I and helix-II regions,
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Figure 3.23: Evolution of percentage helicity of the protein in open (left) and bent
(right) system in OPLS all-atom (top) and PACE (bottom) simulations for each
residue, during the last 200 ns of simulations. We used STRIDE program in VMD to
calculate the helicity, with 1 ns between data points. The purple background in each
plot represents the helicity percentage of each residue of protein in initial structure
for all the simulations, i.e. before the structure was subjected to the pre-production
run set-up steps. The blue line on X-axis represents the position for ERYS residues.
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indicates that the Mini-B part of our protein confirms the initial helical prediction of
our model. Helix-III retains about 60% helicity on average, when the protein is inside
or half-inside the lipid bilayer. By contrast the helicity is completely lost, when the
protein is in the water environment. This indicates that this part is well predicted
by our model, to be helical in lipid environment (open/bent-in/half systems) and
non-helical in water environment (open/bent-out systems). In 5 out of 6 simulations,
helix-IV divides into two smaller helical regions, except in open-out, where the helicity
is more than 70% preserved. When the protein is initially placed inside or half-inside
the bilayer, the Glu-51, Arg-52, Tyr-53, Ser-54 (ERYS) sequence of the protein loses
its helical structure except in the open-half simulation, which could be due to the
presence of salt bridges in this system (discussed in the salt bridges section). This
indicates that despite what the homology modelling predicted for the initial structure,
residues 51 to 54 are unlikely to take on an alpha helical structure.
For hybrid-model simulations, we can see that the helix-I region loses helical struc-
ture, which could be related to its high mobility in the simulation. Our simulations
retain more than 90% of the helix-II region. In the bent-half, unlike the open-half,
we have new helical regions introduced between the helix-II and the helix-III, as
well as the helix-III and the helix-IV. helix-IV is preserved in the bent-half system,
while we have a break in helicity in ERYS part in the open-half system. helix-V is
well-preserved in open-half and partially preserved in bent-half simulations.
3.3.1.4 Salt Bridges
Salt bridges are electrostatic non-covalent bonds between residues with opposite
charges that are suﬃciently close to each other [63]. The distance between the two
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charged residues, i.e. the oxygen of the negatively charged residue and the nitrogen of
the positively charged residue, should be d  4 Å to be considered a salt bridge [64].
There are salt bridges present in SP-B’s structure, which may play an important role
in the protein’s secondary and tertiary structure. We used the default value within
VMD of d  3.2 Å [65] to identify the salt bridges in our system. In Figure 3.24,
we show the location of salt bridges for the last 200 ns of our OPLS-AA simulations
of the protein initially placed inside and half inside the lipid bilayer.
The salt bridges we observe are readily grouped into two categories: a) along the
protein sequence and b) across the “arms” of the hairpin, reminiscent of disulphide
bonds (the arm is the sequence of SP-B, excluding the loop region). Figure 3.24
indicates that all of our simulations make at least one salt bridge along the protein
sequence i.e. D59-R64. Another salt bridge, from D59-R52 is an interesting one,
and only occurs in the open-half simulation. This salt bridge in combination with
D59-R64 and E51-R52 form a wall-like structure, in which the side chains stack next
to each other (Figure 3.24), that prevents the ERYS sequence from losing its helical
structure, which it does in the other simulations (Figure 3.24 and Figure 3.23). In
the open-half and the bent-half simulations, we have a salt bridge between adjacent
amino acids E51-R52. These two residues are thought to play a role in quaternary
structure, as they have been proposed to form salt bridges between pairs of SP-B in
dimers [42, 44].
The main diﬀerence between open and bent simulations is the presence of the
D59-K24 salt bridge in the bent structures (both bent-in and bent-half). The loca-
tion of this salt bridge is quite notable, in that it is located at or near the “hinge”
separating the parallel-to-membrane and transverse portions of the protein in the
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Figure 3.24: Final structures of SP-B in open and bent simulations using OPLS-AA
forcefield. On the left, we can see a sequence representation of the protein and on the
right, we can see a corresponding snapshot from near the end of the simulation. In the
protein sequence, PHE-1 is in pink, the helical regions are in red, the disulphide bonds
are in solid black lines and salt bridges are in dashed blue lines. In the snapshots,
the PHE-1 is in pink spheres, the protein is in gray, the helical regions are in gray
cylinders, negatively and positively charged residues are in red and blue, respectively
with the salt-bridge-forming residues bolded, P atoms of lipid head group are in green
spheres and water molecules are in silver lines. The last 200 ns of simulation is used
for our calculations. 40% presence is chosen as the minimum to show the helicity.
We used the default value of d 3.2 Å within VMD to identify the salt bridges in our
system.
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bent-half simulation. This salt bridge constrains and stabilizes the central portion of
the protein (the part between Cys11-Cys71 and Cys35-Cys46 disulphide bonds) and
appears to prevent the protein from opening up and widening the “trough” of water
molecules between the arms.. We speculate that the twisting of the two arms implicit
in the formation of this bridge, as the residue side chains turn from pointing up to-
wards the water to pointing more towards each other, may assist in conformational
changes required for bending, i.e., forming or stabilizing the hinge. The other salt
bridge across the protein sequence is E51-R36, which is close to the loop as well as the
Cys35-Cys46 disulphide bond. The close proximity of this salt bridge to the disul-
phide bond renders it less important in geometrically constraining the loop portion
of the protein.
All of the salt bridges in the bent-half simulation appear after the pore formation
(after 600 ns), which could indicate the role of flexibility in pore formation. The D59-
K24 salt bridge forms around 600 ns, E51-R52 forms after 1 µs, and both E51-R36
and D59-R64 form after 1.5 µs. In the open simulations, the salt bridges along the
protein sequence appear in the early steps of the simulations, except for the D59-R52
salt bridge which appears in the last 800 ns of the simulation. In the bent simulations,
these salt bridges are formed after almost 1.5 µs of the simulation. In the bent-in
simulation, the D59-K24 salt bridge forms in the first few ns of the simulation. In
this system, the E51-R36 and E51-R52 salt bridges appear only in the first few ns of
the simulation and disappear in the rest of the simulation. Similarly, in the open-half
simulation, the D59-K24 salt bridge appears only in the first few ns and disappears
in the rest of the simulation. Thus, we see a breadth of time scales associated with
salt bridges. Unfavourable bridges can break up and favourable ones can form, if the
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configuration and local environments of the protein are suitable, on the order of ns.
By contrast, some salt bridge formation requires on the order of a µs to form, whether
along or across the arms of the protein.
The bent-half simulation contains almost all of the possible salt bridges, which
is interesting in that this configuration represents a step between an open structure
parallel to the bilayer surface (open-in and open-half) and one that is completely bent
and disruptive of the membrane (bent-in). Indeed, in Figure 3.14 we see snapshots
for which the protein takes on a long, linear structure, but is tilted by about 30  with
respect to the bilayer, e. g. in 1050 ns. We can see in Figure 3.24 that the N/C
terminal regions are parallel to the lipid bilayer, similar to the open simulations, and
the central loop interacts with the pore region, similar to the bent-in simulation. De-
spite the kink between parallel and transverse parts of this protein configuration, the
overall structure is similar to that of the open structures, as evidenced by the residue
distance plot (Figure 3.19). In other words, bending, which results in portions of
the protein changing environments in terms of surrounding lipid and water, can occur
through localized changes. It is not unreasonable to assume a supportive role played
by salt bridges in maintaining protein conformation.
As a salt bridge can form not only between residues, but also between a lipid
head group and a residue, one might expect that the propensity to form intrapeptide
salt bridges will vary depending on whether the lipids are zwitterionic (as in our
POPC bilayer) or anionic (like PG), and this may aﬀect preferred protein structure.
In the lung, where a significant portion of the lipid head groups are anionic, the
likelihood of forming the cross-arm D59-K24 bridge that appears to stabilize bent
configurations, may be diﬀerent, and hence the bent (membrane disrupting) and open
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(parallel to membrane) configurations may occur with diﬀerent relative frequencies,
aﬀecting functionality.
3.3.2 REMD Simulations
Here we present data for REMD simulations, for which each temperature replica
started with with the same bent-half-PACE initial configuration. While REMD re-
quires significantly more computational resources as all temperature replicas run in
parallel, the presumed advantage stems from the possibility that higher temperatures
allow a freer exploration of protein configurations and more fluidity in the lipid bi-
layer. In our case, while we do recover trends observed in regular MD simulations of
bent-half-PACE (Figure 3.21), we see a richer set of protein structures in REMD.
In Figure 3.25, we show snapshots from the T = 310.3 K replica of the REMD
ensemble (the T of all of the regular MD simulations). As in regular MD of the PACE
potential, broadly speaking, the protein flattens out into an open configuration and
remains near the lipid-water interface. We also see (at 565 ns) the protein in a
straight, but tilted pose, similar to what was briefly seen in the bent-half-OPLS-AA
simulation.
Most strikingly, the first seven (or so) residues of the proline-rich N-terminus make
a few excursions through the membrane to the other leaflet (325 ns, 1818 ns, 2662 ns),
and otherwise can be seen in a disordered configuration in the region of lipid tails,
but not far from the headgroups (595 ns, 2212 ns). These observation supports the
idea that this initial portion of the protein serve as an “insertion sequence” [15,16,22].
These excursions of the N-terminus are not seen in the regular MD PACE simulations,
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Figure 3.25: Diﬀerent snapshots of bent-half-REMD system during the simulation at
T = 310.3 K. We can see that initially SP-B has a bent structure, and is located
among the lipid headgroups half-inside the lipid bilayer. Hydrophobic sidechains
(white coloured) face towards the centre of bilayer, while the hydrophilic sidechains
(coloured) face towards the water molecules (blue dots). We can see during the REMD
simulation the protein is in structures, e.g. in 325 ns, 1818 ns and 2662 ns, which
were not observed in MD simulations.
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and thus we see the benefit of REMD. In contrast to simulations using OPLS-AA,
which confers helical-like structure to these first residues, no helical structure is ob-
served for these residues in PACE.
Despite the greater exploration of configurations, we do not see the central loop
portion of the protein making excursions deep into the membrane, and this implies
that the PACE version of the protein lacks this functionality. The slightly greater
overall helicity of the PACE system, particularly in the loop portion (around residue
40), and the lower flexibility this implies, may be responsible for this. Also, the “hinge”
portions around D59 and K24 tend to be more helical for PACE than for OPLS-AA.
Notably, the D59-K24 salt bridge is all but absent from PACE simulations.
These specific structural discrepancies between PACE and OPLS-AA, namely in
helicity of the “insertion sequence” and helicity near the “hinge” and central loop,
serve to highlight the connection between flexibility, conferred through lack of helical
structure, and the ability to penetrate the membrane.
3.4 Discussion and Conclusions
Obtaining information on equilibrium properties of biomolecular systems from molec-
ular simulation is inherently challenging, given the many orders of magnitude in time
separating atomic motions and diﬀerent conformational changes undertaken by the
protein. Our work is based on using all-atom simulations in order to gain some un-
derstanding of the basic structural properties of the SP-B protein when interacting
with a lipid bilayer. We compare our all-atom results with the coarse-grained PACE
potential, which allows longer time scales to be accessed more easily at that expense of
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accuracy in describing the physical interactions within the system. Insight from sim-
ulation is particularly pertinent given the great diﬃculty in obtaining experimental
data on this extremely hydrophobic protein.
The basic question addressed by this chapter is: what are the energetically rea-
sonable conformations that SP-B can take within or near the bilayer? Our 2-2.5 µs
OPLS-AA simulations for the protein within the bilayer express two main answers.
First of all, an open structure parallel with and partially submerged within the lipid
bilayer appears to be rather stable structure of the protein in lipid-water interface.
Second, both “ends” of the protein, i.e., the flexible, largely hydrophobic central two
helices and the loop between them, as well as the two more helical termini that remain
in close proximity (Mini-B part), are able to retain or even seek out transmembrane
orientations. These transmembrane portions can be associated with greater mem-
brane disruption through the stabilization or creation of pores or pore-like structures
characterized by the presence of lipid headgroups and water molecules in the mem-
brane interior, and decreases in the value of the order parameter during formation.
In all cases, the charged and polar residues maintain proximity to headgroups and
water.
When placed outside the bilayer, SP-B rearranges itself into a compact, closed
structure, sacrificing helical region H-III to accomplish the folding but increasing
helicity elsewhere. While the two closed structures we obtain are diﬀerent, they
both share the characteristic of using one of two hydrophilic “sides” to stick to the
membrane, while exposing the other two water. In one case (open-out), H-I, H-II and
part of H-V act to anchor the protein to the membrane while hydrophilic residues
of H-IV are left away into the water. In the other case (bent-out), H-IV anchors to
123
the membrane while H-I, H-II and H-V point away. These findings are consistent
with coarse-grained MARTINI simulations of Bauokina et al. [27] that show SP-B
simultaneously binding to two lipid vesicles while outside the membrane, in that the
portion of the closed structure pointing away from the membrane can “accept” and
stick to a second, approaching membrane. We also note that the closed structure that
forms from the open-out simulation, does so through a rather non-trivial sequence of
configurational changes during the course of roughly 1.5 µs.
In adjudicating the degree to which the simulations are equilibrated and hence
our confidence in assessing whether the conformations we observe truly reflect stable
or metastable protein structures, we note the diﬀerent time scales on which diﬀerent
structural changes take place. On quite short time scales, less than 10 ns, we see the
rather energetically unfavourable initially bent configuration close like a clam outside
the membrane (in a mostly aqueous environment). On the order of 100 ns, we observe
smoothing out of the initial bend in our V-shaped bent configurations within the
bilayer, tipping of the protein that accompanies its bending and straightening while
in the membrane (see Figure 3.14 from 750 ns to 1590 ns) and the bending motion
about a hinge (see Figure 3.14 from 1800 ns to 2400 ns). On the time scale of 1 µs,
we see the complete flattening of the initially bent-half-PACE simulation. In this last
case, the protein is never in a position to reach across the membrane and all motion
takes place near the upper leaflet. Formation or loss of salt bridges also seems to span
time scales from 100 ns to 1 µs. With all this in mind, we can reasonably conclude
that the open structure situated near the lipid-water interface is a stable, or at least
metastable, configuration of SP-B, i.e., apart from optimizing its local interactions
and secondary structure, larger scale movements, such as having part of the protein
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adopt a transmembrane pose, occur on significantly longer time scales presumably
because of a free energy barrier.
With regard to the metastability of configurations in which at least one part
of the protein adopts a transmembrane position, we note that the bent-half-OPLS-
AA simulation evolves towards the formation of a pore-like defect with the loop
portion of the protein progressively engaging with the lower leaflet. The progression
towards a configuration strongly implies a free energy minimum associated with the
configuration. With regard to the stability of the N/C termini being in a partially
transmembrane pose, we can only point to the longevity of the pose, perhaps aided
by the dimpling of the bottom leaflet.
Our results regarding salt bridges imply a role for them both in terms of stabilizing
or forming the hinge which allows the loop end of the protein to bend towards the
bottom leaflet, and in terms of aﬀecting secondary structure as in ERYS segment.
The propensity to form intraprotein salt bridges may be aﬀected by the nature of
the lipid headgroups, and this implies a role in the local composition of the lipid
membrane in the action of SP-B.
We now comment on how well our structures predicted through homology mod-
eling fair for the OPLS-AA and PACE potentials. For the open and bent structures,
the helical portions of the protein after lengthy simulation generally fall within the
areas predicted by homology modelling. There is a decrease in helicity in the simu-
lated protein, but this only serves to bring the overall helicity of the protein in line
with experiments. One notable exception to the agreement between simulation and
homology modeling is the polar and charged ERYS sequence in H-IV, which tends to
break up the helix. We note that for tertiary structure, our guess at where the protein
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bends when adopting a V-shaped configuration is not far oﬀ, initially modeled to oc-
cur between residues 21-24 and 63-66 but simulation showing a hinge slightly closer to
the central loop and located around the salt bridge D59-K24, involving residues 23-25
and 58-60. For the closed structures, we do not make a homology-based prediction,
and from a visual comparison, we find little structural similarity between either of
them and NK-lysin, confirming the diﬃculty in predicting SP-B structure from other
members of the saposin family.
In comparing the results of the coarse-grained PACE potential from MD and
REMD simulations with those obtained with the all-atom OPLS potential, we note
diﬀerences significant enough to indicate qualitative diﬀerences in the way that the
protein interacts with the membrane. For PACE, at no point do we observe the cen-
tral loop portion of the protein (roughly residues 35 to 45) venturing deeply into the
bilayer, i.e., probing the opposite leaflet. We do observe, especially within REMD sim-
ulations, a variety of open structures with significant diﬀerences, e.g., tilted but with a
loop portion clinging to the lipid headgroup-water interface, and structures for which
the insertion sequence (first 7 residues), but only this sequence, adopts a transmem-
brane configuration, a configuration that is not supported by experiment [15, 16, 22].
While the overall helicity for both PACE and OPLS-AA is compatible with experi-
ment, the distribution of helicity of PACE is diﬀerent from that of OPLS. In particu-
lar, with respect to OPLS, PACE under-represents helicity in the first seven residues
and perhaps also in H-III (residues 30-37), and overemphasizes helicity of residues
41-45, a region directly in the central loop. These observations are consistent with
the idea that lack of helicity (implying flexibility) allows portions of the protein to
probe the interior of the membrane and high helicity (implying rigidity) makes it
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more diﬃcult to do so. Thus, the PACE potential, and therefore the even more
coarse-grained MARTINI potential, likely underestimates the ability of SP-B to pen-
etrate, form pores within, and otherwise promote the lipid structures needed for lung
surfactant to reduce surface tension.
Keeping in mind the ability, implied by OPLS-AA, of SP-B to be present within
the membrane interior, it may be worthwhile to speculatively expand on the de-
tailed picture of the process of membrane fusion obtained from simulations of SP-B
and vesicle fusion with the MARTINI potential [23]. This picture could also explain
the experimental results of Oelberg, et al [11], on pore formation ability of SP-B
in artificial lipid bilayers. In Figure 3.26, sequence A-I to A-IV, we present the
four paradigmatic stages of membrane fusion: I) contact, II) stalk, III) diaphragm
and IV) pore [66], respectively. Sequence B-I to B-IV of the same figure provides
schematic representations of SP-B and how it may promote each stage, while se-
quence C-I to C-IV shows configurations from simulation that provide the motivation
for the schematics. For contact (I), the OPLS-AA picture is qualitatively the same
as for the MARTINI potential, in that the protein, while at the membrane surface,
exposes hydrophilic residues that can “stick” to an incoming membrane and facilitate
close contact. General disruption of the membrane by SP-B, especially by configu-
rations tending towards a transmembrane positioning, facilitates both stalk (II) and
diaphragm (III) formation. The ability of SP-B to form or to stabilize pores would
obviously aid in the final stage (IV) of vesicle fusion.
In summary, 2-2.5 µs simulations using the OPLS-AA potential show that SP-B is
stable in an open structure parallel to but slightly embedded in a POPC lipid bilayer.
However, the ends of the protein, i.e., both the central loop and the N/C termini, give
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Figure 3.26: SP-B performing fusion of two lipid bilayers. A) the four main steps of
fusion: I) contact, II) stalk, III) diaphragm and IV) pore. B) the schematic figures of
how SP-B performs the fusion steps: I) anchoring step by SP-B in closed structure,
II)lowering energy barrier in bilayer surface to help the bilayer stalk to each other,
III) the diaphragm step where SP-B can make pore in lipid bilayer and IV) complete
pore. C) snapshots of SP-B simulations: I) outside the lipid bilayer helps to anchor
the bilayers, II) in the open structure reduces the surface tension energy barrier, III
and IV) performs and maintains the pore.
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some indication of their ability to explore the interior of the membrane. In particular,
we witness the (largely hydrophobic) loop’s ability to reach the opposite leaflet and to
stabilize a pore-like structure, aided by the proline residue in it. Lack of strict helicity
in certain parts of the protein seems to be a factor in encouraging the adoption
of transmembrane positioning, while salt bridges can stabilize bent configurations.
Outside the membrane, SP-B is stable in a closed structure. Using the PACE potential
results in underemphasis and overemphasis of helicity in diﬀerent portions of SP-B,
and this seems to alter the ability of SP-B to explore the membrane interior, which
in turn may aﬀect conclusions about how SP-B assists in membrane fusion.
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Chapter 4
Solid state NMR studies of
pulmonary surfactant protein SP-B
interacting with mechanically
oriented lipid bilayers
4.1 Introduction
A mixture of lipids and proteins, i.e. lung surfactant, covers the air-water interface
of the alveoli, which reduces the surface tension and helps us breathe. Of the pro-
teins in lung surfactant, SP-B is the essential protein for breathing [1]. SP-B is
from the saposin protein super-family and is thus predicted to have 4 to 5 helical
regions [2, 3]. SP-B has the highest hydrophobicity among saposin super family pro-
teins (Table 3.1). The exceptionally high hydrophobicity of SP-B makes it diﬃcult
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to study experimentally, even with techniques that have been shown to work with
other hydrophobic proteins such as membrane proteins. Thus far, there is no atomic
resolution experimental structure for SP-B. However, in Chapter 3, I present all-
atom molecular dynamics (MD) simulations of SP-B interacting with a lipid bilayer.
In this chapter, I present steps towards combining the MD simulations with exper-
imental data to provide a high quality structural model that is consistent with the
limited experimental data it is possible to collect on SP-B.
X-ray crystallography and NMR spectroscopy are the two main techniques to elu-
cidate the structure of proteins. X-ray crystallography has been used to determine the
structure of some of the less hydrophobic saposin super-family members [5–8]. With
this method it is necessary to grow crystals of the protein, which is diﬃcult, if not
impossible, for extremely hydrophobic proteins like SP-B. Besides X-ray crystallogra-
phy, people also use solution NMR to determine the structure of membrane proteins,
including some of saposin super-family members, in detergent micelles [10–16, 19].
Even though fragments of SP-B, e.g. Mini-B, have been studied employing solution
NMR [17, 19, 22], nevertheless, the structure of full length SP-B has so far proved
intractable for solution NMR. No one has been able to get any reasonable solution
NMR spectra due to either aggregation and/or conformational inhomogeneity.
Circular dichroism and infrared spectroscopy, while unable to provide information
on the overall 3D structure, do indicate overall secondary structure, and have been
used to show that SP-B has an overall 35-50% helicity [20–22]. Moreover, the homol-
ogy modelling of SP-B, based on saposin super-family proteins, predict 4-5 helical
regions for the protein [25, 26]. Sarker et al. [17] showed that Mini-B, a construct of
SP-B residues 8-25 and 63-78, has two helical regions. Recently, Olmeda et al. [27]
141
fit a homology model of SP-B into a low resolution structural envelope of SP-B,
which was derived from the atomic force microscopy, in combination with electron
microscopy. They proposed a tube-like multimer model for the SP-B structure.
Unlike solution NMR, which is limited to small protein/detergent complexes, solid
state NMR is a powerful method to study the most biologically relevant systems for
membrane proteins, e.g. lipid bilayers and proteins. Researchers have used 2H, 31P
and 15N solid state NMR to understand the position and the orientation of the SP-B
fragments in lipid bilayers [22–24]. Several studies have shown that 15N solid state
NMR is a practical method to study the conformation and orientation of proteins with
relatively large helical regions in oriented lipid bilayers. For example, Kandasamy et
al. [29] studied the role of oligomerization in the structure of the second transmem-
brane helix of GABAA protein, using selectively 15N-labeled protein. Kawaguchi et
al. [29] studied the structure and orientation of the two amphipathic ↵-helical regions
in CAMA antimicrobial peptide, interacting with lipid bilayers. There are other
studies, in which people have studied larger proteins employing solid-sate NMR. For
example, Aisenbrey et al. [30] employed 1D 15N solid state NMR to determine the
orientation of two ↵-helical regions in 209 residue Bcl-XL protein, using selectively
15N-labeled protein. Moreover, Vosegaard et al. [31] used selective labeling of 15N-
methionine, 15N-valine and 15N-glycine in a 7-helix transmembrane protein to find
the tilt angle of each helix.
In general, these oriented sample 15N solid state NMR methods are applied by first
calculating the theoretical NMR spectra of the protein’s helical regions for diﬀerent
orientations within the bilayer. Then, the simulated spectra are compared with the
actual experimental results to indicate the actual structural parameters. My goal is to
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use the SP-B structures derived from my all-atom MD simulations in Chap 3 to help
to determine the actual experimental structure of SP-B. To do this, I will predict the
15N solid state NMR spectra from the computational structures employing theoretical
methods. Then, I need to compare the theoretical spectra with the experimental
spectra of 15N-labeled protein in oriented lipid bilayers. The best fit between the
computed spectra and the actual spectrum should indicate the closest computational
structure to the NMR result.
The Hamiltonian for the chemical shift interaction in solid state NMR can be
written as HCS= I. .B0 , where   is the gyromagnetic ratio, I is the spin vector,   is
the chemical shift tensor and B0 is the external magnetic field. As presented by the
Bechinger group [28, 34–36], in general, one can write the anisotropic chemical shift
interaction of a 15N nucleus as a second-rank tensor:
  =
0BBBBB@
 xx  xy  xz
 yx  yy  yz
 zx  zy  zz
1CCCCCA .
We can find a coordinate system, named the principal axis system (PAS), where
only the diagonal elements of the transformed tensor ( 11,  22 and  33) remain (Fig-
ure 4.1-A). The vector  33 points along the z0 axis of the PAS, which in turn is
parallel to the long axis of an ideal helix. The zz element of the chemical shift ten-
sor in the laboratory frame corresponds to the measured value of chemical shift in
an NMR experiment, assuming that B0 points in the z direction. Employing Euler
angles  , ⇥ and  we can transform coordinates from the lab frame to the PAS with
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Figure 4.1: A) The representation of the 15N chemical shift tensor for a 15N nucleus
in the peptide bond and the angles ⇥ and  , as well as ↵ and   for a helical region of
the peptide (cylinder) in an oriented lipid bilayer. ⇥ and   match ↵ and   when the
bilayer normal and the long axis of the cylinder. On the left,  11 and  33 are in the
plane of the paper, while  22 is into the paper. Panels B and C show the 15N spectra
expected for a helix with a helical axis perpendicular to the bilayer normal, and for a
helix with helical axis parallel to the bilayer normal. Figure is inspired from Ref. 28
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the rotation matrices:
Rz( ) =
0BBBBB@
cos  sin  0
  sin  cos  0
0 0 1
1CCCCCA ,
Ry0(⇥) =
0BBBBB@
cos⇥ 0   sin⇥
0 1 0
sin⇥ 0 cos⇥
1CCCCCA ,
Rz00( ) =
0BBBBB@
cos sin 0
  sin cos 0
0 0 1
1CCCCCA ,
giving  0 lab = R  PASR 1 , where R = Rz00( )Ry0(⇥)Rz( ).
Thus, we obtain  zz in terms of the PAS chemical shift components:
 zz =  11 sin
2⇥ cos2 +  22 sin
2⇥ sin2 +  33 cos
2⇥. (4.1)
The chemical shift values of  11 and  22 are approximately 65 ppm and 85 ppm
respectively, while the chemical shift value of  33 is quite diﬀerent and is in the
vicinity of 230 ppm. With the values of  11 and  22 being similar (compared to  33),
the tensor nearly possesses cylindrical symmetry. In the approximation that  11 and
 22 are equal, we can rewrite Equation 4.1 as [28],
 zz = ( ¯k    ¯?) cos2⇥+  ¯?, (4.2)
where,  ¯? = ( 11 +  22)/2 and  ¯k =  33 and ⇥ corresponds to the angle between
the helix long axis, which is assumed to be parallel to  33, and the bilayer normal.
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This cylindrical symmetry can also be obtained e.g., if one can average over   in the
case that there is no preferred value of  . Equation 4.2 shows that if the peak in the
15N spectrum is located above 200 ppm, this means that the ↵-helical region of the
protein is in a more transmembrane position with respect to the lipid bilayer, i.e. ⇥
roughly equals to zero (Figure 4.1-B). Whereas, if the 15N spectrum of the protein
has a peak located below 100 ppm, the ↵-helical region is expected to be in a parallel
orientation with respect to the lipid bilayer (Figure 4.1-C).
In a more realistic calculation, we should consider the liquid crystalline nature
of the lipid membrane and the dynamics of the protein. Here, we need to take
into account the rotational averaging of the protein around the bilayer normal that
occurs in the membrane due to the continuous diﬀusion of the protein within the lipid
membrane [28]. This averaging generates an axially symmetric tensor, in which  ?
and  k are the perpendicular and parallel components of the chemical shift tensor
(perpendicular and parallel with respect to the bilayer normal). The values of  k
and  ? will be diﬀerent from  ¯k and  ¯? because we are averaging around the bilayer
normal not the axis of the helix. We now introduce the Euler angles of ↵ (pitch)
and   (tilt), explained in Figure 4.1-A, with respect to the bilayer normal. We can
express  k and  ? in terms of ↵ and   as:
 k =  11 cos2 ↵ sin2   +  22 sin2 ↵ sin2   +  33 cos2  ,
 ? =
1
2
[ 11(1  cos2 ↵ sin2  ) +  22(1  sin2 ↵ sin2  ) +  33 sin2  ].
With  xx = ( 11    22) cos2 ↵ +  22, we have:
 k = ( 33    xx) cos2   +  xx, (4.3)
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 ? =
1
2
[( 11 +  22) + ( 33    xx) sin2  ], (4.4)
where we can see the resemblance of Equation 4.3 with Equation 4.2. In the
case of the bilayer normal being parallel to the external magnetic field,  k matches
 zz and  k is the experimentally measured value. For  =0 ,  k= 33 and for  =90 ,
 k= xx = ( 11    22) cos2 ↵ +  22, which is a value between  11 and  22. These
expressions for  k and  ? now can be used instead of  ¯k and  ¯? in Equation 4.2,
where ⇥ now represents the angle between the bilayer normal and B0.
In order to apply these expressions to the chemical shift of a 15N nucleus in the
helical portion of the protein, one must acquire the 15N NMR spectrum of that region.
Then, the standard way to analyze the 15N spectrum is to start with a PDB structure
file of the helical region - either a homology model or an ideal helix. Next, the
researchers find the orientation of the specified residue with respect to the helical
region of the protein. In this method, they rotate the protein’s structure, i.e. the
PDB file, around two axes, the pitch axis, the central axis of the helix structure (pitch
angle) and the tilt axis, the axis perpendicular to pitch axis (tilt angle) [30]. This
will screen all the possible 180 ⇥ 180 degree angles of tilt and pitch angles of helix
structure for the acquired chemical shift value.
My plan was to implement these strategies a little diﬀerently; I had planned to
calculate the expected 15N spectrum, not for all the possible orientations of tilt and
pitch - but using the structures from my MD simulations. An important point in these
calculations is that, since unstructured residues, as well as interhelical loops, possess
no structural information in the 15N solid state NMR studies of oriented samples [43],
thus, there is no data pertaining to these parts in the predicted spectra.
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In this chapter, the goal is to combine the solid state NMR of uniformly 15N-labeled
SP-B in a mechanically oriented lipid bilayer with the computational simulations from
Chapter 3 in order to gain information about the orientation of the helical regions of
the protein with respect to the lipid membrane. Firstly, I write the computational
code to simulate the 15N spectra for each MD simulation. Next, I prepare oriented
bilayers with and without SP-B and use 2H and 31P NMR to check the sample orien-
tation. Finally, I prepare oriented bilayers with uniformly 15N-labelled SP-B and run
15N NMR experiments.
4.2 Materials and Methods
4.2.1 Prediction of 15N Chemical Shifts in NMR Spectra of
Oriented Samples
In this work, I follow the approach used by the Bechinger group to calculate the
expected 15N spectrum of the ↵-helical regions of SP-B from my MD simulations. In
this method, the orientation of each ↵-helical region in the protein provides a defined
15N NMR peak in the spectra [28].
In Chapter 3, I presented the all-atom MD simulations of SP-B interacting with
lipid bilayer systems. Since I use uniformly 15N -labeled protein and acquire 1D NMR
signal with bilayer normal parallel to the B0, we can not specifically distinguish the
source residue of the signal experimentally. Thus, in an ideal case, we can calculate
the tilt angle of the helical region with respect to the lipid bilayer and we use Equa-
tion 4.2. The essential part of calculating the spectra in this method is to find the
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orientation of the NH bond in the protein’s backbone. First, I calculate and store
positions of N and H atoms of the residues in the ↵-helical regions of the structure.
Then I use the N and H position values to determine the NH vector. I use this vector
as an input file for the code, written in MATHEMATICA, to predict the 15N spectra
using Equation 4.2. First, I normalize the NH vector and calculate the ⇥ and   (or
equivalently ↵ and  , while the bilayer normal is parallel to B0) angles of the NH vec-
tor. I calculate these angles for each frame for the last 200 ns of the simulation (200
frames in total). The chemical shift values for the NH bond are 75 ppm, 61 ppm and
223 ppm for  11,  22 and  33 respectively [39]. To introduce the line broadening that
will be present in the experimental solid state NMR spectra, I calculate the observed
chemical shifts for a Gaussian distribution of  zz around the predicted  zz values,
to produce experiment-like 15N spectra. I chose the standard deviation of 2.5 in the
distribution function, however one can try diﬀerent values to match the plot with the
experimental results. In my code, the external magnetic field is set in the Z direction
parallel to the bilayer normal. Details of the code, implementing Equation 4.2, are
in Appendix B.
4.2.2 SP-B Preparation1
We employ recombinant expression to produce SP-B. In this method, we introduce
DNA coding for SP-B into bacteria, which produce the protein. To uniformly label
SP-B with 15N, we grow the bacteria with only one nitrogen source 15NH4Cl.
Our group has optimized the SP-B preparation protocol for refolding SP-B into
1SP-B preparation and purification were carried out primarily by Ms. Donna Jackman, Booth
lab.
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detergent micelles. However, for my solid state NMR experiments, the protein was
refolded into lipids, i.e. POPC/POPG with 9:1 ratio. In general, we confirm the
presence of SP-B by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). However, I also performed 15N solid state NMR with the samples at various
stages of preparation in order to determine how much 15N signal I was getting from
the samples. In the last step of purification, we “desalted” the SP-B in order to remove
any salt, detergent, or other non-tightly bound molecules from the sample.
4.2.3 Mechanically Oriented Lipid Bilayers
To produce mechanically oriented bilayers, I use a method similar to the one described
by Rainey et al. [32], in which they use mica slides to support lipid bilayers and keep
their alignment during the experiment. In Figure 4.2 we can see the diﬀerent steps
of sample preparation. I purchase the Mica Grade-I in packs of 20 sheets from SPI
Supplies®. I cleave several layers from both sides of the mica sheet, using a normal
scalpel, which gives fresh mica surfaces on both sides. Then, I cut the sheet in the
size needed to fit inside the coil of the NMR probe, e.g. 12.5 mm⇥5 mm in my case
(Figure 4.2-A). To cut the plates, I use a scalpel. While cutting the mica plates, one
should avoid cracks and defects, which appear on mica sheet after cleaving it. One
should note that cutting plates from thick sheets produce curved and flaky edges. I
always cut an extra plate to be used as a cap to my plate stack. Finally, I clean the
mica filings oﬀ the plate’s surface, using air flow, then I put them in a petri dish until
depositing my sample on them.
After preparing the mica plates, I prepare my stock solution to deposit on each
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Figure 4.2: Steps of sample preparation. A) Cleaving and cutting mica sheets into
mica plates, B) Depositing stock solution on mica plates, C) Drying out the samples,
D) Depositing deuterium-depleted water on my dried samples, E) Putting samples
in hydration chamber and F) stacking the mica plates and wrap them to prepare my
NMR sample.
plate. Depending on the type of the experiment, I use slightly diﬀerent methods to
prepare my stock solutions. For my thesis, I run two experiments, one to prepare
a mechanically oriented lipid bilayers sample using pure POPC and the other to
prepare mechanically oriented lipid bilayers containing SP-B sample, i.e. SP-B plus
the POPC/POPG lipid associated with it as part of the refolding and purification
process, added to deuterated POPC. To prepare the stock solution for the pure POPC
151
sample, I dissolve 5 mg of POPC lipid (POPC:POPCd31) with 3:7 mass ratio, in
100 µl of chloroform:methanol (C:M) with 1:1 volume ratio. For the next one, the
SP-B+POPC/POPG+POPCd31 stock solution, I use more steps as the SP-B does
not dissolve in C:M with 1:1 volume ratio. Normally, for small peptides in oriented
bilayers, we prepare a stock solution of protein+lipid by co-dissolving them in C:M
solvent. However, this protocol had to be modified for SP-B which is not soluble in
C:M. Thus, I dissolve 2.5 mg of the protein sample, i.e. SP-B+POPC/POPG, in 3 ml
methanol. The standard procedure of preparing SP-B in detergents produces 0.4–2 mg
(⇠1.2 mg on average) of SP-B in approximately 12 mg of SP-B+detergents, i.e. 10%
of the sample is pure SP-B. Thus, based on my calculations, if I have the same ratio
of protein to lipid in my SP-B sample, 2.5 mg of the SP-B sample contains ⇠0.25 mg
of SP-B and ⇠2.25 mg of lipids, which are tightly bounded to the SP-B. Separately,
I dissolve 12 mg of POPCd31 in 100 µl of C:M with 1:1 volume ratio (similar to the
pure POPC sample). Finally, I mix the 2.5 mg of SP-B+POPC/POPG stock solution
with the 12 mg of POPCd31 stock solution, which gives me ⇠0.2 mol% ratio of protein
to lipid. For both the pure POPC and the SP-B+POPC/POPG+POPCd31 systems,
the stock solutions should be clear with no observable solid particles in them. These
stock solutions are less concentrated than is normally used for making mechanically
oriented bilayers and are hard to deposit on the plates. Therefore I concentrate the
stock solutions under a stream of nitrogen gas, until they are easy to work with.
In the next step, I deposit the stock solution on the mica plates, using a micro
pipette with a 10 µl pipette tip (Figure 4.2-B). On each round of depositing the
stock solution, I add about 0.5 µl of the solution, as a thick line in the centre of the
rectangular plates. I need to prevent it from going near the edges, which could ruin
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my sample. After each round, I wait for a minute or two for the plates to partially
dry, which helps to control the newly poured material in the middle of each plate. At
the end of this step, which may take up to 3 hours, I have my mica plates covered
with a thick-line-shaped pile of partially dried materials. One should prevent air
bubbles being trapped inside the dried material and keep the cap plate blank. In
each experiment, each plate should have 0.5-1.2 mg of the sample. Exceeding the
1.2 mg of the sample can increase the risk of the sample over flow on the edges and
lead to randomly oriented lipid bilayers. On the other hand, using less than 0.5 mg
of the material on each plate will prevent the mica plates from fully contacting and
thus, the lipid between them can not make the mechanically oriented structure.
Then, we need to dry out the samples, completely. Here, I put my samples under
the fume hood for about an hour. Then, I put the plates into the vacuum chamber for
overnight (about 15-20 hours) to completely evaporate the solvent out of the sample
(Figure 4.2-C).
Now, I hydrate the sample with deuterium-depleted water. I add 0.5 µl of water
to each dried pile of material on the mica plates (Figure 4.2-D). I need to wait
approximately 3 minutes after each round of water deposition to let my sample absorb
the water. Similar to depositing the stock solution on mica plates, one should prevent
the material running towards the edges of plates. I continue these steps until each
plate gets 3-4 µl of deuterium-depleted water. I then added each mica plate to a
hydration chamber. To prepare the chamber, I pour ⇠200 ml of distilled water in the
bath and add 65 gr of ammonium phosphate dibasic, as well as a small amount of
sodium azide to prevent bacterial growth (Figure 4.2-E). The amount of water to
add to the mica plates, as well as the duration of keeping them inside the chamber
153
depends on the sample contents. However, to get the full hydration, the samples
should be in the chamber for a minimum of 24 hours.
In the final step of sample preparation, I need to stack and wrap the mica plates,
which must be performed with great care in order to achieve good orientation (Figure
4.2-F). In this step, after taking the samples out of the hydration chamber, I start
placing plates on each other, using a fine tip tweezer. One should prevent the plates
sliding over each other. I make stacks of 4-5 mica plates with an additional plate used
as a cap. Then, I use plastic wrap to seal each stack.
After covering my samples in 3-4 rounds of plastic wrap, I put them in my NMR
tube (one or more stacks depending on the experiment). Then, I add about 1 µl of
deuterium-depleted water to prevent the sample from drying out (but note that too
much water will destroy the sample). Then I seal the NMR tube with paraﬃn wax and
keep in the fridge for at least 24 hours before doing the experiment, which allows the
lipid bilayers to become further oriented. I divide my SP-B+POPC/POPG+POPCd31
sample into 3 packs, each containing 5 stacks of mica plates. Then, I wrap them
individually. After running 2H NMR, I keep the mechanically oriented samples to do
15N NMR experiment.
4.2.4 NMR Acquisition
All of the experiments are performed at 298 K. In the mechanically oriented samples,
the bilayer normal is perpendicular to the magnetic field. The 2H experiments are
performed on Dr. Morrow’s locally-assembled 9.4 T spectrometer, using a cylindrical
coil. In deuterium experiments, we applied a quadrupolar echo sequence of (⇡/2y  
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⌧   ⇡/2x  ⌧) to avoid problems with preamplifier recovery time [33]. The ⌧ is set to
30 µs with a pulse length of 4-4.25 µs with a recycle delay of 0.9 s.
Both 31P and 15N experiments are performed on a Bruker Avance II 14.1 T
(600 MHz) spectrometer in the Centre for Chemical Analysis, Research and Train-
ing (C-CART) facility, employing a Bruker 4 mm triple double-tuned flat coil probe
HN(P). The 1D 31P solid state NMR spectrum in Figure 4.5 is acquired at 243.01 MHz.
85% H3PO4 is used to reference the phosphorous chemical shift frequencies at 0 ppm,
externally. The spin echo pulse sequence in our experiments is (⇡/2   ⌧   ⇡ acq)
with the ⇡/2 pulse length of 12 µs, ⌧ of 22 µs and a recycle delay of 3 s with a 62.5kHz
high-power decoupling pulse, used during the acquisition. For the 15N experiments,
we used cross polarization (CP) experiments, performed in a 62.5 kHz B1 field. The
contact and the recycle delay times are 1.5 ms and 5 s respectively. Here, we ac-
quire the signal using high power 1H decoupling pulses. In Figure 4.6-E the bilayer
normal is parallel to the external magnetic field. We set glycine as the reference to
35.7 ppm, which corresponds to 0 ppm of the liquid NH3.
4.3 Results
4.3.1 Predicted Spectra
In chapter 3, we discussed the results we got from the computational simulations
of SP-B interacting with a POPC bilayer. Having the coordinates of the N and
associated H atoms in all-atom simulations, we can predict the 15N spectra of SP-B.
In Figure 4.3, we can see the predicted NMR spectra for SP-B, as a summation of
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every calculated spectrum over the last 200 ns of each simulation (20 configurations).
I examined the behaviour of the predicted NMR spectra over the last 200 ns of the
simulation using a script (copied in Appendix B) that displays an animation of the
predicted 15N spectrum for each snapshot. During the simulation, tiny changes in the
secondary structure of the protein in each snapshot slightly alter the intensity of the
spectra. Besides, tiny changes in the orientation of the ↵-helical domains, i.e. changes
in the tilt angle of the helix with respect to the bilayer normal, vary the position of
the peaks in the predicted spectra of the protein. In my simulations, as the overall
orientation of helical regions (not the whole protein) are mainly parallel to the lipid
bilayer, the predicted spectra look similar to each other. As expected for helices that
are generally positioned in parallel with the lipid surface, the spectra have most of
their intensity below 100 ppm.
4.3.2 Experimental Results
The standard protocol used in the lab to prepare SP-B experimentally produces SP-
B in detergent micelles. However, detergent micelles are not compatible with the
solid state NMR method I need to employ, which requires that the protein be in
mechanically oriented lipid bilayers. Therefore, I needed to use SP-B produced via a
modified protocol that resulted in SP-B being refolded and purified in POPC/POPG
with 9:1 ratio (POPC/POPG is associated with SP-B). A second modification to the
standard SP-B production method was also needed. Normally, oriented solid state
NMR samples are produced via co-dissolving the dry protein and dry lipid components
in an organic solvent such as a mixture of chloroform and methanol. Thus, my SP-B
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Figure 4.3: Predicted 15N solid state NMR spectra of all-atom MD simulations of
SP-B configurations in oriented POPC lipid bilayer, presented in Chapter 3. Each
spectrum is calculated for 20 configurations sampled over the last 200 ns of simulation
(1 configuration per 10 ns). The scaling in the vertical direction is in the same for
each panel.
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protein (in POPC/POPG) needed to be dried via lyophilization (freeze-drying). The
protein and lipid contents of my SP-B sample were estimated at ⇠0.25 mg of SP-B
and ⇠2.25 mg of POPC/POPG (9:1).
Before collecting 15N data on oriented SP-B samples, I first need to practice with
the pure POPC to enhance my experience in orienting the lipid bilayers between mica
plates. This practice was important to ensure that any loss of orientation observed for
the samples with SP-B was due to the protein and not to an inadequacy in the sample
preparation. I use 2H solid state NMR experiments, employing a locally-assembled
9.4 T spectrometer, to study the orientation of the lipid bilayers in my POPC lipid
bilayer samples. Figure 4.4-A represents the deuterium spectrum of mechanically
oriented lipid bilayers of a pure POPC sample for an hour of scanning, i.e. 4000 scans.
This sample contains 5 mg of POPC/POPCd31 (3:7), deposited on 5 rectangle mica
plates.
As a second step I needed to ensure that I could obtain well oriented samples in
the presence of SP-B, as well. Figure 4.4-B represents the 2H NMR spectrum of
the mechanically oriented bilayer containing SP-B. Here, the lipid bilayers show less
orientation compared to the SP-B-free sample in Figure 4.4-A, indicating the eﬀect
of SP-B on the bilayers. However, based on the position of peaks in the 2H spectrum
(Figure 4.4-B) and the results of the 31P spectrum in Figure 4.5 (discussed in
the following text), the amount of perturbed lipid in the system is not so much,
as to ruin the sample for 15N NMR experiments. I made 3 similar stacks of SP-
B+POPC/POPG+POPCd31 sample. However, only one of the three samples formed
well oriented bilayers, while the other two were randomly oriented due to mishandling
the sample in the wrapping step. The sample shown in Figure 4.4-B contains the
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Figure 4.4: The deuterium spectra of lipid bilayers. A) a mechanically oriented POPC
lipid bilayer, B) mechanically oriented POPC lipid bilayer containing⇠0.8 mg of SP-B
sample and 4 mg of POPCd31, i.e. the SP-B+POPC/POPG+POPCd31 sample. The
spectra were acquired with 4000 transients for A, which contains 5 mg of POPCd31
and 16000 transients for B, which contains 4 mg of POPCd31 at 298 K, employing a
locally-assembled 9.4 T spectrometer. Vertical scale is the same for both spectra.
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15N-labelled SP-B plus the unlabeled lipids that bound to SP-B during the refolding
process, as well as the deuterated lipids I added to the sample. The 0.8 mg of
SP-B+POPC/POPG is estimated to contain ⇠0.1 mg of SP-B and ⇠ 0.7 mg of
POPG/POPG (9:1) and to this I added 4 mg of POPCd31 (12 mg for 3 samples,
thus, 4 mg for one sample), deposited over 4 rectangle mica plates. The spectrum is
acquired with 16000 transients. The spectrum of Figure 4.4-A is typical of a well
oriented lipid sample, while in the presence of SP-B, in Figure 4.4-B, the spectrum
is consistent with a superposition of spectra: a well oriented portion, similar to panel
A, superimposed with a spectrum typical of a randomly oriented sample at half
the oriented splittings. I have tried this experiment with higher concentrations of
protein/POPCd31, but these samples were not well oriented. This could be due to the
fact that SP-B perturbs lipid bilayers at the higher concentrations of protein/lipid.
In addition to 2H spectra, I use the 31P and 15N spectra, employing a Bruker
Avance II 14.1 T spectrometer to study my SP-B+POPC/POPG+POPCd31 sample.
To ensure the sample is oriented after my 15N NMR experiment, I run the 31P spectra
of the SP-B+POPC/POPG+POPCd31 system (Figure 4.5). The peak at 37.4 ppm
represents oriented lipid bilayers perpendicular to the external magnetic field. The
small randomly oriented part in the spectrum (⇠-12 ppm) could be due to the influ-
ence of the protein on lipid bilayers by slightly perturbing the mechanical orientation
of the system. The spectrum we acquired from the highly oriented sample indicates
that this sample retains its orientation at room temperature after 6 days of running
an 15N experiment.
In my initial 15N NMR experiment I acquired 110000 scans with a sample esti-
mated to contain almost 0.1 mg of 15N labelled SP-B (0.8 mg of SP-B+ POPC/POPG
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Figure 4.5: The 31P spectrum of the POPC lipid bilayer in SP-
B+POPC/POPG+POPCd31 system. We can see the main portion of the lipid
bilayer is oriented (peak value of 37.4 ppm) and a small portion is the 90 degree
edge of randomly oriented lipids. The spectrum were acquired with 256 transients at
298 K, employing a Bruker Avance II 14.1 T spectrometer. This sample is the same
as Figure 4.4-B.
sample) that was reasonably well oriented as judged by 2H (Figure 4.4-B) and 31P
(Figure 4.5) spectra. Unfortunately, I could not see any 15N signal. Potential ex-
planations for this include 1) Estimates of the protein content of the sample were
higher than the actual amount of protein in the sample; 2) SP-B conformational
heterogeneity/dynamics; 3) Wrong NMR acquisition parameters.
To help diagnose the problem, I ran 15N solid state NMR in diﬀerent stages of
protein purification and preparation, as well as in my mechanically oriented SP-
B+POPC/POPG+POPCd31 sample, to track the signal intensity and predict the
amount of required protein in my sample (Figure 4.6 and Table 4.1). Here, I
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Figure 4.6: The 15N spectra of diﬀerent steps of SP-B purification and the SP-
B+POPC/POPG+POPCd31 sample. A) the 15N spectrum of the bacterial lysate,
containing the expressed SP-B, as well as bacterial proteins and cellular debris, B)
after the first step of purification, C) after the second step of purification, D) the
last step of purification, i.e. SP-B+POPC/POPG, E) mechanically oriented SP-
B+POPC/POPG+POPCd31 sample. We can see that there are no 15N signals at last
two steps (D and E). The spectra were acquired with 2900 transients for A, 46300
transients for B, 18400 transients for C, 15700 transients for D, and 110000 transients
for E at 298 K, employing a Bruker Avance II 14.1 T spectrometer. The E spectrum
is for the same sample as Figure 4.4-B and 4.5. The y-scale is not the same for
each spectra. 162
take a sample at each four steps of protein purification, as well as the final sample
in mechanically oriented bilayers, (totally five samples) called: A, B, C, D and E.
Sample-A is the lyophilized powder of the bacterial lysate, containing the expressed
SP-B, as well as bacterial proteins and cellular debris. Sample-B is the sample we
have after the first step of purification. Sample-C is similar to Sample-B, with cleaved
proteins and no further purification. Sample-D is the SP-B sample in the last step
of purification after desalting the protein, i.e. SP-B+POPC/POPG. Sample-E is the
SP-B+POPC/POPG+POPCd31 mechanically oriented sample ready to run NMR.
All of the samples are in powder form except Sample-E, which contains the SP-
B+POPC/POPG+POPCd31 bilayers.
We did not measure how much 15N-labelled SP-B was present in samples A to C,
which are for SP-B preparation and purification steps. For sample-D and sample-E
(which is sample-D+POPCd31), based on our previously prepared samples of SP-B
in detergents, we expect that the SP-B+POPC+POPG sample (sample-D) contains
only 10% of 15N-labelled protein, by weight. In the discussion section we discuss the
validity of our estimation.
In Figure 4.6-A, we can see the 15N spectrum of 52 mg (visually about 1% of
total amount) of sample-A. It takes less than 4 hours of scanning, ⇠2900 scans, to get
the spectrum, which confirms the high amount of 15N in sample-A (Figure 4.6-A and
Table 4.1). In my next experiment, I run NMR on 13.3 mg (visually less than 5% of
total amount) of sample-B for 46300 scans (about 2 days and 17 hours) (Figure 4.6-B
and Table 4.1). Here, it appears there might be a small, broad signal above baseline
over the 50-150 ppm. The low intensity compared to that of Figure 4.6-A is due to
the lower amount of 15N nucleus in this sample compared to Sample-A. Next, I run
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System NMR sample mass (mg) visual % ratio⇤ number of scans 15N signal
Sample-A 52 1 2900
Sample-B 13.3 5 46300 ⇠
Sample-C 84.1 10 18400 ⇠
Sample-D 15.4 75 15700 7
Sample-E 4.8 33 110000 7
Table 4.1: Measurement summary for each sample, A to E. ⇤The “visual % ratio”
indicates the visual % ratio of each sample compared to the the total amount of
product, produced in each step.
15N NMR experiment on 84.1 mg (visually about 10% of the total amount) of the
sample-C for ⇠18400 scans, which takes about 1 day (Figure 4.6-C and Table 4.1).
Here, compared to the sample-B, we run the experiment for a shorter time (1/3 of
sample-B), but we have more than 6 times the material by weight. In Figure 4.6-
C similar to Figure 4.6-B, we can see there might be a small, broad signal above
baseline over 50-150 ppm. Similar to sample B, in sample C, the lower intensity of
signal compared to sample-A is due to the lower amount of 15N nuclei in these samples
compared to the sample-A. In Figure 4.6-D, we can see the 15N solid state NMR
spectrum of the 15.4 mg of the sample-D after 15700 scans Table 4.1. We can see
that there is no signal in the spectrum, which is due to the very low amount of protein
in my sample. In Figure 4.6-E, we can see the 1D 15N spectrum of sample-E, i.e.
SP-B in the mechanically oriented lipid bilayer. The spectrum has no signal after
about 110000 scans (6 days), which could be due to an inadequate amount of the
labeled protein in my sample.
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4.4 Discussion
The 2H and 31P solid state NMR experiments prove my ability to prepare long lasting
mechanically oriented POPC lipid bilayers, using mica plates (Figure 4.4 and Fig-
ure 4.5). The step-by-step 15N solid state NMR experiment indicates that the signal
intensity decreases after each step of purification (Figure 4.6-A and Table 4.1).
In sample-B and sample-C, because of high amounts of lipid added to the sample in
the process of purification, the concentration of the labeled protein is low. Thus, we
expect a low NMR spectra intensity for these two samples. However, for the final
step of SP-B purification, sample-D, we need to modify our dialyzing procedure to
remove more lipids from our sample and gain more SP-B as the final product. We
may be able to decrease the amount of extra lipids when preparing our stock solu-
tion to spread on the plates, however, a larger SP-B to lipid ratio will make it more
diﬃcult to produce well oriented bilayers.
In Figure 4.7, similar to Figure 4.6-D, we can see the 15N NMR signal of 6 mg
of dried powder of GAD-1 anti-microbial peptide with 2 of 21 residues selectively 15N-
labeled, collected by Gagandeep Sandhu in our group. Here, the signal is obtained at
298 K with 12000 transients, using the same acquisition parameters as in my experi-
ments. This sample is similar to my sample-D, only with diﬀerent protein contents.
A simple calculation indicates that the GAD-1 powder sample (Figure 4.7), contains
almost 0.6 mg of 15N-labeled residues in the total of 6 mg of GAD-1 peptides:
2 labeled residues
21 unlabeled residues
⇥ 6 mg = 0.57 ' 0.6 mg labeled residues.
Assuming 10% of my sample contains pure 15N-labeled SP-B protein, I should have
1.54 mg of 15N-labeled SP-B (Table 4.1), which is a higher amount of labeled protein
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15N Powder pattern of Gad-1
Figure 4.7: The 15N spectra of GAD-1 AMP powder. The spectrum was acquired
with 12000 transients at 298 K, employing a Bruker Avance II 14.1 T spectrometer.
Used with permission from Gagandeep Sandhu.
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compared to Sandhu’s sample (Figure 4.7).
One possibility for my diﬃculty in observing an NMR signal might have been with
the NMR acquisition parameters used. However, my NMR acquisition parameters,
which I used for sample-D in Figure 4.6-D, were identical to those used for the
spectrum in Figure 4.7, so this is not likely to be the case. Another possibility is that
my estimate of the weight of the protein in my sample was faulty. This estimate was
based on assuming the same protein:lipid ratio in my sample as has been measured
for protein:detergent samples. If SP-B binds to much more lipid than it does to
detergent, this estimate might be oﬀ. However, a sample of SP-B in lipid was sent
out for amino acid sequencing by bradford and fluorescamine assays (results not shown
here) and the results confirmed our calculated protein concentration. However, this
may not exclude the possibility of SP-B binding to the glass vials or pipet tips during
sample preparation. One should consider this possibility in the future experiments of
SP-B. A third possibility is that SP-B has “conformational flexibility and dynamics”
that reduces the signal intensity. Protein conformational flexibility is often a reason
for observing less signal than expected in an NMR experiment. However, even in the
powder samples, less signal was observed than expected (in sample-D case, no signal).
A fourth possibility could be the binding of some ferromagnetic atoms to SP-B during
the protein purification. This is an unlikely rare possibility, since the desalting steps
in the purification should remove all unwanted salts from the protein.
The all-atom MD simulations in Chapter 3 predict diﬀerent structures for SP-B
interacting with POPC lipid bilayers. However, the predicted 15N spectra of these
simulations represent similar plots for these diﬀerent structures (Figure 4.3). Thus,
the uniform 15N labeling of SP-B can not provide us many details of the protein’s
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orientation in lipid bilayers.
To acquire more details on the orientation and the structure of the protein in lipid
bilayers, we could use a residue specific labeling method, e.g. selectively 15N-labelled
residues, as well as deuterium-labeled 2H3-Ala in the sequence of the protein. In
the selectively 15N-labeled method, we grow SP-B on an unlabeled minimal medium
with the particular 15N-labeled amino acid(s) of our choice. To employ this method,
we can label one or more of Leu, Val or Ala amino acids, which are more frequent
residues in the protein’s sequence. SP-B contains 14 Leu, 9 Val and 8 Ala residues.
Besides the high number of these amino acids in SP-B’s sequence, these residues are
predicted to be present in the helical portions of the protein, based on the last 200 ns
of my MD simulations (Figure 3.24).
In addition to 15N-labelled residues, we can also get structural information from
2H-labelled amino acids. Here, we can add the pitch and tilt angle of the [2H3-Ala]
to SP-B, to add more restraints to the orientation of the protein and help us find the
final structure. The deuterated alanine(s) should be in the same helical region(s) as
the selectively 15N-labelled residues, to perform the information on the orientation of
the region with respect to lipid bilayers. The CH3 group of alanine rotates fast around
the C↵   C  bond, which results into a single quadrupole splitting peak, for which
the value of the splitting frequency  ⌫Q can be measured and related to peptide
orientation via,
 ⌫Q =
3
2
e2qQ
h
(3 cos2⇥  1)
2
, (4.5)
where e
2qQ
h is the static quadrupole coupling constant and ⇥ is the angle between the
C↵ C  bond and the B0 [39]. Similar to the 15N-labelled residues, one must use the
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PDB structure of the protein to find the orientation of the [2H3-Ala] in the helical
region of the protein. To find the orientation of each helical region of the protein in
lipid bilayers, we use the predicted 180⇥180 counterplot of pitch and tilt angles of
15N-labeled, as well as the 2H-labelled Ala residues in the protein and compare them
with the experimental values [30].
In general, similar to the uniformly-labeled SP-B, by using selectively 15N-labelled
residues in the sequence of SP-B, if we have a single peak at less than 100 ppm, this
would indicate that the whole protein is parallel to the lipid bilayers. Otherwise, if
we have a single peak at more than 200 ppm, this would indicate that the whole
protein is perpendicular to the lipid bilayers, which is highly unlikely based on my
MD results in Chapter 3. However, if we have two or more peaks in the spectra, this
could indicate the protein is not entirely parallel to the lipid bilayers.
In addition to 1D 15N experiments, we can use 2D PISEMA experiments, to find
the orientation of helical regions of SP-B. In this method, we take the N-H dipolar
splitting into account and predict changes in PISEMA plots, while changing the tilt
angle of the helical portion of the protein (the PDB file) with respect to the bilayer
normal [29, 30]. Then, we compare the predicted results to the experimental results
and find the matching tilt angles. In this method, we need clear 15N NMR signals.
However, since we have diﬃculties in acquiring 1D 15N NMR spectrum of SP-B, we
can not consider running 2D 15N NMR until we have clear, high-resolution 15N NMR
signals of SP-B.
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Chapter 5
Conclusions and future work
During my PhD studies, I employed computational simulations and solid state NMR
experiments to study two types of membrane-active proteins, antimicrobial peptides
(AMPs) and lung surfactant (LS) proteins. Chapter 1 provides a short, brief intro-
duction to definitions and methods I use in my thesis. In the first part of my stud-
ies (discussed in Chapter 2), I employed molecular dynamics simulations to study
two histidine-containing antimicrobial peptide paralogs (GAD-1 and GAD-2) derived
from cod, interacting with self-assembled bilayers. This work is published in BBA-
Biomembranes journal [1]. In the second part of my studies, I worked on compu-
tational (discussed in Chapter 3) and experimental (discussed in Chapter 4) studies
of pulmonary surfactant protein B interacting with lipid bilayers. In this chapter, I
provide a short summary of my studies in each chapter of my thesis along with ideas
for future work. A shorter version of chapter 3 (mainly the all-atom force field simu-
lations) is accepted to be published as an article in BBA-Biomembranes journal [2].
177
5.1 Computational Simulations of AMPs
In my first project, I worked on GAD-1 and GAD-2 antimicrobial peptide paralogs
derived from codfish [3–6]. Since our peptides were rich in histidine (which is pH
sensitive), we used our peptides with both neutral and positively charged histidines.
In our MD simulations, following the method used by Salgado et al. [7] we used a self-
assembly method to set up our systems. Here, most systems formed a bilayer with a
stable pore in it, which lasted during the simulation time. The bilayer self-assembled
in the presence of a peptide, and thus the peptide could find low energy conformations
within the membrane without being biased by the initial system configuration. Thus,
the study did not address the steps involved in peptide-induced pore formation in a
well-formed membrane. The most interesting result of our simulations stemmed from
the observation that the N-terminus half of GAD peptides tended to interact with
the pore region of the lipid bilayer. We indicated that this preference was related
to the position of histidine pairs in the sequence of peptides, not the other types of
charged pairs, e.g. histidine-arginine. In this work, we discussed that due to the
constrained structure of histidines (regardless of whether the histidine is neutral or
positively charged), the more aqueous pore regions provided an energetically more
favourable site for the histidine pairs.
This work could be extended by running the simulations much longer for the
protein structures to converge and reach an equilibrium [8]. Future studies could
include simulating the GAD peptides in an aqueous environment, i.e., without lipids.
This will provide another point of comparison of structure with experiment, and
may be important as AMP’s are transported throughout the body via the blood.
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The results could be compared to the ones experimentaly studied by McDonald, et
al. [9]. To explore the peptide-induced pore formation steps, rather than using self-
assembly method employed in chapter 2, we could run new sets of simulations, and
place peptides inside, half inside and outside a pre-formed lipid bilayer, similar to my
simulations in Chapter 3. In order to study GADs in multimeric structures, we can
run our systems with more than a single peptide in each simulation box, similar to
Mihajlovic et al. [10], in which they used two pre-assembled toroidal and cylindrical
pores and place their proteins inside the pore. They indicated that the type of the
pore strongly depends on the charge of the protein. In this way, we could study
the ability of our antimicrobial peptides to form multimers, as well as importance
of pH change in the change of pore preference. Simulating both GAD-1 and GAD-2
peptides together could provide insight on whether and how these two peptides could
function synergistically.
In another study, Kim et al. [11], used gramicidin A antimicrobial peptide in
monomeric and dimeric structures to study the pore formation in diﬀerent lipid types.
They studied the influence of hydrophobic mismatch on the pore type. Similarly,
we could use more complex lipid mixtures, e.g. by adding negatively-charged lipid
molecules like PG (which is more frequent in bacterial membranes) and other lipid
types to study the importance of hydrophobic mismatch and charge preference of
our AMPs. In addition to placing our peptides inside the lipid bilayer, we can put
them randomly in the simulation box, similarly to Leontiadou et al. [12], where they
studied the eﬀect of magainin MG-H2 peptide aggregation on pore formation. In
their studies they placed their peptide randomly near the bilayer surface. After
running their simulations, peptides bound to the bilayer and aggregated to form a
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pore, while the non-aggregated peptides remained parallel to the membrane. As
another suggestion, we can compare our computational results with the solid state
NMR results currently being performed by Gagandeep Sandhu in our group, similar
to the work of Pino-Angeles et al. [8] and Thogersen et al. [13]. In these studies,
they run long time simulations of multimers of AMPs in pre-assembled bilayers and
compare their structure with the experimental ones.
To use other methods of simulation, in addition to replica exchange MD simula-
tions (which is explained in Chapter 3) we can use Coarse-Grained (CG) force fields
to run our simulations for a long time and convert the equilibrated system to all-atom
simulation, similar to Thogersen et al. [13], in which they run their simulations in CG
and convert it to all-atom to run for 50 ns. To characterize the free energy of pore
formation, we could use umbrella sampling method similar to the work of Mirjalili et.
al. [14].
5.2 Computational Simulations of SP-B
In Chapter 3, I worked on computational studies of pulmonary surfactant protein SP-
B interacting with lipid bilayers. Here, I used MD (employing OPLS-AA [15,16] and
PACE [17,18] force fields) and REMD (employing PACE force field) methods to run
my simulations. Since the 3D structure of SP-B is unknown, I constructed my model
of SP-B, based on the structure of Mini-B (construct of SP-B with known experimen-
tal structure) with the help of homology models of NK-lysin [19] and Saposin-C [20,21]
and theoretical predictions on the structure of SP-B. For each simulation, I used a
monomer of SP-B in open and V-shaped bent structures, initially placed inside, half
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inside and outside the POPC lipid bilayer. Most of the OPLS-AA MD simulations
ran for 2–2.5 µs while all MD and REMD simulations using PACE force field ran for
3 µs.
Our all-atom MD simulations provides us with energetically feasible structures
of SP-B within or near bilayer. Besides, final structures fine-tune the secondary
structure predicted by our model. The interesting result in our simulation was that
the central loop and R52 region can help promote non-lamellar lipid structures and
structural plasticity and salt bridges play an important role in SP-B/lipid interactions.
In our PACE simulations (MD and REMD), proteins are mainly parallel to the lipid
bilayer. In these simulations, the proteins lack the plasticity in the structure, which
prevents them form producing bent structure. In these PACE simulations, the first
7 residues lack the helicity structure. Despite the similarity in the results of the
MD and REMD simulations, REMD simulations provide transmembrane structures,
which are not supported by NMR experiments [22].
One thing that the PACE simulations showed was the unwinding of the helicity
results indicated of first 7 residues in the protein. We can improve our initial model of
protein, using results obtained in my simulations, e.g. remove helicity from the ERYS
sequence in helix-IV, or even use other hypotheses in the literature, e.g. construct the
first seven residues of the protein N-terminal in a random coil structure. Moreover,
to enhance the setup procedure, in addition to the open and bent structures, we
can use a closed structure as an initial structure for SP-B. For these simulations, we
can obtain our initial structure from a closed structure, formed at the end of the
open-out and/or bent-out simulations and place it inside, half inside and outside the
lipid bilayer. Besides, considering that SP-B may be functional in dimeric and/or
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multimeric structures, our new simulations could contain dimer(s) of SP-B similar
to Baoukina et al.’s coarse-grained simulations [23], where they studied the role of
SP-B monomers in the fusion of two lipid vesicles, in the presence of SP-C proteins.
In their simulations they randomly placed the proteins in their system and ran it for
> 5 µs. Although their simulations lacked the details of SP-B’s role owing to their
use of the MARTINI coarse-grained force field [24–26], their results indicated that the
presence of SP-B facilitates the the fusion of vesicles with each other. Moreover, to
mimic the lung surfactant lipids in our simulations better, we can use more complex
lipid mixtures by adding DPPC and POPG lipid molecules, which are present in the
lung lipid contents. We can also produce more complex lipid structures by adding
monolayers of lipid into our simulation system, similar to Baoukina et al. [27], where
they studied diﬀusion of two lipid vesicles and a lipid bicelle into lipid monomers in
the presence of SP-B monomers and dimers. After being familiar with the system,
we can run our simulations using bilayer self-assembly methods, similar to the works
in Chapter 2. Depending on the system size, self-assembly method could consume a
high amount of simulation time. However, this method could provide information on
more favoured environments for SP-B within or near a lipid bilayer.
5.3 Solid State NMR Experiments on SP-B
In Chapter 4, I followed up on my studies of SP-B interacting with lipid bilayers.
Here, instead of using computational simulations, I used 15N, 2H and 31P solid-state
NMR experiments to study my system. In Chapter 4, the goal was to compare
the experimental NMR spectrum with the computational results from Chapter 3. I
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used an 15N-labelled SP-B sample, which was recombinantly expressed in our group.
Unfortunately, I was unable to obtain any 15N NMR signal from my oriented pro-
tein+lipid sample, most probably owing to the insuﬃcient amount of protein in my
NMR samples. Although I could not reach the final goal of this chapter, my work
presented information that could be helpful for similar systems. In order to compare
with experiments, I calculated 15N NMR spectra of SP-B, based on the computation-
ally predicted SP-B structures of chapter 3 using the method introduced in ref. [28]
(the procedure is described in Chapter 4 and Appendix B).
In addition to improving the eﬃciency of SP-B purification, to get more reliable
results in future experiments, we should use more complex lipid mixtures in our
samples, e.g. by adding DPPC and POPG lipid molecules, which mimic the LS lipid
contents better. The computational structures could provide information on how
to specifically label SP-B in order to gain detailed structure of my system. Here,
we can label residues, which are predicted to be present in a specific helical region
and see if the helix exists. The code I employed to predict NMR spectra from my
simulations could be used for other proteins, e.g. GAD-1 and GAD-2. This could help
reveal information on the orientation of GAD peptides, currently being studied by
Gagandeep Sandhu employing solid-state NMR. Here, one could construct a predicted
structure of GADs and rotate it in diﬀerent orientations with respect to lipid bilayer
to calculate the NMR spectrum.
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Appendix A
GROMACS input files
To run MD simulations using GROMACS, we should prepare the simulation box by
energy minimization, NVT and finally NPT steps. In the first step, we should apply
a force field of our choice to the protein, using pdb2gmx command. This force field
could be one of the default force fields of GROMACS or a new (or customized) force
field, which you have installed in the force fields folder (if you use the default path way
in GROMACS installation it should be in: /usr/local/gromacs/share/gromacs/top).
After this step, GROMACS makes a “.itp” file, which contains the force field details
applied to our system, a “.top” file, which contains the topology of details of our
system and a “.gro” file, which contains details of system size and the position of each
particle in our system. If our system contains lipid bilayers, we should manually add
the corresponding files of the bilayer to the .gro, .top and .itp files. After adding
the bilayer, we should add solvent and ions to our system. In this step, the whole
content of the simulation box is complete and we are ready to run energy minimize the
system. To run MD simulations, GROMACS need a “.mdp” file, which contains details
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of simulation like running parameters, output control, bond parameters, neighbour
searching methods, electrostatics, temperature and pressure couplings.
An example of a .top file, while the system is ready to run MD simulation is as
follow:
; Include forcefield parameters
#include “oplsaa.ﬀ/forcefield.itp”
#include “lipid_se_oplsaa_LM_Nov06.itp”
#include “POPC_LM_Nov2006.itp”
#include “spb.itp”
; Include Position restraint file
#ifdef POSRES
#include “spb_porse.itp”
#endif
; Include water topology
#include “oplsaa.ﬀ/tip4p.itp”
#ifdef POSRES_WATER
; Position restraint for each water oxygen
[ position_restraints ]
; i funct fcx fcy fcz
1 1 1000 1000 1000
#endif
; Include topology for ions
#include “oplsaa.ﬀ/ions.itp”
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[ system ]
; Name
SP-B and POPC in water
[ molecules ]
; Compound
Protein 1
POPC 496
SOL 38000
CL 7
An example of a .mdp file, while the system is ready to run NPT simulation is as
follow:
define = -DFLEXIBLE ; position restrain the protein
include = -I../include ; include directory with itp files
; Run parameters
integrator = md ; leap-frog integrator
nsteps = 3000000000 ; 0.001 * 500000 = 500 ps
dt = 0.002 ; 2 fs
; Output control
nstxout = 500000 ; save coordinates every 0.5 ps
nstvout = 500000 ; save velocities every 0.5 ps
nstenergy = 500000 ; save energies every 0.5 ps
nstlog = 500000 ; update log file every 0.5 ps
; Bond parameters
continuation = no ; Restarting after NVT
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constraint_algorithm = lincs ; holonomic constraints
constraints = all-bonds ; all bonds (even heavy atom-H bonds) constrained
lincs_iter = 1 ; accuracy of LINCS
lincs_order = 3 ; also related to accuracy
; Neighborsearching
ns_type = grid ; search neighboring grid cels
nstlist = 5 ; 10 fs
rlist = 1.2 ; short-range neighborlist cutoﬀ (in nm)
rcoulomb = 1.2 ; short-range electrostatic cutoﬀ (in nm)
rvdw = 1.2 ; short-range van der Waals cutoﬀ (in nm)
; Electrostatics
coulombtype = PME ; Particle Mesh Ewald for long-range electrostatics
pme_order = 4 ; cubic interpolation
fourierspacing = 0.15 ; grid spacing for FFT
; Temperature coupling is on
tcoupl = Nose-Hoover ; More accurate thermostat
tc-grps = Protein POPC CL SOL ; three coupling groups - more accurate
tau_t = 0.1 0.1 0.1 0.1 ; time constant, in ps
ref_t = 310 310 310 310 ; reference temperature, one for each group, in K
; Pressure coupling is on
pcoupl = Parrinello-Rahman ; Pressure coupling on in NPT
pcoupltype = semiisotropic ; uniform scaling of x-y-z box vectors
tau_p = 5.0 ; time constant, in ps
ref_p = 1 1 ; reference pressure, x-y, z (in bar)
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compressibility = 4.5e-5 4.5e-5 ; isothermal compressibility, barˆ-1
; Periodic boundary conditions
pbc = xyz ; 3-D PBC
; Selection of energy groups =
energygrps = Protein POPC CL SOL
; Dispersion correction
DispCorr = EnerPres ; account for cut-oﬀ vdW scheme
; Velocity generation
gen_vel = yes ; Velocity generation is oﬀ
gen_temp = 310 ; temperature for Maxwell distribution
gen_seed = -1 ; generate a random seed
; COM motion removal
; These options remove motion of the protein/bilayer relative to the solvent/ions
nstcomm = 1
comm-mode = Linear
comm-grps = Protein POPC CL SOL
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Appendix B
Mathematica calculations
I used MATHEMATICA v.9 to write my code based on Equation 4.2 in Chapter 3.
The code is as follows (comments are in italics inside parentheses below each line of
code):
Remove["Global‘*"]
(*This line removes all the previously saved symbols in the MATHEMATICA code,
which allows us to reevaluate of the entire code, while run it each time. *)
SetDirectory[“Directory name”]
(*This line sets your input files directory to be reached. *)
FN = FileNames[“N–H_*”];
(*This line calls the N–H input files as “FN”. *)
alldata = Map[Import[#, “Table”] &, FN];
(*This line imports “FN” data in “alldata” for each time steps. *)
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Do[ Do[ cos✓i,j =
alldata[[i, j,3]]
.q 
alldata[[i, j, 1]]2 + alldata[[i, j, 2]]2 + alldata[[i, j, 3]]2
 
,
{j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
(*This line calculates the cos⇥ values of N–H vectors as described in Figure 4.1-
A.*)
value = {65, 85, 230};
Do[ Do[  11i,j = value [[1]], {j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
Do[ Do[  22i,j = value [[2]], {j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
Do[ Do[  33i,j = value [[3]], {j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
(*These lines inputs the  11,  22 and  33 values respectively.*)
Do[ Do[  paralleli,j =  33i,j, {j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
(*This line calculates  k based on Equation 4.2.*)
Do[ Do[  perpendiculari,j = 12*( 11i,j+ 22i,j)), {j, 1, Length[alldata[[i]]], 1}], {i,
1, Length[FN], 1}];
(*This line calculates  ? based on Equation 4.2.*)
Do[ Do[  zzi,j = (  paralleli,j– perpendiculari,j)*cos2✓+  perpendiculari,j, {j, 1,
Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
(*This line calculates  zz based on Equation 4.2.*)
Do[ Do[ filei,j = NormalDistribution [ zzi,j, 2.5],
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{j, 1, Length[alldata[[i]]], 1}], {i, 1, Length[FN], 1}];
(*This lines applies a normal distribution with standard deviation of 2.5 to the
 zz values.*)
reverseplot= ListLinePlot[ Table[ Sum[ Sum[ PDF[ filei,j, x], {j, 1, Length[alldata[[i]]],
1}], {i,1, Length[FN], 1}], {x, 0, 250}], ScalingFunctions ! {“Reverse”, Identity},
TicksStyle ! Directive[FontSize ! 28], Axes !{True, False},
AxesLabel ! {Style[“ppm”, Black, FontSize! 32], “ ”},
PlotRange ! {{0, 240}, {0, 30}}, ImageSize !Large]
(*This line plots the  zz spetra for all the N–H input values for all time steps.*)
Export[“spectra.pdf”, reverseplot]
(*This line exports the  zz (15N) spectra plot as a pdf file.*)
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